<HTML><HEAD>
<!-- This document was created from RTF source by rtftohtml version 3.8 -->
<TITLE>HL7 V2.2 Chapter 7</TITLE></HEAD>
<BODY BACKGROUND="" BGCOLOR="#FFFFFF" TEXT="#000000">

<H1>
References to other Chapters
</H1>
<A HREF="hl7.html">Index HL7</A><br>
<A HREF="hl7chp1.html">Chapter 1</A><br>
<A HREF="hl7chp2.html">Chapter 2</A><br>
<A HREF="hl7chp3.html">Chapter 3</A><br>
<A HREF="hl7chp4.html">Chapter 4</A><br>
<A HREF="hl7chp5.html">Chapter 5</A><br>
<A HREF="hl7chp6.html">Chapter 6</A><br>
<A HREF="hl7chp8.html">Chapter 8</A><br>

<hr>

<p>

<H1>
7</H1>
<UL>
<LI><A HREF="#Heading1">7 </A>
<UL>
<LI><A HREF="#Heading2">7.1 INTRODUCTION AND OVERVIEW</A>
<UL>
<LI><A HREF="#Heading3">7.1.1 Glossary</A>
<LI><A HREF="#Heading4">7.1.2  Narrative reports as batteries with many OBX results   </A>
<LI><A HREF="#Heading5">7.1.3  Suffixes for defining observation IDs  for common components of narrative reports</A>
<UL>
<LI><A HREF="#Heading6">7.1.3.1 Diagnostic impressions (IMP)</A>
<LI><A HREF="#Heading7">7.1.3.2 Recommendations (REC)</A>
<LI><A HREF="#Heading8">7.1.3.3 Confirming procedure (CNP)</A>
<LI><A HREF="#Heading9">7.1.3.4 Procedure medication (MED)</A>
<LI><A HREF="#Heading10">7.1.3.5 Anatomic site (ANT)</A>
<LI><A HREF="#Heading11">7.1.3.6 Devices (DEV)</A>
<LI><A HREF="#Heading12">7.1.3.7 Gross or general description (GDT)</A>
<LI><A HREF="#Heading13">7.1.3.8 Secondary or microscopic description (MDT)</A>
<LI><A HREF="#Heading14">7.1.3.9 Technician comment (TCM)</A>
<LI><A HREF="#Heading15">7.1.3.10 Addendum note (ADT) </A>
<LI><A HREF="#Heading16">7.1.3.11 Diagnosis (problem) onset date-time (ITM). </A>
<LI><A HREF="#Heading17">7.1.3.12 Diagnosis (problem) resolution date-time (RTM). </A>
<LI><A HREF="#Heading18">7.1.3.13 Comparison study (CMS) </A>
<LI><A HREF="#Heading19">7.1.3.14 Comparison date-time (CMT) </A>
<LI><A HREF="#Heading20">7.1.3.15 Comparison results (CMR) </A>
<LI><A HREF="#Heading21">7.1.3.16 Comparison change (CMC) </A>
<LI><A HREF="#Heading22">7.1.3.17 Predicted (PRD) </A>
<LI><A HREF="#Heading23">7.1.3.18 Percent of predicted (PPR) </A>
<LI><A HREF="#Heading24">7.1.3.19 After drug observed (AFD) </A>
<LI><A HREF="#Heading25">7.1.3.20 Predicted value after drug (ADP) </A>
<LI><A HREF="#Heading26">7.1.3.21 Percent predicted after drug (APP) </A>
<LI><A HREF="#Heading27">7.1.3.22 Expanded AS4 codes </A>
</UL>
<LI><A HREF="#Heading28">7.1.4  Identifying reporting units  </A>
<UL>
<LI><A HREF="#Heading29">7.1.4.1 Background</A>
<LI><A HREF="#Heading30">7.1.4.2 ISO and ANSI customary units abbreviations </A>
<LI><A HREF="#Heading31">7.1.4.3 Local unit codes</A>
</UL>
</UL>
<LI><A HREF="#Heading32">7.2  MESSAGE DEFINITIONS </A>
<UL>
<LI><A HREF="#Heading33">7.2.1  ORU - unsolicited transmission of an observation </A>
<LI><A HREF="#Heading34">7.2.2  Query for results of observation    </A>
<UL>
<LI><A HREF="#Heading35">7.2.2.1 Query usage notes</A>
</UL>
</UL>
<LI><A HREF="#Heading36">7.3  SEGMENTS </A>
<UL>
<LI><A HREF="#Heading37">7.3.1  OBR - Observation request  -</A>
<LI><A HREF="#Heading38">7.3.2  OBX - Observation/Result segment -</A>
<UL>
<LI><A HREF="#Heading39">7.3.2.1 Set ID - observation simple (SI) 00569</A>
<LI><A HREF="#Heading40">7.3.2.2 Value type (ID) 00570</A>
<LI><A HREF="#Heading41">7.3.2.3 Observation Identifier (CE) 00571</A>
<LI><A HREF="#Heading42">7.3.2.4 Observation Sub-ID (ST) 00572</A>
<LI><A HREF="#Heading43">7.3.2.5 Observation value  (*) 00573</A>
<LI><A HREF="#Heading44">7.3.2.6 Units (CE) 00574</A>
<LI><A HREF="#Heading45">7.3.2.7 References range (ST) 00575  </A>
<LI><A HREF="#Heading46">7.3.2.8 Abnormal flags (ID) 00576</A>
<LI><A HREF="#Heading47">7.3.2.9 Probability (NM) 00577</A>
<LI><A HREF="#Heading48">7.3.2.10 Nature of abnormal test (ID) 00578</A>
<LI><A HREF="#Heading49">7.3.2.11 Observ result status (ID) 00579</A>
<LI><A HREF="#Heading50">7.3.2.12 Effective date last obs normal value (TS) 00580</A>
<LI><A HREF="#Heading51">7.3.2.13 User defined access checks  (ST) 00581</A>
<LI><A HREF="#Heading52">7.3.2.14 Date-time of the observation  (TS) 00582</A>
<LI><A HREF="#Heading53">7.3.2.15 Producer's ID (CE) 00583</A>
<LI><A HREF="#Heading54">7.3.2.16 Responsible Observer (CN) 00584</A>
</UL>
</UL>
<LI><A HREF="#Heading55">7.4  EXAMPLE TRANSACTIONS </A>
<UL>
<LI><A HREF="#Heading56">7.4.1  Query/response </A>
<LI><A HREF="#Heading57">7.4.2  Unsolicited </A>
<LI><A HREF="#Heading58">7.4.3 Example message (from ASTM 1238-91)</A>
<LI><A HREF="#Heading59">7.4.4  Example of narrative report messages (from ASTM 1238-91) </A>
<LI><A HREF="#Heading60">7.4.5  Reporting cultures and sensitivities </A>
<UL>
<LI><A HREF="#Heading61">7.4.5.1 Culture battery/report representation</A>
<LI><A HREF="#Heading62">7.4.5.2 Sensitivity battery/report representation</A>
<LI><A HREF="#Heading63">7.4.5.3 Identification of the organism for a sensitivity battery</A>
</UL>
<LI><A HREF="#Heading64">7.4.6  Results reporting </A>
<LI><A HREF="#Heading65">7.4.7  Patient-specific clinical data with an order -</A>
</UL>
<LI><A HREF="#Heading66">7.5  OUTSTANDING ISSUES </A>
<LI><A HREF="#Heading67">7.6  (Informative)   Universal (AS4) Identifiers for Common Test Battery  </A>
<UL>
<LI><A HREF="#Heading68">7.6.1  Components That Do Not Have Uniquely Defined CPT-4 Codes  -</A>
<LI><A HREF="#Heading69">7.6.2  General Approach </A>
<LI><A HREF="#Heading70">7.6.3  Message Structure </A>
<LI><A HREF="#Heading71">7.6.4  OM1 - General Segment (Fields That Apply to Most Observations) </A>
<UL>
<LI><A HREF="#Heading72">7.6.4.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading73">7.6.4.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading74">7.6.4.3 Producer's Test/Observation ID (CE) 00587</A>
<LI><A HREF="#Heading75">7.6.4.4 Permitted Data Types (ID) 00588</A>
<LI><A HREF="#Heading76">7.6.4.5 Specimen Required (ID) 00589</A>
<LI><A HREF="#Heading77">7.6.4.6 Producer ID (CE) 00590</A>
<LI><A HREF="#Heading78">7.6.4.7 Observation Description (TX) 00591</A>
<LI><A HREF="#Heading79">7.6.4.8 Other Test/Observation IDs for the Observation (CE) 00592</A>
<LI><A HREF="#Heading80">7.6.4.9 Other Names (Recognized by the Producer for the Observation) (ST) 00593</A>
<LI><A HREF="#Heading81">7.6.4.10 Preferred Report Name for the Observation (ST) 00594</A>
<LI><A HREF="#Heading82">7.6.4.11 Preferred Short Name or Mnemonic for the Observation (ST) 00595</A>
<LI><A HREF="#Heading83">7.6.4.12 Preferred Long Name for the Observation (ST) 00596</A>
<LI><A HREF="#Heading84">7.6.4.13 Orderability (ID) 00597</A>
<LI><A HREF="#Heading85">7.6.4.14 Identity of Instrument Used to Perform This Study (CE) 00598</A>
<LI><A HREF="#Heading86">7.6.4.15 Coded Representation of Method (CE) 00599</A>
<LI><A HREF="#Heading87">7.6.4.16 Portable (ID) 00600</A>
<LI><A HREF="#Heading88">7.6.4.17 Observation Producing Department/Section (ID) 00601</A>
<LI><A HREF="#Heading89">7.6.4.18 Telephone Number of Section (TN) 00602</A>
<LI><A HREF="#Heading90">7.6.4.19 Nature of Test/Observation (ID) 00603</A>
<LI><A HREF="#Heading91">7.6.4.20 Report Subheader (CE) 00604</A>
<LI><A HREF="#Heading92">7.6.4.21 Report Display Order (ST) 00605</A>
<LI><A HREF="#Heading93">7.6.4.22 Date/Time Stamp for Any Change in Definition for the Observation (TS) 00606</A>
<LI><A HREF="#Heading94">7.6.4.23 Effective Date/Time of Change in Test Procedure That Make Results Non-Comparable (TS) 00607</A>
<LI><A HREF="#Heading95">7.6.4.24 Typical Turn-around Time from Receipt of Specimen/Subject to Result Produced (NM)  00608</A>
<LI><A HREF="#Heading96">7.6.4.25 Processing Time (NM) 00609</A>
<LI><A HREF="#Heading97">7.6.4.26 Processing Priority (ID) 00610</A>
<LI><A HREF="#Heading98">7.6.4.27 Reporting Priority (ID) 00611</A>
<LI><A HREF="#Heading99">7.6.4.28 Outside Site(s) Where Observation May Be Performed (CE) 00612</A>
<LI><A HREF="#Heading100">7.6.4.29 Address of Outside Site(s) (AD) 00613</A>
<LI><A HREF="#Heading101">7.6.4.30 Phone number of outside site (TN) 00614 </A>
<LI><A HREF="#Heading102">7.6.4.31 Confidentiality Code (ID) 00615</A>
<LI><A HREF="#Heading103">7.6.4.32 Observations Required to Interpret This Observation (CE) 00616</A>
<LI><A HREF="#Heading104">7.6.4.33 Interpretation of Observations (TX) 00617</A>
<LI><A HREF="#Heading105">7.6.4.34 Contraindications to Observations (CE) 00618</A>
<LI><A HREF="#Heading106">7.6.4.35 Reflex Tests/Observations (CE) 00619</A>
<LI><A HREF="#Heading107">7.6.4.36 Rules That Trigger Reflex Testing (TX) 00620</A>
<LI><A HREF="#Heading108">7.6.4.37 Fixed Canned Message (CE) 00621</A>
<LI><A HREF="#Heading109">7.6.4.38 Patient Preparation (TX) 00622</A>
<LI><A HREF="#Heading110">7.6.4.39 Procedure Medication (CE) 00623</A>
<LI><A HREF="#Heading111">7.6.4.40 Factors That May Effect the Observation (TX) 00624</A>
<LI><A HREF="#Heading112">7.6.4.41 Test/Observation Performance Schedule (ST) 00625</A>
<LI><A HREF="#Heading113">7.6.4.42 Description of Test Methods (May Include Bibliographic Citations) (TX) 00626</A>
</UL>
<LI><A HREF="#Heading114">7.6.5  OM2 - Numeric Observation Segment </A>
<UL>
<LI><A HREF="#Heading115">7.6.5.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading116">7.6.5.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading117">7.6.5.3 Units of Measure (CE) 00627</A>
<LI><A HREF="#Heading118">7.6.5.4 Range and Decimal Precision (NM) 00628</A>
<LI><A HREF="#Heading119">7.6.5.5 Corresponding SI Units of Measure (CE) 00629</A>
<LI><A HREF="#Heading120">7.6.5.6 SI Conversion Factor (TX) 00630</A>
<LI><A HREF="#Heading121">7.6.5.7 Reference (Normal) Range for Ordinal and Continuous Observations (CM) 00631</A>
<UL>
<LI><A HREF="#Heading122">7.6.5.7.1  The Reference (Normal) Range</A>
<LI><A HREF="#Heading123">7.6.5.7.2 Sex</A>
<LI><A HREF="#Heading124">7.6.5.7.3 Age Range</A>
<LI><A HREF="#Heading125">7.6.5.7.4 Gestational Age Range</A>
<LI><A HREF="#Heading126">7.6.5.7.5 Species</A>
<LI><A HREF="#Heading127">7.6.5.7.6 Race/Subspecies</A>
<LI><A HREF="#Heading128">7.6.5.7.7 Conditions</A>
<LI><A HREF="#Heading129">7.6.5.7.8 Examples</A>
</UL>
<LI><A HREF="#Heading130">7.6.5.8 Critical Range for Ordinal and Continuous Observations (CM) 00632</A>
<LI><A HREF="#Heading131">7.6.5.9 Absolute Range for Ordinal and Continuous Observations (CM) 00633</A>
<LI><A HREF="#Heading132">7.6.5.10 Delta Check Criteria (CM) 00634</A>
<LI><A HREF="#Heading133">7.6.5.11 Minimum Meaningful Increments (NM) 00635</A>
</UL>
<LI><A HREF="#Heading134">7.6.6  OM3 - Categorical Test/Observation Segment </A>
<UL>
<LI><A HREF="#Heading135">7.6.6.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading136">7.6.6.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading137">7.6.6.3 Preferred Coding System (ID) 00636</A>
<LI><A HREF="#Heading138">7.6.6.4 Valid Coded "Answers" (CE) 00637</A>
<LI><A HREF="#Heading139">7.6.6.5 Normal Text/Codes for Categorical Observations (CE) 00638</A>
<LI><A HREF="#Heading140">7.6.6.6 Abnormal Text/Codes for Categorical Observations (CE) 00639</A>
<LI><A HREF="#Heading141">7.6.6.7 Critical Abnormal Text/Codes for Categorical Observations (CE) 00640</A>
<LI><A HREF="#Heading142">7.6.6.8 Data Type (ID) 00641</A>
</UL>
<LI><A HREF="#Heading143">7.6.7  OM4 - Observations That Require Specimens </A>
<UL>
<LI><A HREF="#Heading144">7.6.7.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading145">7.6.7.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading146">7.6.7.3 Derived Specimen (ID) 00642</A>
<LI><A HREF="#Heading147">7.6.7.4 Container Description (TX) 00643</A>
<LI><A HREF="#Heading148">7.6.7.5 Container Volume (NM) 00644</A>
<LI><A HREF="#Heading149">7.6.7.6 Container Units (CE) 00645</A>
<LI><A HREF="#Heading150">7.6.7.7 Specimen (CE) 00646</A>
<LI><A HREF="#Heading151">7.6.7.8 Additive (CE) 00647</A>
<LI><A HREF="#Heading152">7.6.7.9 Preparation (TX) 00648</A>
<LI><A HREF="#Heading153">7.6.7.10 Special Handling Requirements (TX) 00649</A>
<LI><A HREF="#Heading154">7.6.7.11 Normal Collection Volume (CQ) 00650</A>
<LI><A HREF="#Heading155">7.6.7.12 Minimum Collection Volume (CQ) 00651</A>
<LI><A HREF="#Heading156">7.6.7.13 Specimen Requirements (TX) 00652</A>
<LI><A HREF="#Heading157">7.6.7.14 Specimen Priorities (ID) 00653</A>
<LI><A HREF="#Heading158">7.6.7.15 Specimen Retention Time (CQ) 00654</A>
</UL>
<LI><A HREF="#Heading159">7.6.8  OM5 - Observation Batteries (Sets) </A>
<UL>
<LI><A HREF="#Heading160">7.6.8.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading161">7.6.8.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading162">7.6.8.3 Tests/Observations Included Within an Ordered Test Battery (CE) 00655</A>
<LI><A HREF="#Heading163">7.6.8.4 Observation ID Suffixes (ST) 00656</A>
</UL>
<LI><A HREF="#Heading164">7.6.9  OM6 - Observations That Are Calculated from Other Observations </A>
<UL>
<LI><A HREF="#Heading165">7.6.9.1 Segment Type ID (ST) 00585</A>
<LI><A HREF="#Heading166">7.6.9.2 Sequence Number (NM) 00586</A>
<LI><A HREF="#Heading167">7.6.9.3 Derivation Rule (TX) 00657</A>
</UL>
</UL>
</UL>
</UL>
<hr size=4>
<p><br>
</p>

<h1>
<A NAME="Heading1">7 </A></h1>

<p>Observation
Reporting</p>
<h2>
</h2>

<h2>
<A NAME="Heading2">7.1 INTRODUCTION AND OVERVIEW</A></h2>

<p><br>
This chapter describes the transaction set required for sending structured
patient oriented clinical data from one computer system to another.  A common
use of these transaction sets will be to transmit observations and results of
diagnostic studies from the producing system (e.g., clinical laboratory system,
EKG system) (the filler), to the ordering system (e.g., HIS order entry,
physician's office system) (the placer).  However, the transaction set is not
limited to such transactions.  Observations can be sent from producing systems
to archival medical record systems ( not necessarily the order placer) and from
such medical record systems to other systems that were not part of the ordering
loop, e.g., an office practice system of the referring physician for inpatient
test results ordered by an inpatient surgeon.<br>
These transaction sets permit the transmission of any kind of clinical
observations including (but not limited to) clinical laboratory results, the
results of imaging studies (excluding the image), EKG pulmonary function
studies, measures of patient status and condition, vital signs, Intake and
output, severity and/or frequency of symptoms, drug allergies, problem lists,
diagnostic lists, physician and nursing history, physicals, progress notes,
operative notes and so on.  These transaction sets carry information that is
reported as text, numeric or categorical values.  These messages do not carry
the images or tracings themselves. (See ACR NEMA Publication 300-1988<i>
Digital Imaging and Communications Standard</i>, for image standards, and ASTM
E1467.91 <i> Standard specification for transferring digital neurophysiological
data between independent computer systems</i>, for transmitting EEG and EMG
tracings.)<br>
An observation can be one of many data types.  The main ones are text, numbers
and codes. This provides the flexibility needed to transmit observations that
are recorded as continuous values (e.g., glucose, diastolic blood pressure), as
categorical values, e.g., patient position (sitting, reclining or standing),
VDRL (reactive, weakly reactive or nonreactive), or as text. An entire History
and Physical could be transmitted as an observation whose value is one large
chunk of formatted text.<br>
This chapter provides mechanisms for transmitting <i>structured</i>,
record-oriented reports.  This means that individual observations are
transmitted as separate logical entities (objects), and within this entity,
separate fields are defined for identifying the observation, its values, its
units, normal ranges, etc, such that the receiving system can "understand,"
reorganize and/or react to the contents of these messages.  Structured reports
are to be distinguished from text oriented reports which can also be
transmitted via HL7 using the UDM message described in Chapter 2.  The latter
are ASCII images of nonstandard printed reports intended for display to humans.
For practical purposes their contents are not "understandable" to the computer.
<br>
Observations may be transmitted in a solicited (in response to a query) or
unsolicited mode.  In the solicited mode, a user requests a set of observations
according to criteria transmitted by the user. The sending system responds with
existing data to satisfy the query (subject to access controls).  Queries do
not elicit new observations by the target system, they simply retrieve "old"
observations. (See Chapter 2 for full discussion of the query transmission.)<br>
The unsolicited mode is used primarily to transmit the values of new
observations. It is the mode used by producing services to return the values of
observations requested by an ordering system.  A laboratory system, for
example, would usually send the results of an AM electrolytes to the ordering
HIS via the unsolicited mode.  An intensive care system would send the blood
pressures to the same HIS by the same mode.  Calling such transactions
unsolicited may sound like a misnomer, but is not.  The placing service
solicits the producing service to make the observation.  It could also (through
a query) solicit the value of that observation after it has been made.
However, such an approach would demand continuous polling of the producing
system until the result was produced.  Using the unsolicited mode, the
producing service returns the value of an observation as soon as it is
available.  The unsolicited mode can also be used to transmit new results to a
system (e.g. an archival medical record system) that did not order the
observation.  The transactions that define these modes are more fully described
in Section 7.2.<br>
Observations are usually ordered and reported as sets (batteries) of many
separate observations. Physicians order electrolytes (consisting of sodium,
potassium, chloride, bicarbonate) or vitals (consisting of diastolic blood
pressure, systolic blood pressure, pulse, and temperature).  Moreover, tests
that we may think of as single entity, e.g., cardiac echo, usually yield
multiple separate measurements, e.g. left ventricular diameter, left atrial
diameter, etc.  Moreover, observations that are usually reported as text (e.g.
the review of systems from the history and physical) can also be considered a
set of separately analyzable units (e.g. cardiac history, pulmonary history,
genito-urinary history, etc).  We strongly suggest that all "text" clinical
reports be broken down into such separate analyzable entities and that these
individual entities be transmitted as separate OBX segments.  Because many
attributes of a set of observations taken at one time will be identical, one
OBR segment serves as a header for the report and carries the information that
applies to all of the individual observations in the set.  In the case of
ordered observations, the OBR segment is a "turn-around document" like the
manual request forms it replaces.  It carries information about the order to
the producing service; a copy of the OBR with additional fields completed is
returned with the observations to the requesting service.  <br>
Not all observations are preceded by an order.  However, all observations
whether explicitly ordered or initiated without an order are reported with an
OBR segment as the report header.<br>
The major segments (OBR, OBX) defined in this chapter, their fields, and the
code tables have been defined in collaboration with ASTM E31.11 with the goal
of keeping HL7 observation transmission the same as ASTM E1238 in pursuit of
the goals of ANSI HISPP and the Message Standards Developers Subcommittee.
(Many sections of this chapter have been taken with permission directly from
the E1238-91 document and vice versa in pursuit of those goals).   <br>
The OBR segment provides information that applies to all of the observations
that follow.  It includes a field that identifies a particular battery (or
panel or set) of observations (e.g., electrolytes, vital signs or Admission
H&amp;P).  For simplicity we will refer to the observation set as the battery.
The battery usually corresponds to the entity that is ordered or performed as a
unit. (In the case of a query, observation sets may be a more arbitrary
collection of observations.)  The OBX segment provides information about a
single observation, and it includes a field that identifies that single
observation (e.g., potassium, diastolic blood pressure or admission diagnosis).
Both of these fields assume master tables that define coding systems (the
universe of valid identifying codes) for batteries and observations,
respectively.  These tables will usually be part of the producing and sending
services application and (usually) include many other useful pieces of
information about the observation or battery.  HL7 and ASTM are currently
developing a segment for transmitting such master file information between
systems that produce and systems that use clinical information.  <br>
This standard does not require the use of a particular coding system to
identify either batteries or single observations.  These are often defined
locally, within a single institution or consortium of institutions.  However,
they may be based on an externally defined coding standard.  Chapter 2's
discussion of CE data types indicates how to identify the battery and
observation coding system.  We encourage the use of universal coding systems
when they are available (see Figure 2-2 of Chapter 2) to facilitate the
exchange of clinical information between organizations (e.g., from physician's
office, to hospital or nursing home and back).  Moreover, we provide
suggestions about constructing codes for observations (such as the components
of the history and physical, EKG, cardiac cath, etc.) that are often not
included in either "universal" or local procedure coding systems.  These are
given in Appendix A of Chapter 7.  Most of these codes are presented as
extensions to the CPT4 code system.  But the same construction rules could be
used to extend any procedure code system. <br>
Many parts of this document (the discussion and tables defining units, the
discussion of the rules of mapping observations to OBX segments, many of the
examples at the end of the chapter, and Appendix 7.A), have been copied (with
permission) from ASTM E1238-91. <br>
As is true throughout this standard, the emphasis should be on the abstract
messages, defined without regard to the encoding rules.  The example messages,
however, are based upon the HL7 encoding rules.</p>
<h3>
</h3>

<h3>
<A NAME="Heading3">7.1.1 Glossary</A></h3>

<p><br>
<b>placer:</b>  Person or service that requests (places order for) an
observation battery, e.g., the physician, the practice, clinic, or ward
service, that orders a lab test, xray, vital signs, etc.  The meaning is
synonymous with, and used interchangably with, requestor.  See <i>ORC-3-placer
number</i>, Section 4.5.2.3.<br>
 <br>
<b>filler:</b>  Person, or service, who produces the observations (fills the
order) requested by the requestor.  The word is synonymous with "producer" and
includes diagnostic services and clinical services and care providers who
report observations about their patients.  The clinical laboratory is a
producer of lab test results (filler of a lab order), the nursing service is
the producer of vital signs observations (the filler of orders to measure vital
signs), and so on.  See <i>ORC-4-filler number</i>, Section 4.5.2.4.<br>
<b>battery:</b>  A set of one or more observations identified as by a single
name and code number, and treated as a shorthand unit for ordering or
retrieving results of the constituent observations.  Vital signs, electrolytes,
routine admission tests, and obstetrical ultrasound are all examples. Vital
signs (conventionally) consist of diastolic and systolic blood pressure, pulse,
and respiratory rate.  Electrolytes usually consist of Na+, K+, Cl-, and HCO3-.
Routine admission tests might contain CBC, Electrolytes, SMA12, and Urinalysis.
(Note that the elements of a battery for our purposes may also be batteries).
Obstetrical ultrasound is a battery made up of traditional component
measurements and the impression, all of which would be returned as separate
"results" when returned to the requestor.  In keeping with the mathematical
conventions about set, a battery can be a single observation. <br>
	The word battery is used in this specification synonymously with the word
profile or panel.  The individual observation elements within a battery may be
characteristic of a physiologic system (e.g., liver function tests), or many
different physiologic systems.  <br>
 <br>
<b>observation:</b>  A measurement of a single variable or a single value
derived logically and/or algebraically from other measured or derived values.
A test result, a diastolic blood pressure, and a single chest xray impression
are examples of observations. <br>
 <br>
<b>segment (record):</b>  A typed aggregate of data elements (fields)
describing one complete aspect of a message.  For example, the information
about one order is sent as type of segment (OBR), the information related to an
observation is sent as another segment (OBX).  <br>
 <br>
	The segment in a message is analogous to a record in a database, and in
previous versions of the standard we used record in place of the word segment.
We have changed the nomenclature to be consistent with HL7 and other standards
organizations in this version. <br>
 <br>
<b>field:</b>  One specific attribute of a segment, for example, patient
diagnosis, which may contain aggregates of data elements further refining the
basic attribute. <br>
 <br>
<b>repeated value:</b>  some fields may contain many repeat data elements.  For
example, the diagnoses field may contain many different diagnoses.<br>
<b>field components:</b>  a field entry may also have discernable parts or
components.  For example, the patient's name is recorded as last name, first
name, and middle initial, each of which is a distinct entity separated by a
component delimiter (sub-subfield in ASTM E1238-94 -- see footnote 15).</p>
<h3>
</h3>

<h3>
<A NAME="Heading4">7.1.2  Narrative reports as batteries with many OBX results   </A></h3>

<p><br>
	Narrative reports from services such as Radiology usually consist of a number
of subcomponents (e.g., a chest xray report may consist of a description, an
impression, and a recommendation).  Other studies, such as echocardiograms,
contain analogous components, as well as numeric observations (e.g., left
ventricular and diastolic diameter).  Surgical pathology reports may contain
information about multiple specimens and reports: the anatomic source, the
gross description, the microscopic description, and a diagnostic impression for
each specimen.  <br>
	The current standard treats each component of a narrative report as a separate
"test" or observation.  Just as a CHEM12 is transmitted as an order segment
(OBR) plus 12 OBX segments, a chest xray would be transmitted as an order (OBR)
segment plus three OBX segments, one for the description, one for the
impression, and one for the recommendations.  Similarly, an EKG report would be
transmitted as an order segment (OBR), two OBX segments for the impression and
recommendation, and additional OBX segments for each EKG measurement, e.g. the
PR interval, QR interval, QRS axis, and so on.<br>
	We have defined code suffixes for constructing observation IDs for the common
components of narrative reports (see Table 7.1).  The observation identifier
for each such component is obtained by concatenating the observation battery ID
(the ID in <i>OBR-4-universal service ID</i> of the preceding OBR from any
coding system) with the appropriate suffix.  The observation ID for a chest
xray impression, for example, would be the chest xray observation ID (if CPT4,
it would be 71020), a subcomponent delimiter, and the suffix, "IMP", i.e.,
71020&amp;IMP.  <br>
	This same combining rule applies to other coding systems including local and
universal procedural codes (see Chapter 4).  For example, if a local code for
EKG was E793, and the locally agreed upon designation for that local code was
EKG, the impression would be identified as E793&amp;IMP^^99EKG.  <br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b>Note:</b>
The "99EKG" in the 3rd component is included to indicate a local code.  The
EKG's description, in this case, would be E793&amp;GDT^^99EKG.
</p>
<BR></TD></TR></TABLE><p><br>
	Optionally, when agreed upon by the sender and receiver, the "observation ID"
component of a result segment could be omitted when they are the same as the
observation ID of the preceding OBR.  In this case, only the ampersand and the
suffix would have to be sent, e.g., &amp;IMP or &amp;REC, in
<i>OBX-3-observation identifier</i> of a result segment.  The full code would
be assumed as the test identifier (recorded in the order segment) plus the
category identifier recorded in the observation segment.<br>
	Figure 7-1  Observation ID suffices<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>Coded
Results
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Suffix</p>
<BR></TD>
<TD colspan=1 align="center"><p>Type</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>Diagnostic
impression<br>
Recommendation<br>
Confirming Procedures<br>
Procedure medication<br>
Anatomic site<br>
Device/instrument<br>
Serial # device/instrument<br>
Bulk Text Reports<br>
Gross or general description of the study<br>
Microscopic or secondary description<br>
Technician's comment<br>
Addendum note<br>
Other<br>
Diagnosis onset date/time<br>
Diagnosis resolution date/time<br>
Comparison study<br>
Comparison date/time<br>
Comparison results<br>
Comparison change<br>
Predicted value<br>
Percent predicted<br>
After drug observed<br>
Predicted value after drug<br>
Percent predicted after drug
</p>
<BR></TD>
<TD colspan=1 align="center"><p>IMP<br>
REC<br>
CNP<br>
MED<br>
ANT<br>
DEV<br>
SER<br>
GDT<br>
MDT<br>
TCM<br>
ADT<br>
ITM<br>
RTM<br>
CMS<br>
CMT<br>
CMR<br>
CMC<br>
PRD<br>
PPR<br>
AFD<br>
ADP<br>
APP
</p>
<BR></TD>
<TD colspan=1 align="center"><p>CE<br>
CE<br>
CE<br>
CE<br>
CE<br>
CE<br>
ST<br>
TX or FT<br>
TX or FT<br>
TX or FT<br>
TX or FT<br>
TS<br>
TS<br>
CE<br>
TS<br>
CE<br>
CE<br>
ST<br>
ST<br>
ST<br>
ST<br>
ST
</p>
<BR></TD></TR></TABLE><p></p>
<h3>
</h3>

<h3>
<A NAME="Heading5">7.1.3  Suffixes for defining observation IDs  for common components of narrative reports</A></h3>

<p><br>
	The following subsections define each of the suffixes.</p>

<h4>
<A NAME="Heading6">7.1.3.1 Diagnostic impressions (IMP)</A></h4>

<p><br>
	When the suffix is IMP (<i>OBX-3-observation identifier</i>), the result is a
diagnosis or finding, stored as a CE data type.  When multiple distinct
diagnostic impressions are being reported, for example, mitral valve prolapse
and aortic stenosis, each distinct impression should be sent in a separate OBX
segment.  More than one code may be included within one coded result segment,
but only when such codes are modifiers of the principal impression, e.g. to
report additional detail about the finding, not to report an entirely different
finding.  <br>
	The coded data type for impressions does not mean that a reporting service
must actually code all such impressions.  The diagnostic impression can be sent
as dictated text, but the text should be sent in the second component of the CE
data type to distinguish it from code, i.e. it should be preceded by a
component delimiter, e.g. ^congestive heart failure.  <br>
	When multiple text impressions are being reported, they should be reported in
separate OBX segments to indicate that they are distinct impressions.</p>

<h4>
<A NAME="Heading7">7.1.3.2 Recommendations (REC)</A></h4>

<p><br>
	When the suffix is REC (<i>OBX-3-observation identifier</i>), the value is a
CE result, representing the reading physician's recommendations about repeat
testing, follow up or therapy.  For example, when an ambiguous lesion result is
seen on a mammogram, the reading physician might recommend a repeat mammogram
in six months, or a needle biopsy immediately.  The recommended procedures are
recorded as codes and/or text descriptions in the coded identifier structure.
<br>
	If more than one follow up study is recommended, each such recommendation is
sent in a separate REC.    </p>

<h4>
<A NAME="Heading8">7.1.3.3 Confirming procedure (CNP)</A></h4>

<p><br>
	The confirming procedure OBX suffix identifies additional studies used to
confirm the diagnosis reported in the IMP OBX.  If, for example, electron
microscopy was done to confirm a surgical pathology diagnosis, the identifier
for electron microscopy <i>OBX-3-observation identifier</i> would be stored as
the value field of an observation ID with a confirming procedure suffix.
Confirming procedures are most important in surgical pathology reports.  But
they might also be used by services such as endoscopy, to record the fact that
a biopsy, culture, etc., was taken during the procedure.</p>

<h4>
<A NAME="Heading9">7.1.3.4 Procedure medication (MED)</A></h4>

<p><br>
	A coded result segment with a suffix of MED (<i>OBX-3-observation
identifier</i>) indicates that the segment contained information about
medication given as part of the procedure -- contrast medication, medication
intended to invoke a physiologic response (e.g., to be used in stress testing)
or premedication.  When patients receive more than one procedure medication,
each medication should be reported in a separate OBX medication segment.  If
the transmitting system has codes available for medications, they would be
recorded as the first component of <i>OBX-3-observation identifier</i>.  The
name and/or the dosages could be included in the second component of
<i>OBX-5-observation value</i>. </p>

<h4>
<A NAME="Heading10">7.1.3.5 Anatomic site (ANT)</A></h4>

<p><br>
	Some diagnostic studies include observations about more than one anatomic site
within one report.  If, for example, a patient had an appendectomy incidental
to gallbladder surgery, the pathologist's assessment of both specimens would
usually be included under a single specimen number in one report.  Each
distinct anatomic site would be reported as a separate OBX segment with a
suffix of ANT (<i>OBX-3-observation identifier</i>).</p>

<h4>
<A NAME="Heading11">7.1.3.6 Devices (DEV)</A></h4>

<p><br>
	When required, the instrument or device which generated an observation can be
transmitted as an additional "result" of the study.  In this case, the suffix
of <i>OBX-3-observation identifier</i> is DEV.  Examples include: an automated
instrument in the laboratory; an imaging device and model number in radiology;
or an automatic blood pressure machine on the ward.  The device is specified as
a coded entry in anticipation that these identifiers could be specified as
codes.  Initially, we expect that most of the information about devices will be
transmitted as text in the second component of the CE identifier.   <br>
 </p>

<h4>
<A NAME="Heading12">7.1.3.7 Gross or general description (GDT)</A></h4>

<p><br>
	The general description suffix identifies the description component of a
diagnostic studies.  In the case of anatomic pathology, it applies to the
macroscopic (gross) description of the specimen.  If the description consists
of multiple paragraphs, the paragraphs should be separated by repeat delimiters
so that the receiving computer can display them as paragraphs.  It will not be
necessary to include a description segment for a report when the impression
segment says it all, e.g., for normal studies or studies such as EKG, whose
reports are traditionally terse. </p>

<h4>
<A NAME="Heading13">7.1.3.8 Secondary or microscopic description (MDT)</A></h4>

<p><br>
	For most studies, a secondary description will not be needed.  In the case of
surgical pathology, however, the microscopic description is a separate part of
the report.  It describes the histology as seen through the microscope.  The
microscopic description will be sent in a segment with the suffix MDT in
<i>OBX-3-observation identifier</i>.</p>

<h4>
<A NAME="Heading14">7.1.3.9 Technician comment (TCM)</A></h4>

<p><br>
	This is free text stored in a result segment whose <i>OBX-3-observation
identifier</i> has a suffix of TCM for technician comment.  It is used to
record information about technical performance of the procedure, usually
recorded by the technician.  </p>

<h4>
<A NAME="Heading15">7.1.3.10 Addendum note (ADT) </A></h4>

<p>
<br>
	Use to report information that is added as an addendum after the original
dictation and sent as a separate labeled section of the report. <br>
 </p>

<h4>
<A NAME="Heading16">7.1.3.11 Diagnosis (problem) onset date-time (ITM). </A></h4>

<p>
<br>
	Use to record the date-time that a problem was first perceived to exist. <br>
 </p>

<h4>
<A NAME="Heading17">7.1.3.12 Diagnosis (problem) resolution date-time (RTM). </A></h4>

<p>
<br>
	Use to record the date-time that a problem became inactive, i.e., the problem
was cured or remitted. </p>

<h4>
<A NAME="Heading18">7.1.3.13 Comparison study (CMS) </A></h4>

<p><br>
	When the reader of a diagnostic report compares the results for the current
study with those of a previous study, this suffix allows them to report the
nature of the comparison study as a separate result, i.e., an OBX segment with
a segment whose observation ID has a suffix of CMS. Ordinarily, this would not
be required because the observation ID in the other comparison OBX's would
identify the test, if any of the other comparison values were transmitted.<br>
 </p>

<h4>
<A NAME="Heading19">7.1.3.14 Comparison date-time (CMT) </A></h4>

<p>
<br>
	When the reader of a diagnostic procedure compares the current results with a
previous study, this suffix allows them to report the date-time of the previous
study (time optional) as a separate result within the current report.  </p>

<h4>
<A NAME="Heading20">7.1.3.15 Comparison results (CMR) </A></h4>

<p>
<br>
	When the reader of a diagnostic procedure compares the current results with
those of a previous study on the same patient, this suffix allows them to
report the results (impression) of the previous study as a discrete result
within the current report.  <br>
  </p>

<h4>
<A NAME="Heading21">7.1.3.16 Comparison change (CMC) </A></h4>

<p>
<br>
	When a diagnostic service reports a comparison between the current and a
previous study, this suffix is used to report the degree of change (e.g., much
worse, worse, minimal worsening, no change, slightly better, better, much
better, returned to normal) as a separate result within the report. <br>
 <br>
	In current dictation, information about comparison is usually contained in the
descriptions of the study.  The provision of the comparison suffixes listed
above do not imply a <i>requirement</i> to send this information as separate
components.  The comparison variables are only meant to be enabling.  When a
system would like to transmit them as discrete report components, these
suffixes give them the option.  </p>

<h4>
<A NAME="Heading22">7.1.3.17 Predicted (PRD) </A></h4>

<p>
<br>
	When an observation has a predicted value as is the case for many spirometry
tests, this suffix identifies the predicted observation as distinguished from
the actual observation.  The AS4 code for forced vital capacity is 94010.1 (see
appendix 7A).  The predicted forced vital capacity would be 94010.1&amp;PRD.
<br>
 </p>

<h4>
<A NAME="Heading23">7.1.3.18 Percent of predicted (PPR) </A></h4>

<p>
<br>
	This is a computed observation = (actual observation)/(predicted observation).
For forced vital capacity the percent predicted would be identified as
94010.1&amp;PPR.<br>
 </p>

<h4>
<A NAME="Heading24">7.1.3.19 After drug observed (AFD) </A></h4>

<p>
<br>
	An observation might be taken before and after a drug is given. This occurs
especially in Spirometry.  The predose observation is identified by the base
ID.  The post drug measure is identified by the AFD suffix.  Using the AS4 base
code for the forced vital capacity the post drug result would be identified by
94010.1&amp;AFD. <br>
 </p>

<h4>
<A NAME="Heading25">7.1.3.20 Predicted value after drug (ADP) </A></h4>

<p>
<br>
	The post drug predicted value is identified by the suffix, ADP. Following the
pattern of the above example, it would be 94010.1&amp;ADP. </p>

<h4>
<A NAME="Heading26">7.1.3.21 Percent predicted after drug (APP) </A></h4>

<p><br>
	The percent predicted after drug is identified by applying the suffix, APP to
the base code -- 94010.1&amp;APP if using the AS4 code for forced vital capacity.</p>

<h4>
<A NAME="Heading27">7.1.3.22 Expanded AS4 codes </A></h4>

<p><br>
	To accommodate the additional observations included in the expanded scope of
this revision, we have expanded the AS4 codes in Appendix 7.A for identifying
clinical observations. <a name="fnB0" href="#fn0">[1]</a></p>
<h3>
</h3>

<h3>
<A NAME="Heading28">7.1.4  Identifying reporting units  </A></h3>

<p></p>

<h4>
<A NAME="Heading29">7.1.4.1 Background</A></h4>

<p><br>
	When an observation's value is measured on a continuous scale, one must report
the measurement units within the units field of the OBX segment.  In HL7
version 2.2 of the specification, all fields that report units are of data type
CE.  The default coding system for the units codes consists of the ISO
abbreviation for a single case unit (ISO 2955-83) plus extensions that do not
collide with ISO abbreviations.  We designate this coding system as ISO+ (see
Figure 7-5).  Both the ISO unit's abbreviations and the extensions are defined
in section 7.1.4.2.  The ISO+ abbreviations <i>are</i> the codes for the
default coding system.  Consequently, when ISO+ units are being used, only ISO+
abbreviations need be sent, and the contents of the units field will be
backward compatible to HL7 version 2.1 and ASTM 1238-88.  <br>
	We strongly encourage observation producers to use ISO+ abbreviated units
exclusively, but permit the use of other code systems, including US customary
units (ANSI X3.50) and locally defined codes where necessary.  Local units are
designated "L" or 99zz where z is an alpha numeric character.  ANSI X3.50 -1986
provides an excellent description of these standards, as well as a table of
single case abbreviations for US customary units such as foot or gallon.<br>
	We had originally intended to include the ANSI X3.50 - 1986 US customary units
in the default ISO+ coding system.  However, there are overlaps between ISO's
abbreviations and the abbreviations for US customary units.  For example, "ft"
is the abbreviation for foot in US customary units and for femtotesla in ISO;
"pt" is the abbreviation for pint in US customary and for picotesla in ISO.
(Be aware that the ANSI document also differs from the ISO document regarding
the abbreviation of a few ISO units, as well.)   In order to avoid potential
ambiguity, we have defined another coding system, designated ANS+.  It includes
the US customary units (e.g., feet, pounds) and "ISO" abbreviations defined in
ANSI X3.50-1986, as well as other non-metric units listed in Table 24 and the
ISO combinations of these units.  Be aware that a few of the ANSI "ISO" unit
abbreviations  differ from their abbreviations in ISO (see note at bottom of
table 24).  Because the ANS+ specification includes both "ISO" and US customary
units, as well as miscellaneous non-metric units, some of the abbreviations are
ambiguous.  Although there should be little confusion, in the context of a
particular observation, this ambiguity is a good reason for avoiding ANS+ unit
codes when possible.<br>
	When ANS+ units codes (abbreviations) are being transmitted, "ANS+" must be
included in the 3rd (6th) component of the field.  If the units of distance
were transmitted as meters (ISO+) it would be transmitted as "m" because ISO+
is the default coding system for units.  However, if transmitted in the US
customary units of feet, the units would be transmitted as "ft^^ANS+".  When
required, the full text of the units can be sent as the second component in
keeping with the CE data type conventions. <br>
	Both ISO and ANSI also provide a set of mixed case abbreviations, but these
abbreviations cannot be translated to single case without loss of meaning, and
should not be used in this specification whose content is required to be case
insensitive.</p>

<h4>
<A NAME="Heading30">7.1.4.2 ISO and ANSI customary units abbreviations </A></h4>

<p>
<br>
	ISO builds its units from seven base dimensions measured as meters, kilograms,
seconds, amperes, kelvins, moles and candelas (see Figure 7-2).  Other units
can be derived from these by adding a prefix to change the scale and/or by
creating an algebraic combination of two or more base or derived units.
However, some derived units have acquired their own abbreviations (see Figure
7-2).  Abbreviations for U.S. customary units are given in Figure 7-3.  <br>
	The ISO rules, well explained in ANSI X3.50, provide a way to create units of
different scales by adding "multiplier" prefixes.  These prefixes can be
expressed as "words" or abbreviations.  In this standard we are only concerned
with the abbreviations.<br>
	Figure 7-2  ISO single case units abbreviations<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD>
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD>
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>Base
units code/abbreviations
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>ampere</p>
<BR></TD>
<TD colspan=1 align="left"><p>a</p>
<BR></TD>
<TD colspan=1 align="left"><p>kelvin</p>
<BR></TD>
<TD colspan=1 align="left"><p>k</p>
<BR></TD>
<TD colspan=1 align="left"><p>meter</p>
<BR></TD>
<TD colspan=1 align="left"><p>m</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>candela</p>
<BR></TD>
<TD colspan=1 align="left"><p>cd</p>
<BR></TD>
<TD colspan=1 align="left"><p>kilogram</p>
<BR></TD>
<TD colspan=1 align="left"><p>kg</p>
<BR></TD>
<TD colspan=1 align="left"><p>mole</p>
<BR></TD>
<TD colspan=1 align="left"><p>mol</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p>second</p>
<BR></TD>
<TD colspan=1 align="left"><p>s</p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>Derived
units with specified name and abbreviation
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>coulomb</p>
<BR></TD>
<TD colspan=1 align="left"><p>c</p>
<BR></TD>
<TD colspan=1 align="left"><p>hour</p>
<BR></TD>
<TD colspan=1 align="left"><p>hr</p>
<BR></TD>
<TD colspan=1 align="left"><p>pascal</p>
<BR></TD>
<TD colspan=1 align="left"><p>pal</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>day</p>
<BR></TD>
<TD colspan=1 align="left"><p>d</p>
<BR></TD>
<TD colspan=1 align="left"><p>joule</p>
<BR></TD>
<TD colspan=1 align="left"><p>j</p>
<BR></TD>
<TD colspan=1 align="left"><p>volt</p>
<BR></TD>
<TD colspan=1 align="left"><p>v</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>degree
Celsius
</p>
<BR></TD>
<TD colspan=1 align="left"><p>cel</p>
<BR></TD>
<TD colspan=1 align="left"><p>minute
(time)
</p>
<BR></TD>
<TD colspan=1 align="left"><p>min</p>
<BR></TD>
<TD colspan=1 align="left"><p>watt</p>
<BR></TD>
<TD colspan=1 align="left"><p>w</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>farad</p>
<BR></TD>
<TD colspan=1 align="left"><p>f</p>
<BR></TD>
<TD colspan=1 align="left"><p>newton</p>
<BR></TD>
<TD colspan=1 align="left"><p>n</p>
<BR></TD>
<TD colspan=1 align="left"><p>weber</p>
<BR></TD>
<TD colspan=1 align="left"><p>wb</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>hertz</p>
<BR></TD>
<TD colspan=1 align="left"><p>hz</p>
<BR></TD>
<TD colspan=1 align="left"><p>ohm</p>
<BR></TD>
<TD colspan=1 align="left"><p>ohm</p>
<BR></TD>
<TD colspan=1 align="left"><p>year</p>
<BR></TD>
<TD colspan=1 align="left"><p>ann</p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>Other
units
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>atomic
mass unit
</p>
<BR></TD>
<TD colspan=1 align="left"><p>u</p>
<BR></TD>
<TD colspan=1 align="left"><p>grey</p>
<BR></TD>
<TD colspan=1 align="left"><p>gy</p>
<BR></TD>
<TD colspan=1 align="left"><p>minute
of arc
</p>
<BR></TD>
<TD colspan=1 align="left"><p>mnt</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>bel</p>
<BR></TD>
<TD colspan=1 align="left"><p>b</p>
<BR></TD>
<TD colspan=1 align="left"><p>henry</p>
<BR></TD>
<TD colspan=1 align="left"><p>h</p>
<BR></TD>
<TD colspan=1 align="left"><p>radian</p>
<BR></TD>
<TD colspan=1 align="left"><p>rad</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>decibel</p>
<BR></TD>
<TD colspan=1 align="left"><p>db</p>
<BR></TD>
<TD colspan=1 align="left"><p>liter</p>
<BR></TD>
<TD colspan=1 align="left"><p>l</p>
<BR></TD>
<TD colspan=1 align="left"><p>siemens</p>
<BR></TD>
<TD colspan=1 align="left"><p>sie</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>degree</p>
<BR></TD>
<TD colspan=1 align="left"><p>deg</p>
<BR></TD>
<TD colspan=1 align="left"><p>lumen</p>
<BR></TD>
<TD colspan=1 align="left"><p>lm</p>
<BR></TD>
<TD colspan=1 align="left"><p>steradian</p>
<BR></TD>
<TD colspan=1 align="left"><p>sr</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>gram</p>
<BR></TD>
<TD colspan=1 align="left"><p>g</p>
<BR></TD>
<TD colspan=1 align="left"><p>lux</p>
<BR></TD>
<TD colspan=1 align="left"><p>lx</p>
<BR></TD>
<TD colspan=1 align="left"><p>tesla</p>
<BR></TD>
<TD colspan=1 align="left"><p>t</p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>See
ISA 2955-1983 for full set
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR></TABLE><p>
The ISO abbreviations for multiplier prefixes are given in Figure 7-4.
Prefixes ranging from 10<sup>-18</sup> (1/billion billionth) to 10<sup>18</sup>
(a billion billion) are available.  The single case abbreviation for kilo
(x1000) is "k".  A unit consisting of 1000 seconds would be abbreviated as
"ks", 1000 grams as "kg", 1000 meters as "km", and so on.  Some prefixes share
the abbreviation of a base unit.  Farad and femto, for example,
(10<sup>-18</sup>) both have the abbreviation of "f".  To avoid confusion, ISO
forbids the use of solitary prefixes.  Thus, "f" always means farad, "ff" would
mean 1 million billionth of a farad.  Compound prefixes are not allowed.  <br>
	A unit can be raised to an exponential power.  Positive exponents are
represented by a number immediately following a unit's abbreviation, i.e., a
square meter would be denoted by m2.  Negative exponents are signified by a
negative number following the base unit, e.g., "1/m<sup>2</sup>" would be
represented by as "m-2".  The multiplication of units is signified by a period
(.) between the units, e.g., meters X seconds would be denoted "m.s".  Notice
that spaces are not permitted.  Division is signified by a slash (/) between
two units, e.g. meters per second would be denoted as "m/s".   Algebraic
combinations of ISO unit abbreviations constructed by dividing, multiplying, or
exponentiating base ISO units, are also valid ISO abbreviations units.<br>
	Figure 7-3  ANSI+ unit codes for some U.S. customary units<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD>
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD>
<TD colspan=1 align="left"><p>Units</p>
<BR></TD>
<TD colspan=1 align="left"><p>Abbreviation</p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>LENGTH</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>VOLUME</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>TIME</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>inch</p>
<BR></TD>
<TD colspan=1 align="left"><p>in</p>
<BR></TD>
<TD colspan=1 align="left"><p>cubic
foot
</p>
<BR></TD>
<TD colspan=1 align="left"><p>cft</p>
<BR></TD>
<TD colspan=1 align="left"><p>year</p>
<BR></TD>
<TD colspan=1 align="left"><p>yr</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>foot</p>
<BR></TD>
<TD colspan=1 align="left"><p>ft</p>
<BR></TD>
<TD colspan=1 align="left"><p>cubic
inch
</p>
<BR></TD>
<TD colspan=1 align="left"><p>cin</p>
<BR></TD>
<TD colspan=1 align="left"><p>month</p>
<BR></TD>
<TD colspan=1 align="left"><p>mo</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>mile
(statute)
</p>
<BR></TD>
<TD colspan=1 align="left"><p>mi</p>
<BR></TD>
<TD colspan=1 align="left"><p>cubic
yard
</p>
<BR></TD>
<TD colspan=1 align="left"><p>cyd</p>
<BR></TD>
<TD colspan=1 align="left"><p>week</p>
<BR></TD>
<TD colspan=1 align="left"><p>wk</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>mautical
mile
</p>
<BR></TD>
<TD colspan=1 align="left"><p>nmi</p>
<BR></TD>
<TD colspan=1 align="left"><p>tablespoon</p>
<BR></TD>
<TD colspan=1 align="left"><p>tbs</p>
<BR></TD>
<TD colspan=1 align="left"><p>day</p>
<BR></TD>
<TD colspan=1 align="left"><p>d</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>rod</p>
<BR></TD>
<TD colspan=1 align="left"><p>rod</p>
<BR></TD>
<TD colspan=1 align="left"><p>teaspoon</p>
<BR></TD>
<TD colspan=1 align="left"><p>tsp</p>
<BR></TD>
<TD colspan=1 align="left"><p>hour</p>
<BR></TD>
<TD colspan=1 align="left"><p>hr</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>yard</p>
<BR></TD>
<TD colspan=1 align="left"><p>yd</p>
<BR></TD>
<TD colspan=1 align="left"><p>pint</p>
<BR></TD>
<TD colspan=1 align="left"><p>pt</p>
<BR></TD>
<TD colspan=1 align="left"><p>minute
</p>
<BR></TD>
<TD colspan=1 align="left"><p>min</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p>quart</p>
<BR></TD>
<TD colspan=1 align="left"><p>qt</p>
<BR></TD>
<TD colspan=1 align="left"><p>second</p>
<BR></TD>
<TD colspan=1 align="left"><p>sec</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p>gallon</p>
<BR></TD>
<TD colspan=1 align="left"><p>gal</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p>ounce
(fluid)
</p>
<BR></TD>
<TD colspan=1 align="left"><p>foz</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>AREA</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>MASS</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>square
foot
</p>
<BR></TD>
<TD colspan=1 align="left"><p>sqf</p>
<BR></TD>
<TD colspan=1 align="left"><p>dram</p>
<BR></TD>
<TD colspan=1 align="left"><p>dr</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>square
inch
</p>
<BR></TD>
<TD colspan=1 align="left"><p>sin</p>
<BR></TD>
<TD colspan=1 align="left"><p>grain</p>
<BR></TD>
<TD colspan=1 align="left"><p>gr
(avoir)
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>square
yard
</p>
<BR></TD>
<TD colspan=1 align="left"><p>syd</p>
<BR></TD>
<TD colspan=1 align="left"><p>ounce
(weight)
</p>
<BR></TD>
<TD colspan=1 align="left"><p>oz</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p>pound</p>
<BR></TD>
<TD colspan=1 align="left"><p>lb</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>Other
ANSI units, derived units, and miscellanous
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>**British
thermal unit
</p>
<BR></TD>
<TD colspan=1 align="left"><p>btu</p>
<BR></TD>
<TD colspan=1 align="left"><p>**degrees
fahrenheit
</p>
<BR></TD>
<TD colspan=1 align="left"><p>degf</p>
<BR></TD>
<TD colspan=1 align="left"><p>**millirad</p>
<BR></TD>
<TD colspan=1 align="left"><p>mrad</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>cubic
feet/minute
</p>
<BR></TD>
<TD colspan=1 align="left"><p>cft/min</p>
<BR></TD>
<TD colspan=1 align="left"><p>**feet/minute</p>
<BR></TD>
<TD colspan=1 align="left"><p>ft/min</p>
<BR></TD>
<TD colspan=1 align="left"><p>**RAD</p>
<BR></TD>
<TD colspan=1 align="left"><p>rad</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>Note
the abbreviations for conventional U.S. units of time are the same as ISO,
except for year.  ISO = ANN, AMSI = yr.  The metric units in X3.50 are the same
as ISO, except for: pascal ("pa" in ANSI, "pal" in ISO); ANSI uses "min" for
both time and arc while ISO uses "mnt" for minutes of arc; and in ISA seconds
are abbreviated "s", in ANSI, "sec". 
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p><br>
This list is not exhaustive.  Refer to ANSI X3.50-1986, Table 1, for other
metric and standard U.S. units.
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>**Non-metric
units not explicitly listed in ANSI
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR></TABLE><p><br>
	Figure 7-4  Single case ISO abbreviations for multiplier prefixes<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><br>
Prefix
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p><br>
Code
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
Prefix
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><p><br>
Code
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p><br>
exa
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
10<sup>18
</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
ex
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
atto
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
10<sup>-18
</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
a
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>peta</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>15</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>pe</p>
<BR></TD>
<TD colspan=1 align="left"><p>femto</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-15</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>f</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>tera</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>12</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>t</p>
<BR></TD>
<TD colspan=1 align="left"><p>pico</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-12</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>p</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>giga</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>9</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>g</p>
<BR></TD>
<TD colspan=1 align="left"><p>nano</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-9</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>n</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>mega</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>6</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>ma</p>
<BR></TD>
<TD colspan=1 align="left"><p>micro</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-6</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>u</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>kilo</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>3</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>k</p>
<BR></TD>
<TD colspan=1 align="left"><p>milli</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-3</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>m</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>hecto</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>2</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>h</p>
<BR></TD>
<TD colspan=1 align="left"><p>centi</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-2</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>c</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>deca</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>1</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>da</p>
<BR></TD>
<TD colspan=1 align="left"><p>deci</p>
<BR></TD>
<TD colspan=1 align="left"><p>10<sup>-1</sup></p>
<BR></TD>
<TD colspan=1 align="left"><p>d</p>
<BR></TD></TR></TABLE><p><br>
	Figure 7-5 lists the abbreviations for common ISO derived units.  It also
includes standard unit abbreviations for common units, e.g., Milliequivalents,
and international units, mm(Hg), and for counting per which we denote by a
division sign, a denominator, but no numerator, e.g., /c, that are not part of
the above referenced ISO standards.  <br>
	 Figure 7-5  Common ISO derived units and *ISO extensions<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>
Name
</p>
<BR></TD>
<TD colspan=1 align="left"><p>
Code/Abbr.
</p>
<BR></TD>
<TD colspan=1 align="left"><p>
Name
</p>
<BR></TD>
<TD colspan=1 align="left"><p>
Code/Abbr.
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>
1/L<br>
*10<sup>3</sup>/Liter<br>
*10<sup>6</sup>/Liter<br>
*10<sup>9</sup>/Liter<br>
*10<sup>12</sup>/Liter<br>
*1/milliliter <br>
*10<sup>3</sup>/milliliter<br>
*10<sup>6</sup>/milliliter<br>
*10<sup>9</sup>/milliliter<br>
*1000 red blood cells<br>
 Beats Per Min<br>
*Bodansky U<br>
*Body surface area<br>
*Calories <br>
*Catalytic Fraction<br>
 Cells/Liter<br>
*CM of Water<br>
*Colony Forming Units<br>
 Day	<br>
 Decibels <br>
*Decibels a Scale<br>
 Degrees Celsius<br>
 Degrees of Angle<br>
 Femtogram<br>
 Femtoliter<br>
 Femtomole<br>
*Fibers/ml<br>
*grams creatinine<br>
*grams hemoglobin<br>
*grams total nitrogen<br>
*grams total protein<br>
*Grams wet weight tissue<br>
 Gram/Deciliter<br>
 Gram/Liter<br>
 Grams	<br>
*International Units<br>
*International Unit/Day<br>
*International Unit/Milliliter<br>
*International Unit/Liter<br>
*kg body weight<br>
*Katal	<br>
*Katal/Kilogram<br>
*Katal/Liter<br>
 Kilocalories<br>
 Kilogram/liter<br>
 Kilograms<br>
*Kunkel U<br>
 Lumen	<br>
 Lumen Per Squre Meter<br>
*MacLagan U<br>
 Meters	<br>
 Meters/Second<br>
 Meters/Second<sup>2</sup><br>
*Micro international unit <br>
 Picogram/Milliliter<br>
*Picokatel<br>
 Picometer<br>
*Picomole
</p>
<BR></TD>
<TD colspan=1 align="left"><p>/l
<br>
10*3/l<br>
10*6/l<br>
10*9/l<br>
10*12/l<br>
1/ml<br>
10*3/ml<br>
10*6/ml<br>
10*9/ml<br>
10*3(rbc)<br>
/min<br>
(bdsk_u)<br>
(bsa)<br>
(cal)<br>
1	<br>
/l<br>
cm (h20)<br>
(cfu)<br>
d<br>
db<br>
dba<br>
cel<br>
deg<br>
fg<br>
fl<br>
fmol<br>
/ml<br>
g(creat)<br>
g(hgb)<br>
g(tot_nit)<br>
g(tot_prot)<br>
g(wet_tis)<br>
g/dl<br>
g/l <br>
g <br>
iu<br>
iu/d<br>
iu/ml<br>
iu/l <br>
kg(body_wt)      at<br>
kat/kg<br>
kat/l<br>
(kcal)<br>
kg/l<br>
kg<br>
(knk_u)<br>
lm<br>
lm/m2<br>
(mclg_u)<br>
m<br>
m/s<br>
m/s2<br>
uiu<br>
pg/ml<br>
pkat<br>
pm<br>
pmol
</p>
<BR></TD>
<TD colspan=1 align="left"><p>
Picosecond<br>
 Microgram<br>
 Microgram/Deciliter<br>
 Microgram/Gram<br>
 Microgram/Liter<br>
 Microgram/Minute<br>
 Microgram/Day<br>
*Micro katel<br>
 Micro meter = Micron<br>
 Micro mole     <br>
 Micro second<br>
*Milliequivalents<br>
*Microequivalents<br>
 Milliequivalents/Liter<br>
 Milligram/Day<br>
 Milligram/Deciliter<br>
 Milligram/Liter<br>
 Milligram/Min<br>
 Milligram<br>
 Milligram/Deciliter<br>
 Milligrams/Cubic Meter<br>
 Milliliter<br>
 Milliliter/Minute<br>
 Milliliter/Second<br>
 Millimeter<br>
*Millimeter (HG)<br>
 Millimeter/HR<br>
 Millimole/Liter<br>
 Millimoles/Day<br>
*Milliosmols/Liter<br>
*Milliunits/Milliliter<br>
 Moles/Kilogram<br>
 Moles/Liter<br>
 Moles/Second<br>
 Nanogram<br>
*Nanokatel<br>
 Nanometer<br>
 Nanosecond<br>
 Nanogram/Liter<br>
 Nanogram/Milliliter<br>
 Nanomoles/Second<br>
*O.D. (optical density)<br>
*P.U.<br>
*Pa<br>
*pH<br>
*Particles/Total Count<br>
*Particles/Cubic Meter<br>
*Particles/Liter<br>
*Parts Per Billion<br>
*Parts Per Million<br>
 Pascal<br>
*Per High Power Field<br>
*Percent<br>
 Picogram<br>
 Picogram/Liter<br>
*Todd U<br>
 Volume Fraction
</p>
<BR></TD>
<TD colspan=1 align="left"><p>ps<br>
ug<br>
g/dl<br>
ug/g<br>
ug/l<br>
ug/min<br>
ug/d<br>
ukat<br>
um<br>
mol<br>
us<br>
meq<br>
ueq<br>
eq/l<br>
g/d<br>
g/dl<br>
g/l<br>
g/min<br>
mg<br>
g/dl<br>
g/m3<br>
ml<br>
l/min<br>
ml/s<br>
mm<br>
m(hg)<br>
m/hr  <br>
mol/l<br>
mol/d<br>
osm/l<br>
iu/ml<br>
ol/kg<br>
ol/l<br>
ol/s<br>
ng<br>
nkat<br>
nm<br>
ns<br>
ng/l<br>
g/ml<br>
mol/s<br>
(od)<br>
(pu)<br>
(pa)<br>
(ph)<br>
(tot)<br>
/m3<br>
/l<br>
ppb)<br>
ppm)<br>
pal<br>
(hpf) <br>
%<br>
pg<br>
pg/l<br>
td_u)<br>
1
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>*
Starred items are not genuine ISO, but do not conflict.
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD>
<TD colspan=1 align="left"><BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading31">7.1.4.3 Local unit codes</A></h4>

<p><br>
	Local codes can be used for the units by indicating the code source of "L" in
the third component.  In the case of local codes, the text name of the codes or
the description of the units should also be transmitted (in the second
component), so that the receiving system can compare the results with results
for the same measurement sent by another service.  An "L" should be stored in
the third component to indicate that the code is locally defined.  More
specialized local code designations, as specified in the CE data type
definition, can also be employed.</p>
<h2>
</h2>

<h2>
<A NAME="Heading32">7.2  MESSAGE DEFINITIONS </A></h2>

<p><br>
The triggering events that follow are all served by the ORU (Observational
report - Unsolicited) or the ORF (Observational Report Response) messages in
combination with ACK and QRY.  Each triggering event is listed below, along
with the messages  exchanged, and the segments that comprise the messages.  The
notation used to describe the sequence, optionality, and repeating of segments
is described in Chapter 2, "Format for  Defining Abstract Messages."   <br>
   </p>
<h3>
</h3>

<h3>
<A NAME="Heading33">7.2.1  ORU - unsolicited transmission of an observation </A></h3>

<p><br>
	With the type (OBX) defined in this chapter, and the OBR defined in Chapter 4,
one can construct almost any clinical report as a three-level hierarchy, with
the PID segment defined in Chapter 3 at the upper level, an order record (OBR)
at the next level and one or more observation records (OBX) at the "bottom."
<br>
	One result segment (OBX) is transmitted for each component of a  diagnostic
report, such as an EKG or obstetrical ultrasound or electrolyte battery.
<br>
<tt><u>ORU                Observational Results (Unsolicited)   Chapter
</u></tt><br>
<tt>MSH                Message Header                          2</tt><br>
<tt>{  </tt><br>
<tt>   [</tt><br>
<tt>    PID            Patient Identification                  3 </tt><br>
<tt>     [{NTE}]       Notes and comments                      2</tt><br>
<tt>     [PV1]         Patient Visit                           3</tt><br>
<tt>   ]</tt><br>
<tt>    {</tt><br>
<tt>     [ORC]         Order common                            4</tt><br>
<tt>      OBR          Observations Report ID                  7</tt><br>
<tt>      {[NTE]}      Notes and comments                      2</tt><br>
<tt>        {</tt><br>
<tt>         [OBX]     Observation/Result                      7</tt><br>
<tt>          {[NTE]}  Notes and comments                      2</tt><br>
<tt>        }   </tt><br>
<tt>     }   </tt><br>
<tt>}   </tt><br>
<tt>[DSC]               Continuation Pointer</tt><br>
<tt><u>ACK                 Acknowledgement                     Chapter
</u></tt><br>
<tt>MSH                 Message header                        2 </tt><br>
<tt>MSA                 Message acknowledgement               2 </tt><br>
 <br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b>Note:</b>
	The ORC is permitted but not required in this message.  Any information that
could be included in either the ORC or the OBR must be included in the OBR on
reporting.  Notice also that the ORU (and the QRY) messages accommodate reports
about many patients.  
</p>
<BR></TD></TR></TABLE><p><br>
	Many report headers (OBR) may be sent beneath each patient segment, with many
separate observation segments (OBX) beneath each OBR.  Note segments (NTE) may
be inserted after any of the above segments.  The note segment applies to the
entity that immediately precedes it, i.e., the patient if it follows the PID
segment, the observation if it follows the OBR segment, and the individual
result if it follows the OBX segment. <br>
 </p>
<h3>
</h3>

<h3>
<A NAME="Heading34">7.2.2  Query for results of observation    </A></h3>

<p>
  <br>
<tt><u>QRY                      Query
Chapter</u></tt><br>
<tt>MSH                      Message Header                     2   </tt><br>
<tt>QRD                      Query Definition                   2</tt><br>
<tt>QRF                      Query Filter                       2   </tt><br>
<tt><u>ORF                      Observational Report            Chapter
</u></tt><br>
<tt>MSH                      Message Header                     2   </tt><br>
<tt>MSA                      Message Acknowledgement            2</tt><br>
<tt>{ </tt><br>
<tt>  QRD                    Query Definition                   2</tt><br>
<tt>    [ QRF ]              Query Filter                       2</tt><br>
<tt>    [ PID ]              Patient ID                         3</tt><br>
<tt>        [{NTE}]</tt><br>
<tt> }</tt><br>
<tt>    {</tt><br>
<tt>      [ ORC ]            Order common   </tt><br>
<tt>         OBR             Observation request                7</tt><br>
<tt>         {[NTE]}         Notes and comments                 2</tt><br>
<tt>         {</tt><br>
<tt>          [OBX]          Observation/Result                 7</tt><br>
<tt>            {[NTE]}      Notes and comments                 2</tt><br>
<tt>         }   </tt><br>
<tt>     }   </tt><br>
<tt>  </tt><br>
<tt>[DSC]                    Continuation Pointer               2</tt></p>

<h4>
<A NAME="Heading35">7.2.2.1 Query usage notes</A></h4>

<p>
<br>
	Display-oriented results reporting is described in Chapter 2, Section 2.7.
The QRD and QRF segments are defined in Chapter 2, Section 2.8.<br>
 <br>
	The subject filters contained in the QRD and QRF segments are defined by local
agreement between the inquiring system and the ancillary system. <br>
 <br>
	The Set ID fields in the various segments (including PID) are used to count
the number of segments of one kind transmitted at one level of the hierarchy.
<br>
 <br>
	The Query Result Level field of the QRD determines the amount of data
requested.  See Chapter 2, Section 2.10.<br>
   </p>
<h2>
</h2>

<h2>
<A NAME="Heading36">7.3  SEGMENTS </A></h2>

<p><br>
	The full definitions of many segments required for reporting clinical
observations are included in other chapters.  The patient identifying segment
(PID) is provided in Chapter 3.  The NTE segment is in Chapter 2.  We include a
section on OBR in this chapter, but it includes only a brief description and a
table listing the fields.  This is included for the convenience of the reader.
The full definition of the OBR segment is given in Chapter 4, Section 4.8.</p>
<h3>
</h3>

<h3>
<A NAME="Heading37">7.3.1  OBR - Observation request  -</A></h3>

<p>
<br>
	In the reporting of clinical data, the OBR serves as the report header.  It
identifies the observation set represented by the following atomic
observations.  It includes the relevant ordering information when that applies.
It contains many of the attributes that usually apply to all of the included
observations.<br>
	When a set of observations is ordered, the order message contains an OBR
segment.  However, observations can be collected and reported without an
antecedent order.  When observations are reported, the report message also
includes one or more OBR segments.  So, the OBR segment is like a turn-around
document.  Some fields in the OBR segment apply only to the ordering message
and some to the reporting message.  To those familiar with health care
procedures, these should be obvious from their names (e.g., transcriptionist or
principal result interpreter could only apply to the reporting phase).
However, we have also flagged them in Table 7.6 to indicate whether placer,
filler, or both may send data in a given field.<br>
<center>Figure 7-6  OBR attributes</center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>Item#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>Element
Name
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8<br>
9<br>
10<br>
11<br>
12<br>
13<br>
14<br>
15<br>
16<br>
17<br>
18<br>
19<br>
20<br>
21<br>
22<br>
23<br>
24<br>
25<br>
26<br>
27<br>
28<br>
29<br>
30<br>
31<br>
32<br>
33<br>
34<br>
35<br>
36
</p>
<BR></TD>
<TD colspan=1 align="center"><p>4<br>
75<br>
75<br>
200<br>
2<br>
26<br>
26<br>
26<br>
20<br>
60<br>
1<br>
60<br>
300<br>
26<br>
300<br>
60<br>
40<br>
60<br>
60<br>
60<br>
60<br>
26<br>
40<br>
10<br>
1<br>
200<br>
200<br>
150<br>
150<br>
20<br>
300<br>
60<br>
60<br>
60<br>
60<br>
26
</p>
<BR></TD>
<TD colspan=1 align="center"><p>SI<br>
CM<br>
CM<br>
CE<br>
ID<br>
TS<br>
TS<br>
TS<br>
CQ<br>
CN<br>
ID<br>
CM<br>
ST<br>
TS<br>
CM<br>
CN<br>
TN<br>
ST<br>
ST<br>
ST<br>
ST<br>
TS<br>
CM<br>
ID<br>
ID<br>
CM<br>
TQ<br>
CN<br>
CM<br>
ID<br>
CE<br>
CM<br>
CM<br>
CM<br>
CM<br>
TS
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
R<br>
C<br>
C<br>
C<br>
C<br>
C<br>
C
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
Y<br>
Y<br>
Y/2<br>
Y<br>
Y/5<br>
Y<br>
Y<br>
Y<br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
0065<br>
0070<br>
0074<br>
0123<br>
0124
</p>
<BR></TD>
<TD colspan=1 align="center"><p>00237<br>
00216<br>
00217<br>
00238<br>
00239<br>
00240<br>
00241<br>
00242<br>
00243<br>
00244<br>
00245<br>
00246<br>
00247<br>
00248<br>
00249<br>
00226<br>
00250<br>
00251<br>
00252<br>
00253<br>
00254<br>
00255<br>
00256<br>
00257<br>
00258<br>
00259<br>
00221<br>
00260<br>
00261<br>
00262<br>
00263<br>
00264<br>
00265<br>
00266<br>
00267<br>
00268
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Set
ID - Observation Request<br>
Placer Order Number  <br>
Filler Order Number + <br>
Universal Service ID <br>
Priority <br>
Requested Date/time <br>
Observation Date/Time # <br>
Observation End Date/Time # <br>
Collection Volume * <br>
Collector Identifier * <br>
Specimen Action Code * <br>
Danger Code <br>
Relevant Clinical Info. <br>
Specimen Received Date/Time [daggerdbl] <br>
Specimen Source * <br>
Ordering Provider <br>
Order Callback Phone Number <br>
Placer field 1 <br>
Placer field 2 <br>
Filler Field 1 +<br>
Filler Field 2 + <br>
Results Rpt/Status Chng - Date/Time +<br>
Charge to Practice +<br>
Diagnostic Serv Sect ID <br>
Result Status +<br>
Parent Result + <br>
Quantity/Timing <br>
Result Copies To <br>
Parent Number + <br>
Transportation Mode <br>
Reason for Study <br>
Principal Result Interpreter + <br>
Assistant Result Interpreter + <br>
Technician +<br>
Transcriptionist + <br>
Scheduled Date/Time + 
</p>
<BR></TD></TR></TABLE><p><br>
	The complete description of these fields is given in Chapter 4.  <br>
	*   Placer sends<br>
	[dagger]   Filler sends<br>
	[daggerdbl]   Either may send - depends on whether specimen is required and
who collects, filler or placer. </p>
<h3>
</h3>

<h3>
<A NAME="Heading38">7.3.2  OBX - Observation/Result segment -</A></h3>

<p><br>
<b>	The OBX segment is used to transmit a single observation or observation
fragment.  It represents the smallest indivisible unit of a report.  Its
structure is summarized in Figure 7-7.</b><br>
<b>	Its principal mission is to carry information about observations in report
messages.  But the OBX can also be part of an observation order (see Section
4.2).  In this case, the OBX carries clinical information needed by the filler
to interpret the observation the filler makes.  For example, an OBX is needed
to report the inspired oxygen on an order for a blood oxygen to a blood gas
lab, or to report the menstrual phase information which should be included on
an order for a pap smear to a cytology lab.  Appendix 7.A includes codes for
identifying many of pieces of information needed by observation producing
services to properly interpret a test result. </b><br>
<center><b>Figure 7-7  OBX attributes</b></center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8<br>
9<br>
10<br>
11<br>
12<br>
13<br>
14<br>
15<br>
16
</p>
<BR></TD>
<TD colspan=1 align="center"><p>4<br>
2<br>
80<br>
20<br>
65536<a name="fnB1" href="#fn1">[2]</a>
</p>
<BR></TD></TR></TABLE><TABLE><TR align="left">
<TD colspan=1 align="left"><p>
60<br>
60<br>
10<br>
5<br>
5<br>
2<br>
26<br>
20<br>
26<br>
60<br>
60
</p>
<BR></TD>
<TD colspan=1 align="left"><p>SI<br>
ID<br>
CE<br>
ST<br>
*<br>
CE<br>
ST<br>
ID<br>
NM<br>
ID<br>
ID<br>
TS<br>
ST<br>
TS<br>
CE<br>
CN
</p>
<BR></TD>
<TD colspan=1 align="left"><p>O<br>
R<br>
R<br>
C<br>
C<br>
 <br>
 <br>
 <br>
 <br>
 <br>
R<br>
 <br>
 <br>
 
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
Y/5
</p>
<BR></TD>
<TD colspan=1 align="left"><p><br>
0125<br>
0078<br>
0080<br>
0085
</p>
<BR></TD>
<TD colspan=1 align="left"><p>00569<br>
00570<br>
00571<br>
00572<br>
00573<br>
00574<br>
00575<br>
00576<br>
00577<br>
00578<br>
00579<br>
00580<br>
00581<br>
00582<br>
00583<br>
00584
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Set
ID - Observational Simple<br>
Value Type <br>
Observation Identifier <br>
Observation Sub-ID<br>
Observation Value<br>
Units<br>
References Range<br>
Abnormal Flags<br>
Probability<br>
Nature of Abnormal Test<br>
Observ Result Status<br>
Date Last Obs Normal Values<br>
User Defined Access Checks<br>
Date/Time of the Observation<br>
Producer's ID<br>
Responsible Observer
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.3.2.0	OBX field definitions</b></p>

<h4>
<A NAME="Heading39">7.3.2.1 Set ID - observation simple (SI) 00569</A></h4>

<p><br>
	Definition:  sequence number.  For compatibility with ASTM. </p>

<h4>
<A NAME="Heading40">7.3.2.2 Value type (ID) 00570</A></h4>

<p><br>
	Definition:  format of the observation value in OBX.  If the value is CE then
the result must be a coded entry.  When the value type is TX or FT then the
results are bulk text.  The valid values for the value type of an observation
are listed in <i>Table 0125 - value type</i>.<br>
	The observation value must be represented according to the format for the data
type defined in Chapter 2, Control Section.  For example, a PN consists of 6
components, separated by component delimiters. <br>
	Although NM is a valid type, observations which are usually reported as
numbers will often have the string (ST) data type because non-numeric
characters are often reported as part of the result, e.g., &gt;300 to indicate
the result was off-scale for the instrument.  In the example, "&gt;300", "&gt;"
is a symbol and the digits are considered a numeric value.<br>
	All HL7 data types are valid except CM, because it is not a specific data
type, CQ, because units for  <i>OBX-5-observation value</i> are always
specified explicitly in an OBX segment with <i>OBX-6-units</i> and SI sequence
ID, because it only applies to HL7 message segments. <br>
	The RP value (reference pointer) must be used if the actual observation value
is not sent in OBX but exists somewhere else.  For example, if the observation
consists of an image (document or medical), the image itself cannot be sent in
OBX.  The sending system may in that case opt to send a reference pointer.  The
receiving system can use this reference pointer whenever it needs access to the
actual image through other interface standards, e.g., ACR-NEMA, or through
appropriate data base servers.<br>
<center>Table 0125  Value type</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>ST<br>
TX<br>
FT<br>
DT<br>
TM<br>
TS<br>
PN<br>
TN<br>
AD<br>
CK<br>
CN<br>
CE<br>
RP<br>
NM<br>
TQ<br>
ID<br>
SI<br>
CM<br>
CQ<br>
CF<br>
MO
</p>
<BR></TD>
<TD colspan=1 align="left"><p>String
data. <br>
Text data (display)<br>
Formatted text (display)<br>
Date<br>
Time<br>
Time stamp (date &amp; time)<br>
Person name<br>
Telephone number<br>
Address<br>
Composite ID with check digit<br>
Composite ID and name<br>
Coded entry<br>
Reference pointer<br>
Numeric<br>
Timing/quantity<br>
Coded value<br>
Sequence ID<br>
Composite<br>
Composite quantity with units<br>
Coded element with formatted values<br>
Money
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading41">7.3.2.3 Observation Identifier (CE) 00571</A></h4>

<p><br>
<tt>	Components:  &lt;identifier&gt; ^ &lt;text&gt; ^ &lt;name of coding
system&gt;^ &lt;alternate identifier&gt; ^ &lt;alternate text&gt; ^ &lt;name of
alternate coding system&gt;</tt><br>
	Definition:  unique identifier for the observation. The format is that of the
Coded Element (CE). Example: 93000.3^P-R interval. <br>
	In most systems the identifier will "point" to a master observation table that
will provide other attributes of the observation that may be used by the
receiving system to process the observations it receives.  A proposed set of
message segments for transmitting such master observation tables is part of the
master file proposal now under ballot.  The relation of an observation ID to a
master observation table is analogous to the relationship between a charge code
(in a billing record) and the charge master.<br>
	When local codes are used as the first identifier in this field we strongly
encourage sending a universal identifier as well to permit receivers to
equivalence results from different providers of the same service (e.g., a
hospital lab and commercial lab that provides serum potassium to a nursing
home).  One possible "universal" identifier is a combination of CPT4 codes and
the AS4 extensions developed by ASTM (see Appendix 7A) which cover all of the
common test results and physiologic variables (e.g., BP, Pulse).<br>
 </p>

<h4>
<A NAME="Heading42">7.3.2.4 Observation Sub-ID (ST) 00572</A></h4>

<p><br>
	Definition:  used to distinguish between multiple OBX segments with the same
observation ID organized under one OBR.  For example, a chest xray report might
include three separate diagnostic impressions.  The standard requires three OBX
segments, one for each impression.  By putting a 1 in the Sub-ID of the first
of these OBX segments, 2 in the second, and 3 in the third, we can uniquely
identify each OBX segment for editing or replacement.<br>
	The sub-identifier is also used to group related components in reports such as
surgical pathology.  It is traditional for surgical pathology reports to
include all the tissues taken from one surgical procedure in one report.
Consider, for example, a single surgical pathology report that describes the
examination of gallbladder and appendix tissue.  This report would be
transmitted roughly as shown in Figure 7-8.<br>
	Figure 7-8  Example of sub-identifier usage <br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>OBR|1|||88304&amp;SURG
PATH REPORT...<br>
OBX|1|CE|88304&amp;ANT|1|T57000^GALLBLADDER^SNM<br>
OBX|2|TX|88304&amp;GDT|1|THIS IS A NORMAL GALLBLADDER<br>
OBX|3|TX|88304&amp;MDT|1|MICROSCOPIC EXAM SHOWS HISTOLOGICALLY NORMAL
GALLBLADDER TISSUE<br>
OBX|4|CE|88364&amp;IMP|1|M-00100^NML^SNM<br>
OBX|5|CE|88304&amp;ANT|2|T66000^APPENDIX^SNM<br>
OBX|6|TX|88304&amp;GDT|2|THIS IS A RED, INFLAMED, SWOLLEN, BOGGY APPENDIX<br>
OBX|7|TX|88304&amp;MDT|2|INFILTRATION WITH MANY PMN's - INDICATING INFLAMATORY
CHANGE<br>
OBX|8|CE|88304&amp;IMP|2|M-40000^INFLAMMATION NOS^SNM
</p>
<BR></TD></TR></TABLE><p><br>
	The example in Figure 5 has two segments for each component of the report, one
for each of the two tissues.  Thus, there are two 88304&amp;ANT segments; there
are two 88304&amp;GDT segments, and there are two 88304&amp;MDT segments.
Segments that apply to the gallbladder all have the sub-identifier 1.  Segments
that apply to the appendix all have sub-identifier 2.  <br>
	The observation sub ID has other grouping uses.  It can be used to organize
the reporting of some kinds of fluid intakes and outputs.  For example, when
intake occurs through multiple intravenous lines; a number of separate
observations (OBX segments), the intake volume, the type of intake (Blood, D5W,
Plasma, etc), the site of the IV line, etc. may be needed for each intravenous
line, each requiring a separate OBX segment.  If more than one IV line is
running, we can logically link all of the OBX segments that pertain to the
first IV line by assigning them an observation sub ID of 1.  We can do the same
with the second IV line by assigning them a sub ID 2 and so on.  The same would
apply to the outputs of surgical drains when there are multiple such drains.<br>
	Use a null or 1 when there is no need for multiples.</p>

<h4>
<A NAME="Heading43">7.3.2.5 Observation value  (*) 00573</A></h4>

<p><br>
	Definition:  value observed by the observation producer.  <i>OBX-2-value
type</i> contains the data type for this field according to which observation
value is formatted.  It is a required field in the OBX segment.<br>
	Representation <br>
	This field contains the value of <i>OBX-3-observation identifier</i> of the
same segment.  Depending upon the observation, the data type may be a number
(e.g., a respiratory rate), a coded answer (e.g., a pathology impression
recorded as SNOMED), or a date-time (the date-time that a unit of blood is sent
to the ward).  An observation value is always represented as the data type
specified in <i>OBX-2-value type</i> of the same segment.  Whether numeric or
short text, the answer shall be recorded in ASCII text.<br>
	Reporting Logically Independent Observations<br>
	The main sections of dictated reports, such as radiologic studies or history
and physicals, are reported as separate OBX segments.  In addition, each
logically independent observation should be reported in a separate OBX segment,
i.e. one OBX segment should not contain the "result" of more than one logically
independent observation.  This requirement is included to assure that the
contents of <i>OBX-6-units</i>, <i>OBX-8-abnormal flags</i>, and
<i>OBX-9-probability</i> can be interpreted unambiguously.  The electrolytes
and vital signs batteries, for example, would be reported as four separate OBX
segments.  Two diagnostic impressions, e.g., congestive heart failure and
pneumonia, would also be reported as two separate OBX segments whether reported
as part of a discharge summary or chest xray report.  Similarly, two bacterial
organisms isolated in a single bacterial culture would be reported as two
separate OBX segments.  <br>
	Though two independent diagnostic "statements" cannot be reported in one OBX
segment, multiple categorical responses are allowed (usually as CE data types
separated by repeat delimiters), so long as they are fragments (modifiers) that
together construct one diagnostic statement.  Right upper lobe (recorded as one
code) and pneumonia (recorded as another code), for example, could be both
reported in one OBX segment.  Such multiple "values" would be separated by
repeat delimiters.<br>
	Multiple OBX Segments With The Same Observation ID and Sub ID<br>
	In some systems, a single observation may include "fragments" of more than one
data type.  The most common example is a numeric result followed by coded
comments (CE).  In this case, the logical observation can be sent in more than
one OBX segment.  For example, one segment of numeric or string data type for
the numeric result and another segment of CE data type for coded comments.  If
the producer was reporting multiple coded comments they would all be sent in
one OBX segment separated by repeat delimiters because they all modified a
single logical observation.  Multiple OBX segments with the same observation ID
and sub ID should always be sent in sequence with the most significant OBX
segment (the one that has the normal flag/units and or reference range and
status flag) first.  The value of <i>OBX-6 through 12</i> should be null in any
following OBX segments with the same <i>  OBX-3-observation identifier</i> and
<i>OBX-4-observation sub-ID</i>.  For the purpose of replacement or deletion,
multiple OBX segments with the same observation ID and sub ID are treated as a
unit.  If any are replaced or deleted, they all are replaced.<br>
	Coded Values <br>
	When an OBX segment contains values of CE data types, the observations are
stored as a combination of codes and/or text.  In Section 7.4.4, examples of
results that are represented as CE data types are shown in the first and second
OBX segments of OBR 1 and the first and second OBX segments of OBR 2.  The
observation may be an observation battery ID (for recommended studies), a
diagnostic code or finding (for a diagnostic impression), or an anatomic site
for a pathology report, or any of the other kinds of coded results.<br>
	It is not necessary to always encode the information stored within a coded
observation.  For example, a chest xray impression could be transmitted as pure
text even though it has a CE data type.  In this case, the test must be
recorded as the second component of the "result code", e.g., <br>
 OBX|1|CE|71020&amp;IMP|1|^CONGESTIVE HEART FAILURE.<br>
	However, separate impressions, recommendations, etc., even if recorded as pure
text, should be recorded in separate result segments.  That is, congestive
heart failure and pneumonia should not be sent as:<br>
OBX|1|CE|71020&amp;IMP|1|^CONGESTIVE HEART FAILURE AND PNEUMONIA|<br>
	but as:<br>
OBX|1|CE|71020&amp;IMP|1|^CONGESTIVE HEART FAILURE| <br>
OBX|2|CE|71020&amp;IMP|2|^PNEUMONIA|.  <br>
	Even better would be fully-coded results that include computer understandable
codes (component 1) instead of, or in addition to, the text description
(component 2).</p>

<h4>
<A NAME="Heading44">7.3.2.6 Units (CE) 00574</A></h4>

<p><br>
	Components:  &lt;identifier&gt; ^ &lt;text&gt; ^ &lt;name of coding
system&gt;^ <br>
	&lt;alternate identifier&gt; ^ &lt;alternate text&gt; ^ &lt;name of alternate
coding system&gt;<br>
	Definition:  units have a data type of CE.  The default coding system for the
units codes consists of the ISO+ abbreviation for a single case unit (ISO
2955-83) plus extensions, that do not collide with ISO abbreviations (see
introductory section to this chapter).  We designate this coding system as
ISO+.  Both the ISO unit's abbreviations and the extensions are defined in
section 7.1.4 and listed in Figure 7-5.  The ISO+ abbreviations <i>are</i> the
codes for the default coding system.  Consequently, when ISO+ units are being
used, only ISO+ abbreviations need be sent, and the contents of the units field
will be backward compatible to HL7 vs. 2.1.  </p>

<h4>
<A NAME="Heading45">7.3.2.7 References range (ST) 00575  </A></h4>

<p><br>
	Components:  numeric values: &lt;lower limit - upper limit&gt;, e.g., for
potassium, 3.5 - 4.5.  <br>
		        alphabetical values: the normal value may be reported in this
location<br>
	Definition:  if the observation quantifies the amount of a toxic substance,
then the upper limit of the range identifies the toxic limit.  If the
observation quantifies a drug, the lower limits identify the lower therapeutic
bounds and the upper limits represent the upper therapeutic bounds above which
toxic side effects are common.</p>

<h4>
<A NAME="Heading46">7.3.2.8 Abnormal flags (ID) 00576</A></h4>

<p><br>
	Definition:  a table lookup indicating the normalcy status of the result.  We
strongly recommend sending this value when applicable.  If the observation is
an antibiotic susceptibility,  the interpretation codes are: S=sensitive;
R=resistant; I=intermediate; MS=moderately sensitive; VS=very sensitive. (See
ASTM 1238 - review for more details).  Refer to <i>Table 0078 - abnormal
flags</i> for valid entries. <br>
	When the laboratory can discern the normal status of a textual report, such as
chest xray reports or microbiologic culture, these should be reported as N when
normal and A when abnormal.  Multiple codes, e.g., abnormal and worse, would be
separated by a repeat delimiter, e.g., A~W. <br>
<center>Table 0078  Abnormal flags</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>L<br>
H<br>
LL<br>
HH<br>
&lt;<br>
&gt;<br>
N<br>
A<br>
AA<br>
null<br>
U<br>
D<br>
B<br>
W
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Below
low normal<br>
Above high normal<br>
Below lower panic limits<br>
Above upper panic limits<br>
Below absolute low-off instrument scale<br>
Above absolute high-off instrument scale<br>
Normal (applies to non-numeric results)<br>
Abnormal (applies to non-numeric results)<br>
Very abnormal (applies to non-numeric units, analagous to panic limits for
numeric units)<br>
No range defined, or normal ranges don't apply<br>
Significant change up<br>
Significant change down<br>
Better--use when direction not relevant<br>
Worse--use when direction not relevant
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>For
microbiology sensitivities only:
</p>
<BR></TD>
<TD colspan=1 align="left"><BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>S<br>
R<br>
I<br>
MS<br>
VS
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Sensitive<br>
Resistant<br>
Intermediate<br>
Moderately sensitive<br>
Very sensitive
</p>
<BR></TD></TR></TABLE><p>
</p>

<h4>
<A NAME="Heading47">7.3.2.9 Probability (NM) 00577</A></h4>

<p><br>
	Definition:  probability of a result being true for results with categorical
values.  It mainly applies to discrete coded results.  It is a decimal number
represented as an ASCII string that must be between 0 and 1, inclusive. <br>
 </p>

<h4>
<A NAME="Heading48">7.3.2.10 Nature of abnormal test (ID) 00578</A></h4>

<p><br>
	Definition:  refer to <i>table 0080 - nature of abnormal testing</i> for valid
codes. <br>
<center>Table 0080  Nature of abnormal testing </center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>A<br>
N<br>
R<br>
S
</p>
<BR></TD>
<TD colspan=1 align="left"><p>An
age-based population<br>
None - generic normal range<br>
A race-based population<br>
A sex-based population
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading49">7.3.2.11 Observ result status (ID) 00579</A></h4>

<p><br>
	Definition:  refer to <i>table 0085 - Observation result status</i> for valid
codes. This field reflects the current completion status of the results for one
Observation Identifier.<br>
<center>Table 0085  Observation result status codes interpretation</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u></u></b><u>Value</u></p>
<BR></TD>
<TD colspan=1 align="left"><p><u>Description</u></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>C<br>
D<br>
F<br>
I<br>
P<br>
R<br>
S<br>
X<br>
U
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Record
coming over is a correction and thus replaces a result<br>
Deletes the OBX record<br>
Final results;  Can only be changed with a corrected result.<br>
Specimen in lab; results pending<br>
Preliminary results<br>
Results entered -- not verified<br>
Partial results<br>
Results cannot be obtained for this observation<br>
Results status change to Final.  Results did not change (don't transmit test).
E.g., radiology changes status from preliminary to final
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading50">7.3.2.12 Effective date last obs normal value (TS) 00580</A></h4>

<p><br>
	Definition:  changes in the observation methods that would make values
obtained from the old method not comparable with those obtained from the new
method.<br>
	Null if there are no normals or units.  If present, a change in this date
compared to date-time recorded, the receiving system's test dictionary should
trigger a manual review of the results to determine whether the new observation
ID should be assigned a new ID in the local system to distinguish the new
results from the old. </p>

<h4>
<A NAME="Heading51">7.3.2.13 User defined access checks  (ST) 00581</A></h4>

<p><br>
	Definition:  permits the producer to record results-dependent codes for
classifying the observation at the receiving system.  This field should be
needed only rarely, because most classifications are fixed attributes of the
observation ID and can be defined in the associated observation master file
(see description in section 7.1). <br>
	However, there are a few cases when such controls vary with the value of the
observation in a complex way that the receiving system would not want to
re-calculate.  An example is an antimicrobial sensitivity result.  Some systems
prefer to display only the sensitivity results of inexpensive antibiotics
depending upon the organism, the source of the specimen and the patients
allergy status.  The sending service wants to send all of the sensitivities so
that certain privileged users (e.g., Infectious Disease specialists) can review
all of the results but nonprivileged users would see only the "preferred"
antibiotics to which the organism was sensitive.  We expect that other cases
also occur.</p>

<h4>
<A NAME="Heading52">7.3.2.14 Date-time of the observation  (TS) 00582</A></h4>

<p><br>
	Definition:  required in two circumstances.  The first is when the
observations reported beneath one report header (OBR) have different dates.
This could occur in the case of queries, timed test sequences, or clearance
studies where one measurement within a battery may have a different time than
another measurement. <br>
	It is also needed in the case of OBX segments that are being sent by the
placer to the filler, in which case the date of the observation being
transmitted is likely to have no relation to the date of the requested
observation.  In France, requesting services routinely send a set of the last
observations along with the request for a new set of observations.  The date of
these observations is important to the filler laboratories.<br>
	In all cases, the observation date-time is the physiologically relevant
date-time or the closest approximation to that date-time.  In the case of tests
performed on specimens, the relevant date-time is the specimen's collection
date-time.  In the case of observations taken directly on the patient (e.g.,
xray images, history and physical), the observation date-time is the date-time
that the observation was performed. </p>

<h4>
<A NAME="Heading53">7.3.2.15 Producer's ID (CE) 00583</A></h4>

<p><br>
<tt>	Components:  &lt;identifier&gt; ^ &lt;text&gt; ^ &lt;name of coding
system&gt;^ &lt;alternate identifier&gt; ^ &lt;alternate text&gt; ^ &lt;name of
alternate coding system&gt;</tt><br>
	Definition:  unique identifier of the responsible producing service.  It
should be reported explicitly when the test results are produced at outside
laboratories, for example.  When this field is null, the receiving system
assumes that the observations were produced by the sending organization.  This
information is needed to satisfy CLIA regulations in the US.  The code for
producer ID is recorded as a CE data type.  In the US, the Medicare number of
the producing service is suggested as the identifier.</p>

<h4>
<A NAME="Heading54">7.3.2.16 Responsible Observer (CN) 00584</A></h4>

<p><br>
<tt>	Components:  &lt;physician ID&gt; ^ &lt;family name&gt; ^ &lt;given
name&gt; ^ &lt;middle initial or name&gt; ^ &lt;suffix (e.g., JR or III)&gt; ^
&lt;prefix (e.g., DR)&gt; ^ &lt;degree (e.g., MD)&gt; ^ &lt;source table
ID&gt;</tt><br>
	Definition:  when required, the identifier of the individual directly
responsible for the observation (i.e., the person who either performed or
verified it).  In a nursing service, the observer is usually the professional
who performed the observation (e.g., took the blood pressure).  In a
laboratory, the observer is the technician who performed or verified the
analysis.  The code for the observer is recorded as a CE data type.  If the
code is sent as a local code, it should be unique and unambiguous when combined
with <i>OBX-15-producer ID</i>.</p>
<h2>
</h2>

<h2>
<A NAME="Heading55">7.4  EXAMPLE TRANSACTIONS </A></h2>

<p>
  </p>
<h3>
</h3>

<h3>
<A NAME="Heading56">7.4.1  Query/response </A></h3>

<p><br>
	The following is a query of the EKG system for the data for a particular
patient number 0123456-1 for reports that have been modified or created since
1/1/88.  The response ends with a continuation pointer.  A continuation query
follows, in reply to which a continutation response is sent.<br>
   <br>
	Query (QRY)<br>
   <br>
<tt>MSH|^~\&amp;|CBD||EKG||||QRY^R02|CDB22222|P&lt;CR&gt;   </tt><br>
<tt>QRD|198904180943|R|I|Q4412|||10|RD|0123456-1|RES&lt;CR&gt;   </tt><br>
<tt>QRF|EKG||198801010000&lt;CR&gt;</tt><br>
	Response<br>
<tt>MSH|^~\&amp;|EKG||CDB||||ORF^R04|X981672|P&lt;CR&gt;   </tt><br>
<tt>MSA|AA|CDB22222|P&lt;CR&gt;   </tt><br>
<tt>QRD|198904180943|R|I|Q4412|||10|RD|0123456-1|RES&lt;CR&gt;   </tt><br>
<tt>QRF|EKG||198804010000&lt;CR&gt;   </tt><br>
<tt>PID|1|0123456-1||ROBERTSON^JOHN^H|||||||9821111&lt;CR&gt;   </tt><br>
<tt>OBR|1|43215^OE|98765^EKG|93000^EKG
REPORT|R|198801111000|198801111330|||RMT||||</tt><br>
<tt>	... 1988011 11330|?|P030||||||198801120930||||||88-126666|A111|</tt><br>
<tt>	... VIRANYI ^ANDREW&lt;CR&gt;   </tt><br>
<tt>OBX|1|ST|93000.1^VENTRICULAR RATE(EKG)||91|/MIN|60-100&lt;CR&gt;   </tt><br>
<tt>OBX|2|ST|93000.2^ATRIAL RATE(EKG)||/MIN|60-100&lt;CR&gt;   </tt><br>
<tt>OBX|3|ST|93000.3^PR INTERVAL||0|/MSEC|1.06-.10&lt;CR&gt;   </tt><br>
<tt>OBX|4|ST|93000.4^QRS INTERVAL||368|/MSEC|.18-.22&lt;CR&gt;   </tt><br>
<tt>               ...   </tt><br>
<tt>               ...   </tt><br>
<tt>               ...   </tt><br>
<tt>OBX|8|CE|93000&amp;IMP^EKG DIAGNOSES|1|^ATRIAL FIBRILATION&lt;CR&gt;
</tt><br>
<tt>OBX|9|CE|93000&amp;IMP^EKG DIAGNOSIS|2|^ST DEPRESSION&lt;CR&gt;  </tt><br>
<tt>OBX|109|FT||93000&amp;ADT^EKG COMMENT||\.in+4\\.ti-4\ 1. When compared with
EKG of</tt><br>
<tt>	... 31-oct-88 ventricular rate has increased by 30 bpm.\.sp\\.ti-4\
</tt><br>
<tt>	... 2. Criteria for Lateral infarct are no longer present.&lt;cr&gt;
</tt><br>
<tt>OBR|2|43217^OE|98767^EKG|93000^EKG
REPORT||198810311004|198810311004||||?|||198810311004|?|P030||||||198810311744||||||</tt><br>
<tt>	... 88-126689|A122|BREAL|WILLIAM&lt;CR&gt;   </tt><br>
<tt>               ...   </tt><br>
<tt>               ...   </tt><br>
<tt>               ...   </tt><br>
<tt>DSC|1896X22;0123456-1&lt;CR&gt;   </tt><br>
	Continuation Query<br>
<tt>MSH|^~\&amp;|CDB||EKG||||QRY^R02|CDB22289|P&lt;CR&gt;   </tt><br>
<tt>QRD|198904180943|R|I|Q4412|||10|RD|0123456-1|RES&lt;CR&gt;   </tt><br>
<tt>QRF|EKG||1988040100000&lt;CR&gt;   </tt><br>
<tt>DSC|1896X22;0123456-1&lt;CR&gt;</tt>   <br>
	Continuation Response   <br>
<tt>MSH|^~\&amp;|EKG||CDB||||ORF^R04|X981672|P&lt;CR&gt;   </tt><br>
<tt>MSA|AA|CDB22289|P&lt;CR&gt;   </tt><br>
<tt>QRD|198904180943|R|I|Q4412|||10|RD|0123456-1RES&lt;CR&gt;   </tt><br>
<tt>QRF|EKG||198804010000&lt;CR&gt;   </tt><br>
<tt>PID||0123456-1||ROBERTSON^JOHN^H|||||||9821111&lt;CR&gt;   </tt><br>
<tt>OBR| ...   </tt><br>
<tt>     ...   </tt><br>
<tt>     ...   </tt></p>
<h3>
</h3>

<h3>
<A NAME="Heading57">7.4.2  Unsolicited </A></h3>

<p><br>
	The following is an unsolicited transmission of radiology data.     <br>
<tt>MSH|^~\&amp;|XRAY||CDB||||ORU^R01|K172|P&lt;CR&gt;   </tt><br>
<tt>PID|1|0123456-1||ROBERTSON^JOHN^H|||||||9821111&lt;CR&gt;   </tt><br>
<tt>OBR|1|X89-1501^OE|78912^RD|71020^CHEST XRAY AP &amp;
LATERAL|R|198703291530|19873290800|||JBM|N &lt;CR&gt;</tt><br>
<tt>OBX|1|CE|71020&amp;IMP^RADIOLOGIST'S IMPRESSION|4||^MASS LEFT LOWER
LOBE|1||A&lt;CR&gt;  </tt><br>
<tt>OBX|2|CE|71020&amp;IMP|2|^INFILTRATE RIGHT LOWER LOBE|||A&lt;CR&gt;</tt><br>
<tt>OBX|3|CE|71020&amp;IMP|3|^HEART SIZE NORMAL|||N&lt;CR&gt;</tt><br>
<tt>OBX|4|FT|71020&amp;GDT|1|circular density (2 x 2 cm) is seen in the
posterior segment of</tt><br>
<tt>	... the LLL.  A second, less well-defined infiltrated circulation density
is</tt><br>
<tt>	... seen in the R mid lung field and appears to cross the minor
fissure#&lt;CR&gt;</tt><br>
<tt>OBX|5|CE|71020&amp;REC||71020^Follow up CXR 1 month||30-45|&lt;CR&gt;</tt>
<br>
	Example message (from ASTM 1238-91)</p>

<h3>
<A NAME="Heading58">7.4.3 Example message (from ASTM 1238-91)</A></h3>

<p><br>
	Laboratory message:  electrolytes, CBC, sed rate, blood cultures and
sensitivities ... &lt;CR&gt;<br>
<tt>MSH...</tt><br>
<tt>PID|...</tt><br>
	Eletrolytes:<br>
<tt>OBR|1|870930010^OE|CM3562^LAB|80004^ELECTROLYTES|R|198703281530|198703290800|||</tt><br>
<tt>	...
401-0^INTERN^JOE^^^^MD^L|N|||||SER|^SMITH^RICHARD^W.^^^DR.|(319)377-4400|</tt><br>
<tt>	... This is requestor field #1. Requestor field #2|Diag.serv.field
#1.|</tt><br>
<tt>	... Diag.serv.field #2.|198703311400|||F&lt;CR&gt; </tt><br>
<tt>OBX|1|ST|84295^NA||150|mmol/l|136-148|H||A|F|19850301&lt;CR&gt; </tt><br>
<tt>OBX|2|ST|84132^K+||4.5|mmol/l|3.5-5|N||N|F|19850301&lt;CR&gt; </tt><br>
<tt>OBX|3|ST|82435^CL||102|mmol/l|94-105|N||N|F|19850301&lt;CR&gt; </tt><br>
<tt>OBX|4|ST|82374^CO2||27|mmol/l|24-31|N||N|F|19850301&lt;CR&gt; </tt><br>
	CBC:<br>
<tt>OBR|2|870930011^OE|HEM3268^LAB|85022^CBC|R|198703281530|198703290800|||401-0 ^</tt><br>
<tt>	... INTERN^JOE^^^^MD^L|N||||BLD|^SMITH^RICHARD^W.^^^DR.|(319)377-4400|This
is</tt><br>
<tt>	... requestor field #1.|This is Requestor field #2.|This is lab field
#1.|Lab</tt><br>
<tt>	... field #2.|198703311400|||F&lt;CR&gt; </tt><br>
<tt>OBX|1|ST|85018^HGB||13.4|GM/DL|14-18|N||S|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|2|ST|85014^HCT||40.3|%|42-52|L||S|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|3|ST|85041^RBC||4.56|10*6/ml|4.7-6.1|L||S|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|4|ST|85021.11^MCV||88|fl|80-94|N||S|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|5|ST|85021.21^MCH||29.5|pg|27-31|N||N|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|6|ST|85041.25^MCHC||33|%|33-37|N||N|F|19860522&lt;CR&gt; </tt><br>
<tt>OBX|7|ST|85048^WBC||10.7|10*3/ml|4.8-10.8|N||N|F|19860522&lt;CR&gt;
</tt><br>
<tt>OBX|8|ST|85048.18^BAND NEUT.%||2|%||||F&lt;CR&gt; </tt><br>
<tt>OBX|9|ST|85048.16^SEG.NEUT.%||67|%||||F&lt;CR&gt; </tt><br>
<tt>OBX|10|ST|85048.42^LYMPH.%||29|%||||F&lt;CR&gt; </tt><br>
<tt>OBX|11|ST|84048.52^MONOCYTE.%||1|%||||F&lt;CR&gt; </tt><br>
<tt>OBX|12|ST|85012.1^EOSIN.%||2|%||||F&lt;CR&gt; </tt><br>
	Sed rate:<br>
<tt>OBR|3|870930011^OE|HEM3269^LAB|85650^ESR|R|198703281530|198703290800|||</tt><br>
<tt>	...
401-0^INTERN^JOE^^^^MD^L|N||||BLD|^SMITH^RICHARD^W.^^^DR.|(319)377-4400|</tt><br>
<tt>	... This is requestor field #1.|This is Requestor field #2.|This is lab
field</tt><br>
<tt>	... #1.|Lab field #2.|198703311400|||F&lt;CR&gt; </tt><br>
<tt>OBX|1|ST|85650^ESR||7|MM/HR|0-10|N||S|F|19860522|E|1|1792|27&lt;CR&gt;
</tt><br>
	Parent micro result, identifies organism<br>
<tt>OBR|4|2740X^OE|BC376^MIC|87040^Blood
culture|R|198703280600|198703290800|||</tt><br>
<tt>	... 99-2^JONES&amp;COLLECTOR|N|Hepatitis risk||198703290830|Bld|</tt><br>
<tt>	... 4010^INTERN^JOE^^^^MD^L|X3472|Requestor field 1|Requestor field
2|</tt><br>
<tt>	... Producer's field 1|Producer's field
2|198703301000|35.00|MB|F|&lt;CR&gt;</tt><br>
<tt>OBX|1|CE|87040^Blood culture|1|^E Coli|||A||F&lt;CR&gt;</tt><br>
<tt>OBX|2|CE|87040^Blood culture|2|^S Aureus|||A||F&lt;CR&gt;</tt><br>
	Child micro result, gives antibiotic sensitivities for organism identified in
first OBX of parent<br>
	<br>
<tt>OBR|5|2740X^OE|BC402^MIC|87186^Antibiotic
MIC|R|198703281230|198703290800||||G|</tt><br>
<tt>	... Hepatitis
risk||198703290830|Bld|401.0^INTERN^JOE^^^^MD^L|X3472|||||</tt><br>
<tt>	...
198703310900|40.00|MB|F|87040^1|||2740X&amp;OE^BC376&amp;MIC&lt;CR&gt;</tt><br>
<tt>OBX|1|ST|87186.2^Ampicillin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|2|ST|87186.5^Carbenicillin MIC||&lt;16|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|3|ST|87186.21^Gentamicin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|4|ST|87186.33^Tetracycline MIC1||&lt;1|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|5|ST|87186.29^Piperacillin MIC||&lt;8|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|6|ST|87186.15^Cefuroxime MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|7|ST|87186.16^Cephalothin MIC||&lt;8|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|8|ST|87186.3^Amoxicillin-Clavulanate||&lt;4|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|9|ST|87186.56^Thienamycin MIC||&lt;1|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|10|ST|87186.17^Chloramphen MIC||&lt;4|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|11|ST|87186.37^Tobramycin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|12|ST|87186.7^Amakacin MIC||&lt;4|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|13|ST|87186.36^Trimeth-Sulf MIC||&lt;2/38|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|14|ST|87186.8^Cefazolin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|15|ST|87186.39^Cefoxitin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|16|ST|87186.14^Ceftriazone MIC||&lt;4|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|17|ST|87186.44^Ceftazidime MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|18|ST|87186.34^Timentin MIC||&lt;8|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|19|ST|87186.41^Ciprofloxacn-MIC||&lt;1|ug/ml||S|&lt;CR&gt;</tt><br>
	Second micro child result, gives sensitivities or organism identified by
Second OBX of parent<br>
<tt>OBR|6|2740X^OE|BC403^MIC|87186^Antibiotic
MIC|R|198703281230|198703290800||||G|</tt><br>
<tt>	... Hepatitis
risk||198703290830|Bld|401.0^INTERN^JOE^^^^MD^L|X3472|||||</tt><br>
<tt>	...
198703310900|40.00|MB|F|87040^2|||2740X&amp;OE^BC376&amp;MIC&lt;CR&gt;</tt><br>
<tt>OBX|1|ST|87186.2^Ampicillin MIC||&lt;8|ug/ml||R|&lt;CR&gt;</tt><br>
<tt>OBX|2|ST|87186.18^Clindamycin MIC||&lt;.25|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|3|ST|87186.21^Gentamicin MIC||&lt;1|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|4|ST|87186.19^Erythromycin MIC||&lt;.5|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|5|ST|87186.27^Oxacillin MIC||&lt;.5|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|6|ST|87186.38^Vancomycin MIC||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|7|ST|87186.28^Penicillin MIC||&lt;8|ug/ml||R|&lt;CR&gt;</tt><br>
<tt>OBX|8|ST|87186.16^Cephalothin MIC2||&lt;2|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|9|ST|87186.17^Chloramphen MIC||&lt;4|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|10|ST|87186.1^Amikacin MIC||&lt;16|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|11|ST|87186.41^Ciprofloxacn-MIC||&lt;1|ug/ml||S|&lt;CR&gt;</tt><br>
<tt>OBX|12|ST|87186.31^Rifampin MIC||&lt;1|ug/ml||S|&lt;CR&gt;</tt></p>
<h3>
</h3>

<h3>
<A NAME="Heading59">7.4.4  Example of narrative report messages (from ASTM 1238-91) </A></h3>

<p><br>
	This example of the body of reports shows the following observation from what
are usually free text reports.  The text within these examples that begins with
**-- and ends with --** are explanatory comments, not a formal part of the
message.  The following outline shows the segments that are included in this
example message.<br>
	a)	patient identifying record (PID)<br>
	b)	EKG order record (OBR)<br>
	c)	EKG coded result record (OBX)<br>
	d)	EKG result records (OBX):<br>
		 1)	ventricular rate<br>
		 2)	atrial rate<br>
		 3)	QRS width<br>
		 4)	PR interval<br>
	e)	order record for chest x-ray (OBR)<br>
	f)	two diagnostic impressions for CXR (OBX)<br>
	g)	description record for CXR (OBX)<br>
	h)	a recommendation record for CXR (OBX)<br>
	i)	an order record for surgical pathology (OBR)<br>
	j)	a gross description record for pathology showing use of anatomy fields
(OBX)<br>
	k)	a microscopic description record for pathology (OBX)<br>
	l)	vital signs request (OBR)<br>
	m)	six vital signs (OBX)<br>
	n)	part of the physical history (OBR &amp; OBX)<br>
	o)	end record<br>
<tt>... MSH ...</tt><br>
<tt>... PID ...</tt><br>
**--Order record for EKG--**<br>
<tt>OBR|1|P8753^OE|EK5230^EKG|93000^EKG|R|198703281530|198703290800|||401-0^INTERN^JOE^^^^MD^L|N
&lt;CR&gt;</tt><br>
**--Two interpretation records for EKG--**<br>
**--[In this case, the result observation ID assumes the observation code in
the order record.]--**<br>
<tt>OBX|1|CE|&amp;IMP|1|^Sinus bradycardia|||A &lt;CR&gt;</tt><br>
<tt>OBX|2|CE|&amp;IMP|2|^Occasional PVCs|||A &lt;CR&gt;</tt><br>
**--Four numeric results for EKG--**<br>
**--[The AS4 code is an extension of the CPT4 code (93000) for EKG plus
extension .1, .2, etc., as detailed in Appendix 7.A.]--**<br>
<tt>OBX|3|ST|93000.2^Ventricular rate||80|/min|60-100 &lt;CR&gt;</tt><br>
<tt>OBX|4|ST|93000.3^Atrial rate||80|/min|60-100 &lt;CR&gt;</tt><br>
<tt>OBX|5|ST|93000.5^QRS width||.08|msec|.06-.10 &lt;CR&gt;</tt><br>
<tt>OBX|6|ST|93000.4^PR interval||.22|msec|.18-.22 &lt;CR&gt;</tt><br>
**--Order record for CXR--**<br>
<tt>OBR|2|P8754^OE|XR1501^XR|71020^Chest Xray AP &amp;
Lateral|R|198703281530|198703290800|||</tt><br>
<tt>   401-0^INTERN^JOE^^^^MD^L|N &lt;CR&gt;</tt><br>
**--Two CXR diagnostic impressions--**<br>
<tt>OBX|1|CE|71020&amp;IMP^Radiologist's
Impression|1|.61^RUL^ACR~.212^Bronchopneumonia^ACR|||A&lt;CR&gt;</tt><br>
<tt>OBX|2|CE|71020&amp;IMP|2|51.71^Congestive heart
failure^ACR|||A&lt;CR&gt;</tt><br>
**--CXR Description with continuation records--**<br>
<tt>OBX|3|TX|71020&amp;GDT||Infiltrate probably representing bronchopneumonia
in the right lower lobe.  Also pulmonary venous congestion cardiomegaly and
cephalization, indicating early congestive heart failure.&lt;CR&gt;</tt><br>
**--Recommendations about CXR report to follow up one month with a repeat
CXR--**<br>
<tt>OBX|4|CE|71020&amp;REC||71020^Followup CXR 1 month^AS4&lt;CR&gt; </tt><br>
**--Order record for pathology report--**<br>
<tt>OBR|3|P8755^OE|SP89-739^SP|88304^Surgical Path
Report|R|198703281530|198703290800|||401-0^INTERN^JOE^^^^MD^L|N&lt;CR&gt;</tt><br>
<tt>OBX|1|CE|&amp;ANT|1|Y0480-912001^orbital region^SNM&lt;CR&gt;</tt><br>
**--Gross description record (with overflow) for pathology--**<br>
<tt>OBX|2|TX|&amp;GDT^GrossSpecimenDescription|1|The specimen is received in
four containers.  The first is labeled with the patient's name and consists of
three fragments of reddish-brown tissue each of which measures 2 mm in greatest
dimension.  They are wrapped in tissue paper and submitted in toto in a single
cassette| &lt;CR&gt;</tt><br>
**--Microscopic description record for pathology--**<br>
<tt>OBX|3|TX|&amp;MDT^MicroscopicDescription|1|A|Sections of the first specimen
received for frozen section diagnosis reveal thick walled, ramifying vessels
lined by a single layer of flattened endothelial cells.  The thick smooth
muscle walls exhibit no malignant cytologic features nor do the endothelial
lining cells.  Within the same specimen are also found fragments of fibrous
connective tissue, bone, and nerve which are histologically
unremarkable&lt;CR&gt;</tt><br>
**--Vital signs--**<br>
<tt>OBR|4|P8756^OE|N2345^NR|3000.02^VITAL
SIGNS|R|198703281530|198703290800|||401-0^INTERN^JOE^^^^MD^L|N&lt;CR&gt;</tt><br>
<tt>OBX|1|ST|1002.3^BP DIAS||90|mm(hg)|60-90|&lt;CR&gt;</tt><br>
<tt>OBX|2|ST|1002.2^BP SYS||120|mm(hg)|100-160|&lt;CR&gt;</tt><br>
<tt>OBX|3|ST|1002.4^BP MEAN||100|mm(hg)|80-120|N&lt;CR&gt;</tt><br>
<tt>OBX|4|ST|1006.2^HEART RATE||74|/min|60-100|N&lt;CR&gt;</tt><br>
<tt>OBX|5|ST|1002.1^BP METHOD||MANUAL BY CUFF|&lt;CR&gt;</tt><br>
<tt>OBX|6|ST|1006.1^PULSE METHOD||MANUAL BY PALP|&lt;CR&gt;</tt><br>
**--Part of the patient's history--** <br>
<tt>OBR|5|P8568^OE|HX2230^CLN||2000^HISTORY|R|198703281530|198703290800|401-0^INTERN^JOE^^^^MD^L|N&lt;CR&gt;</tt><br>
<tt>OBX|1|CE|2000.40^CHIEF COMPLAINT|| ... &lt;CR&gt;</tt><br>
<tt>OBX|2|ST|2000.01^SOURCE||PATIENT&lt;CR&gt;</tt><br>
<tt>OBX|3|TX|2000.02^PRESENT ILLNESS||SUDDEN ONSET OF CHEST PAIN. 2 DAYS, PTA
ASSOCIATED WITH NAUSEA, VOMITING &amp; SOB.  NO RELIEF WITH ANTACIDS OR NTG. NO
OTHER SX. NOT PREVIOUSLY ILL.&lt;CR&gt;</tt><br>
<tt>	.</tt><br>
<tt>	.</tt><br>
and so on.</p>
<h3>
</h3>

<h3>
<A NAME="Heading60">7.4.5  Reporting cultures and sensitivities </A></h3>

<p></p>

<h4>
<A NAME="Heading61">7.4.5.1 Culture battery/report representation</A></h4>

<p><br>
	Organisms and other observations/tests are reported using multiple OBX
segments.  The granularity expected for HL7 culture reports is one observation
per organism.<br>
	All OBX segments which have the same observation ID and sub-ID are part of a
single observation.<br>
	Each organism in a culture battery is assigned a unique <i>OBX-4-observation
sub-ID </i>(and is therefore a separate observation).  The organism name is
given in <i>OBX-5-observation value </i>(results).  It is recommended, but not
required that the organism name may change over time, but the corresponding
observation sub-ID never changes.  (The observation ID will be identical for
all organisms reported.)<br>
	Recommended:<br>
<tt>OBX||CE|organism^413^L|1|^E. Coli|</tt><br>
<tt>OBX||CE|organism^413^L|2|^S. Aureus|</tt><br>
	<br>
	Not Recommended:	<br>
<tt>OBX||CE|organism1^413^L|1|^E. Coli|</tt><br>
<tt>OBX||CE|organism2^413^L|1|^S. Aureus|</tt></p>

<h4>
<A NAME="Heading62">7.4.5.2 Sensitivity battery/report representation</A></h4>

<p><br>
	Each antibiotic should be reported as a separate (OBX) observation where the
Observation ID is a code for the antibiotic.  (OBXs for non-antibiotic
observations and related information may be present in the same battery.)<br>
	MIC and Kirby Bauer sensitivity results cannot be combined in the same OBX
segment.  An OBX can contain an MIC value (in <i>OBX-5-observation value</i>
(results)) and <i>OBX-8-abnormal flag</i> that indicates whether the organism
is sensitive, resistant, or intermediate (see Table 0078 under abnormal flag
fields).<br>
	Or, an OBX can contain a Kirby Bauer result string (e.g., "sensitive") in the
Observation Results field and the Kirby Bauer interpretation in
<i>OBX-8-abnormal flags</i> (e.g., "S").<br>
	A sensitivity battery may only contain results corresponding to a single
organism that has been previously reported in a culture battery.</p>

<h4>
<A NAME="Heading63">7.4.5.3 Identification of the organism for a sensitivity battery</A></h4>

<p><br>
	The following is the preferred, but not required method of organizing data
about antibiotic sensitivities.<br>
	A sensitivity battery may only contain results corresponding to a single
organism that has been previously reported in a culture battery.<br>
	A sensitivity battery is always a child "order" to a culture battery.
<i>OBR-29-parent number</i> (parent's filler order number) in the sensitivity
OBR is equal to <i>OBR-3-filler order number</i> in the parent culture OBR and
is used to link the two batteries logically.<br>
	The sensitivity battery also contains a linkage back to a particular organism
in the culture battery.  <i>OBR-26-parent result</i> of the sensitivity OBR
contains two components--<i>OBX-3-observation identifier</i> (code only) and
<i>OBX-4-observation sub-ID</i> of the OBX in the culture battery which
contains the organism name.<br>
	The identity of an organism/isolate is expected to be refined over time.  When
an organism identification changes, the parent culture battery can be resent
without resending the child sensitivity battery.<br>
	The case may occur where a sensitivity battery is reported on an organism
which has not yet been identified.  In this case, it is required that a
placeholder OBX for the organism name be reported in the corresponding culture
battery so that <i>OBR-26-parent result</i> in the sensitivity OBR will point
to a valid organism OBX in the culture battery.  Transmission of an organism
OBX (in the culture battery) with the Sub-ID field valued must precede the
sensitivity battery which uses the identical Sub-ID in <i>OBR-26-parent
result</i>.<br>
	Discussion and examples:<br>
	Order Micro Results (Blood Culture)<br>
<tt>MSH|^~\&amp;|LAB1||DESTINATION||19910127105114||ORU^R03|LAB1003929</tt><br>
<tt>PID|||900329493||PETRSN~DAVID|||927</tt><br>
<tt>PV1||I|</tt><br>
<tt>ORC|NW|</tt><br>
<tt>OBR||A485388^OE|H29847^LAB1|BLOOD CULTURE|||</tt><br>
	Result for Culture<br>
<tt>ORC|RE</tt><br>
<tt>OBR||A485388^OE|H29847^LAB1|BLOOD CULTURE||</tt><br>
<tt>OBX||FT|SDES^SOURCE||BLOOD-RAPID||</tt><br>
<tt>OBX||FT|EXAM^MICROSCOPIC||GRAM POSITIVE COCCI IN GROUPS||</tt><br>
<tt>OBX||FT|ORGANISM^IDENTIFIER|1|ISOLATE 1||</tt><br>
	Result for Sensitivity<br>
<tt>ORC|RE</tt><br>
<tt>OBR||A485388^OE|H29848^LAB1|BT1^SUSCEPTIBILITY BATTERY|||||MC|to
field</tt><br>
<tt>	... 26|ORGANISM^1|||A485388&amp;OE^H29847&amp;LAB1|</tt><br>
<tt>OBX||CE|ACAPEN^PENICILLIN||0.5|R||</tt><br>
<tt>OBX||CE|ACHNAF^NAICILLIN||1|R||</tt><br>
<tt>OBX||CE|ACHCCLI^CLINDAMYCIN||&lt;=0.1|S||</tt><br>
	Result for Culture ID<br>
ORC|RE<br>
OBR||A485388^OE|H29847^LAB1|BLOOD CULTURE||<br>
OBX||FT|ORGANISM^IDENTIFIER|1|STAPH EPI||<br>
	New Result for Culture ID<br>
ORC|RE<br>
OBR||A485388^OE|H29847^LAB1|BLOOD CULTURE||<br>
OBX||FT|ORGANISM^IDENTIFIER|1|STAPH EPI SERO TYPE 3||<br>
	Assumptions<br>
		1.	All OBXs in the parent order must employ the same coding scheme.<br>
		2.	The Sub-ID of the parent OBXs (result) cannot change.</p>
<h3>
</h3>

<h3>
<A NAME="Heading64">7.4.6  Results reporting </A></h3>

<p><br>
	Suppose an order has been placed to the EKG system for three EKGs to be
performed on successive days.  These results can be reported in various
ways.<br>
	1.  The EKG application needs to communicate to anyone the results of the 1st
EKG:<br>
		ORU message:<br>
<tt>MSH|...</tt><br>
<tt>PID|...</tt><br>
<tt>OBR|||89-551^EKG|93000^EKG REPORT|...         // 1ST child OBR.</tt><br>
<tt>OBX||ST|93000.1^VENTRICULAR RATE (EKG)|...</tt><br>
<tt>OBX||ST|93000.2^...</tt><br>
<tt>	...</tt><br>
<tt>	...</tt><br>
<tt>OBX||FT|93000.14^EKG COMMENT|...</tt><br>
<tt>OBR|...                                        // other observation
segments to follow</tt><br>
	-		Notice that this report is without reference to the original order.<br>
	-		No ORC is required because the identifying Filler's Order Number (and other
ORC fields) are carried in the OBR segment.<br>
	2.	The EKG application needs to communicate to anyone the original order
information, the details of the child orders, the fact of the child spin off,
and the results of all three EKGs:<br>
		ORU message:<br>
<tt>MSH|...</tt><br>
<tt>PID|.</tt><br>
<tt>ORC|PA|A226677^OE|89-450^EKG|...           // original order's ORC.</tt><br>
<tt>OBR||||93000^EKG REPORT|...         // original order segment</tt><br>
<tt>ORC|CH|A226677^OE|89-451^EKG&lt;CR&gt;           // 1st child ORC.</tt><br>
<tt>OBR||||93000^EKG REPORT|...         // 1st EKG child OBR.</tt><br>
<tt>OBX||ST...                          // 1st EKG report</tt><br>
<tt>OBX||ST...</tt><br>
<tt>	...</tt><br>
<tt>OBX||FT...</tt><br>
<tt>ORC|CH|A226677^OE|89-452^EKG&lt;CR&gt;           // 2nd child ORC.</tt><br>
<tt>OBR||||93000^EKG REPORT|...         // 2nd EKG child OBR.</tt><br>
<tt>OBX||ST...                          // 2nd EKG report</tt><br>
<tt>OBX||ST...</tt><br>
<tt>	...</tt><br>
<tt>OBX||FT...</tt><br>
<tt>ORC|CH|A226677^OE|89-453^EKG&lt;CR&gt;           // 3rd child ORC.</tt><br>
<tt>OBR||||93000^EKG REPORT|...         // 3rd EKG child OBR.</tt><br>
<tt>OBX||ST...                          // 3rd EKG report</tt><br>
<tt>OBX||ST...</tt><br>
<tt>	...</tt><br>
<tt>OBX||FT...</tt><br>
<tt>    ...                             // Other parts of message might
follow.</tt><br>
	-	In this case, we are transmitting the information about the fact of child
spin off, the original order and the results all at the same time.  Thus, this
form of the ORU message reports not only the results of an order, but all of
its associated ordering information including the original OBR for three EKGs
that was replaced by three separate OBR EKG segments.</p>
<h3>
</h3>

<h3>
<A NAME="Heading65">7.4.7  Patient-specific clinical data with an order -</A></h3>

<p><br>
		Reporting body weight and height with a creatinine clearance.<br>
<tt>MSH|...</tt><br>
<tt>PID|...</tt><br>
<tt>ORC|NW|...                          // New order.</tt><br>
<tt>OBR||P42^PC||98142.1^Creatinine Clearance|...</tt><br>
<tt>OBX||ST1010.1^Body Weight|62|kg&lt;CR&gt;</tt><br>
<tt>OBX||ST1010.3^Height|190|cm&lt;CR&gt;</tt><br>
<tt>ORC|NW|...                          // Next order.</tt><br>
<tt>...</tt></p>
<h2>
</h2>

<h2>
<A NAME="Heading66">7.5  OUTSTANDING ISSUES </A></h2>

<p>
  <br>
1.	We have not devised universal code extensions for all diagnostic studies.
<br>
   </p>

<h2>
<A NAME="Heading67">7.6  (Informative)   Universal (AS4) Identifiers for Common Test Battery  </A></h2>

<p></p>
<h3>
3<a name="fnB2" href="#fn2">[3]</a></h3>

<h3>
<A NAME="Heading68">7.6.1  Components That Do Not Have Uniquely Defined CPT-4 Codes  -</A></h3>

<p><br>
Appendix 7.AS4 provides codes for common clinical and nursing variables and
codes for extending battery procedure codes to identify important
components.<br>
This standard is highly dependent on the availability of a set of codes for
uniquely identifying the observations carried in an OBX segment.  Here we
suggest a set of codes for the most common clinical observations such as
diastolic blood pressure, urine output per shift, pulse, and Glascow coma
score.  We include these codes both to make concrete how the standard can be
used to transmit most kinds of clinical information, as well as to encourage
standardization of clinical variable codes.  Note that some clinical variables
have categorical (multiple choice) rather than numerical answers.  We have
included a minimal list of suggested answer sets for these variables. <br>
We have also included a set of codes from The Health Outcomes Institute<a
name="fnB3" href="#fn3">[4]</a>, representing the most common outcome variables
such as the Rand Short Form-36, and the Interstudy TyPE Specifications.)<br>
Most procedure systems do not provide individual codes for the component
observations of tests such as the urinalysis, blood cell differential count and
antibiotic sensitivities as the separate observation recorded as part of an EKG
tracing, cardiac echoes, etc., because the constituents of these batteries
cannot be ordered separately.  This appendix also provides extensions for
uniquely identifying the constituents of such test "batteries", such as
differential whole blood, all cultured urinology, EKG, cardiac echo, etc.  <br>
CPT4 is the base procedure coding system used to illustrate how to extend such
procedural coding systems in this appendix.  Because CPT4 is universally
available in the US to code procedures, it is a candidate coding system.
However, CPT4 has many weaknesses.  It does not precisely identify many tests,
it does not provide sufficient discrimination about the method used, and, in
the case of imaging procedures, it often aggregates many separate activities
under one code. ICCS is another candidate. It is a more elegant and
comprehensive procedure classification than CPT4. It has a hierarchical
structure, is more complete (regarding the individual tests included). But at
the present, it is proprietary and is not complete regarding less common tests,
nor does it discriminate by method. SNOMED III will include a procedure coding
system. SNOMED III's codes for diseases, topology, and pathology, are very
good. The procedure codes may be equally good. ASTM E31.12 has an on going
effort to define vocabulary (and abbreviations) for chemistry tests. Euclides<a
name="fnB4" href="#fn4">[5]</a> has an active effort to define codes for all
clinical laboratory tests. Within the scope of both the Euclides and E31.12
effort, the AS4 extensions for test batteries would not be needed. <br>
We have chosen the new codes for the clinical variables to avoid any overlap
with CPT4.  However, such overlap cannot be guaranteed with all procedural
coding systems.  Consequently, when the clinical variables for physical exam,
etc., listed in this appendix are used with code systems other than CPT4, it is
up to the user to either include a local code system designator as the third
component CE data types with these clinical codes, or to verify that there is
no overlap with the procedural coding system of choice.<br>
Patient specific drug/toxicology information has many dimensions and contexts.
From the perspective of a laboratory, drug levels can be measured. However,
different variables need to be defined according to the specimen type, (blood,
serum, blood cells, urine, hair), and the kind of method (quantitative,
semi-quantitative or qualitative), drug dose and timing (peak or trough).  Most
of these distinctions apply to toxic substances as well. <br>
Contextual variables are also important to drug testing. Examples are the dose
of the drug given (where the time and the units would be carried in an OBX
segment), who gave the drug, and how many hours pre-blood draw the last dose
was given. The lab usually requires that these contextual "observations" be
transmitted with the order and are usually reported back as part of the battery
that represents the drug measurement. <br>
 <br>
Drug (treatment) dosing can also be considered from the context of the
prescription for the treatment, and a number of separate drug order related
variables could be defined for each drug, so that users could transmit this
information as an OBX to a patient's computer-based flowsheet (in a critical
care unit, for example) or as part of a study of drug levels.  For example, the
amount of drug given at a particular dosing time (as reported above), the
average daily dose prescribed, the total amount given to the patient, the
percent of compliance (as estimated by the patient), and so on. <br>
In the following, we provide construction rules for building codes for such
drug variables from drug codes.  Our examples are based on the World Health
Organization's drug record number (up to 6 digits) and code for salt (2
digits), for a total of 8 digits, and we identify these extended coding system
as WA.  The World Health drug codes have many advantages, including
international coverage, linkage to a hierarchical code (ATC), to preferred
name, brand names and manufacturers, to multiple component drugs, and to the
American Chemical Societies(ACS) chemical codes. Moreover, it is modestly
priced.  But other drug code systems (e.g., the ACS chemical codes for the
drugs, SNOMED III's drug codes, etc.) could also be used to construct these
drug related variables. <br>
Observation Name 	Identifier<br>
 <br>
<b>Urinalysis:	 </b><br>
 <u>Root Code:</u><br>
 Urinalysis	81000<br>
 <u>Extensions:</u><br>
	Dip stick pH  	.1<br>
	Specific gravity 	.2<br>
	Dip stick protein	.3<br>
	Dip stick glucose	.9<br>
	Reducing substance	.4<br>
	Dip stick Hgb 	.5<br>
	Dip stick bilirubin 	.6<br>
	Dip stick ketones	.7<br>
	Urine Appearance	.8<br>
	Dipstick WBC esterase	.10<br>
	Dipstick Nitrate	.11<br>
	Dipstick Ascorbic acid	.12<br>
	Dipstick Urobilinogen	.13<br>
 <u>Root Code:</u><br>
 Urine Miscroscopic:	81015<br>
 <u>Extensions:</u><br>
	Urine WBC's 	.1<br>
	Urine RBC's	.2<br>
	Urine WBC casts  	.3<br>
	Urine RBC casts  	.4<br>
	Urine hyaline casts 	.5<br>
	Urine granular casts	.6<br>
	Urine waxy casts 	.27<br>
	Urine fatty casts	.7<br>
	Urine bacteria	.8<br>
	Trichomonas	.9<br>
	Uric acid crystals  	.11<br>
	Pyrophosphate crystals 	.12<br>
	Cystine crystals 	.13<br>
	Bilirubin crystals  	.14<br>
	Triple phosphate crystals 	.15<br>
	Ca carbonate crystals  	.16<br>
	Ca PO4 crystals  	.17<br>
	Urine fat globules  	.18<br>
	Urine epithelial cells 	.19<br>
	Urine yeast-like fungi 	.21<br>
	Urine filamentous fungi	.22<br>
 	Urine unidentified crystals	.23<br>
<b>Complete Blood Count Components: </b>	<br>
 <u>Root Code:</u><br>
 Red blood cell (RBC) only	85041<br>
 White Blood Cell (WBC)	85048<br>
 <u>Extensions:</u><br>
	Total neutrophil count 	.11<br>
	Total neutrophil, % 	.12<br>
	Hypersegmented neutrophil count 	.13<br>
	Hypersegmented neutrophil, % 	.14<br>
	Segmented neutrophil count	.15<br>
	Segmented neutrophil, %	.16<br>
	Band neutrophil count  	.17<br>
	Band neutrophil, %  	.18<br>
	Metamyelocyte count 	.19<br>
	Metamyelocyte, % 	.21<br>
	Lymphocyte count 	.41<br>
	Lymphocyte, % 	.42<br>
	Atypical lymphocyte count 	.44<br>
	Atypical lymphocyte, % 	.45<br>
	Monocyte count	.51<br>
	Monocyte, %	.52<br>
	Eosinophil, count	.63<br>
	Eosinophil, %	.64<br>
	Basophil count	.59<br>
	Basophil, %	.60<br>
	Promyelocyte count  	.53<br>
	Promyelocyte, %  	.54<br>
	Myelocyte count  	.55<br>
	Myelocyte, %  	.56<br>
	Blast count	.57<br>
	Blast, %	.58<br>
 	Nucleated RBC count	.59<br>
	Nucleated RBC, %	.60<br>
	Other leukocyte count	.61<br>
 	Other leukocyte, %	.62<br>
 <u>Root Code:</u><br>
 Hemogram, Automated (RBC, WBC, Hgb,<br>
	  Hct and indices only): 	85021<br>
 <u>Extensions:</u><br>
	Mean corpuscular volume--MCV	.11<br>
	Mean corpuscular diameter--MCD 	.15<br>
	Red cell size distribution--RDW	.18<br>
	Mean corpuscular hemoglobin--MCH	.21<br>
	Hemoglobin distribution width--HDW	.26<br>
	Mean corpuscular hemoglobin	.27<br>
	Hypochromia 	.32<br>
	Basophilic stippling	.33<br>
	Toxic Granules	.34<br>
	Microcytes 	.35<br>
	Macrocytes	.36<br>
	Atypical lymphocytes	.37<br>
	Ovalocytes 	.38<br>
	Spherocytes	.39<br>
	Schistocytes  	.41<br>
	Hypersegmented Neutrophils	.42<br>
	Sickle cells	.43<br>
	Poikilocytosis	.44<br>
	Anisocytosis	.45<br>
	Anisochromic  	.46<br>
	Platelet count Auto	.47<br>
 <u>Root Code:</u>		85580<br>
 Platelet Count (Rees-Ecker):	<br>
 <u>Extensions:</u><br>
	Mean platelet volume	.11<br>
	Mean platelet diameter 	.15<br>
Antibiotics (Sensitivities/Levels)<br>
Approach - Use the appropriate CPT-4 code to identify the nature of the
testing.  Append the appropriate antibiotic identifier from the list below for
a complete specification.  <br>
 <u>Root Code</u><br>
	I.E.  Agar diffusion 	87181<br>
	Disk antibiotic sensitivity 	87184<br>
	Minimum inhibitory concentration 	87186<br>
	Minimum bacteriocidal concentration 	87187<br>
	Macrotube dilution method	87188<br>
	Serum bacteriocidal titre 	87197<br>
	Antibiotic level RIA 	80040<br>
	Antibiotic bio assay 	80042<br>
 <u>Extensions:</u>  Add the antibiotic number to one of the above codes <br>
 to obtain a complete code, e.g., 87184.1 is the code for   amikacin disk
antibiotic sensitivity, 87186.1 is the code for amikacin MIC, 80040.1 is the
code for amikacin level done by RIA.<br>
	Amdinocillin  	.54<br>
	Amikacin	.1<br>
	Aminosalicylic acid (e.g., PAS)	.58<br>
	Amoxicillin	.59<br>
	Amoxicillin/clavulanic acid	.3<br>
	Ampicillin 	.2<br>
	Ampicillin/sulbactam	.53<br>
	Anasmycin	.60<br>
	Azithromycin	.61<br>
	Azlocillin 	.4<br>
	Aztreonam	.43<br>
	Bacampicillin	.62<br>
	Capreomycin	.63<br>
	Carbenicillin 	.5<br>
	Cefadroxil	.65<br>
	Cefamandole	.6<br>
	Cefamezin  	.7<br>
	 (do not use = cefazolin)	<br>
	Cefazolin  	.8<br>
	Cefixime	.66<br>
	Ceflacor	.64<br>
	Cefmetazol	.67<br>
	Cefonicid  	.9<br>
	Cefoperazone  	.11<br>
	Cefotaxime 	.12<br>
	Cefoxitin  	.39<br>
	Cefotetan  	.55<br>
	Cefprozil	.68<br>
	Cefsulodin 	.56<br>
	Ceftazidime	.44<br>
	Ceftizoxime	.13<br>
	Ceftriaxone	.14<br>
	Cefuroxime 	.15<br>
	Cefuroxime axetil	.69<br>
	Cephalothin	.16<br>
	Cephradine	.70<br>
	Chloramphenicol  	.17<br>
	Cinoxacin	.71<br>
	Ciprofloxacin 	.41<br>
	Clarithromycin	.72<br>
	Clindamycin 	.18<br>
	Clofazimine	.73<br>
	Cloxacillin	.74<br>
	Colistimethate	.75<br>
	Cyclacillin 	.45<br>
	Cycloserine	.76<br>
	Dapsone	.77<br>
	Demeclocycline	.78<br>
	Dicloxacillin	.79<br>
	Doxycycline	.80<br>
	Enoxacin	.46<br>
	Erythromycin  	.19<br>
	Erythromycin-sulfisoxazole	.81<br>
	Ethambutol	.82<br>
	Ethionamide	.83<br>
	Flucytosine	.84<br>
	Gentamicin 	.21<br>
	Imipenem/cilastatin	.34<br>
	Isoniazid	.85<br>
	Kanamycin	.86<br>
	Lincomycin	.87<br>
	Lomefloxacin	.88<br>
	Methenamine hippurate	.89<br>
	Methenamine Mandelate	.90<br>
	Methicillin	.22<br>
	Metronidazole	.92<br>
	Mezlocillin	.23<br>
	Miconazole	.93<br>
	Minocycline	.94<br>
	Minocycline	.24<br>
	Moxalactam 	.25<br>
	Moxalactam	.95<br>
	Nafcillin	.96<br>
	Nalidixic acid	.97<br>
	Natamycin	.98<br>
	Neomycin	.99<br>
	Netilmicin 	.42<br>
	Nitrofurantoin	.26<br>
	Norfloxacin	.48<br>
	Ofloxacin  	.49<br>
	Oxacillin  	.27<br>
	Oxytetracycline	.100<br>
	Pefloxacin 	.50<br>
	Penicillin	 	.28<br>
	Pentamidine isethionate	.101<br>
 	Piperacillin  	.29<br>
	Polymyxin B	.102<br>
	Proampacin	.103<br>
	Protionamide	.104<br>
	Pyrazinamide	.105<br>
	Pyrimethamine	.106<br>
	Pyrimethamine sulfadoxine	.107<br>
	Ributin	.108<br>
	Rifampin	.31<br>
	Rifampin-isoniazid	.109<br>
	Spectinomycin	.110<br>
	Streptomycin	.111<br>
	Sulfa	.32<br>
	Sulfisoxazole	.112<br>
	Teicoplanin  	.51<br>
	Temafloxacin	.113<br>
	Tetracycline  	.33<br>
	Tetracycline HCl	.114<br>
	Thiabendazole	.115<br>
	Ticarcillin	.52<br>
	Ticarcillin/clavulanic acid	.35<br>
	Tobramycin	.37<br>
	Trimeth-Sulf  	.36<br>
	Trimethoprim	.116<br>
	Trisuflapyrimidines	.117<br>
	Troleandomycin	.118<br>
	Vancomycin 	.38<br>
<b>ISO enzymes:</b><br>
 <u>Root Code:</u><br>
	Creatinine phosphokinase isoenzymes	82550<br>
 <u>Extensions:</u><br>
	CK MB Fraction	.1<br>
	CK MM Fraction	.2<br>
	CK BB Fraction	.3<br>
	CK MM Isoforms	.4<br>
 <u>Root Code:</u><br>
	LDH isoenzymes, electrophoretic<br>
	  separation	83625<br>
	LDH isoenzymes, chemical separation		83626<br>
 <u>Extensions:</u>	<br>
	LDH Isoenzyme I	.1<br>
	LDH Isoenzyme II	.2<br>
	LDH Isoenzyme III	.3<br>
	LDH Isoenzyme IV	.4<br>
	LDH Isoenzyme V		.5<br>
 <u>Root Code:</u><br>
	Alkaline Phosphatase Isoenzyme		84080<br>
 <u>Extensions:</u><br>
	Liver ALK PHOS ISO		.1<br>
	Bone ALK PHOS ISO	.2<br>
	Intestinal ALK PHOS ISO	.3<br>
	Placental ALK PHOS ISO	.4<br>
	Reagin ALK PHOS ISO	.5<br>
	Other ALK PHOS ISO	.6<br>
<b>Clotting Tests:</b><br>
 <u>Root Code:</u><br>
	Prothrombin Time	85618<br>
 <u>Extensions:</u><br>
	Patient Prothrombin	.1<br>
	Control Prothrombin	.2<br>
<b>Skin Tests</b>:		86455<br>
 <u>Codes (CPT4):</u>	<br>
	Coccidiomycosis (mm)		86490<br>
	Histoplasmosis (mm)		86510<br>
	Mumps Interacts (mm)		86540<br>
	Trichophyton (mm)		4000<br>
	Candida (mm)		4001<br>
	Days post application read (#days)		4002<br>
 <u>Root Code:</u><br>
	Tuberculosis intradermal		86580<br>
 <u>Extensions:</u><br>
	1st strength	.1<br>
	PPD	.2<br>
	2nd strength	.3<br>
<b>Cardiac Echo:	</b><br>
 <u>Root Codes</u><br>
	Cardiac echo M mode		93300<br>
	Cardiac echo CSE		93307<br>
	Cardiac echo doppler		93320<br>
 <u>Extensions</u> (add the extension number of the appropriate root<br>
 code given above)<br>
	LV diameter systolic (cm)	.1<br>
	LV diameter diastolic (cm)  	.2<br>
	LV diastolic area (cm2)	.3<br>
	LV systolic area (cm2)	.4<br>
	Fractional area change	.5<br>
	RV diameter (cm)  	.6<br>
	RV diameter systolic (cm)	.7<br>
	RV diameter diastolic (cm)	.8<br>
	RV diastolic area (cm2)	.9<br>
	RV systolic area (cm2)	.10<br>
	Left atrial diameter (cm)	.11<br>
	LA diameter systolic (cm)	.12<br>
	LA diameter diastolic (cm)  	.13<br>
	Right atrial diameter (cm)  	.14<br>
	Aortic valve area (sq cm)	.15<br>
	Interventricular septum thickness (cm)	.16<br>
	LV posterior wall thickness (cm) 	.17<br>
	Mitral valve area (cm2)	.18<br>
	Ejection fraction (%)	.19<br>
	Aortic gradient (mmHg)	.20<br>
	Pulmonic gradient (mmHg)	.21<br>
	Cardiac Echo Impression		&amp;IMP<br>
	Cardiac Echo Recommendation		&amp;REC<br>
	Cardiac Echo Device		&amp;DEV<br>
	RV diameter (cm)<br>
<b>Spirometry</b>	<br>
 <u>Root Code:</u>		94010<br>
 <u>Extensions:</u><br>
	Forced Vital Capacity (FVC)  (l)	.1<br>
	Vital Capacity (l)	.2<br>
	FVC .5 sec (l)	.3<br>
	FVC  1 sec (l)	.4<br>
	FVC  3 sec (l)	.5<br>
	FEV1/FVC	.6<br>
	Peak expiratory flow (l/min)	.7<br>
	Peak inspiratory flow (l/min)	.8<br>
	Flow 50%   (l/min)	.9<br>
	Flow 75% (l/min) 	.10<br>
	F25-75 % (l/min)	.11<br>
	Maximum ventilation value 	.12<br>
	Slow Vital Capacity	.13<br>
	Inspiratory Capacity  	.14<br>
	Expiratory reserve volume	.15<br>
	Bronchodilator use	.16<br>
	<u>Answers</u><br>
	Not used<br>
	Pre-bronchodilators<br>
	Post-bronchodilators<br>
	Bronchodilators ID 	.17<br>
	  (text name of drug used)<br>
	Bronchodilator dose	.18<br>
	Total lung capacity, helium (sgl. breath)	.19<br>
	Total lung capacity, nitrogen (mult. breath)	.20<br>
	Total lung capacity, plethysmography	.21<br>
	Total resid. vol/total lung capacity	.22<br>
	Drug given	.23<br>
	Dose of drug	.24 <br>
	Spirometry Impression		&amp;IMP<br>
	Spirometry Recommendation		&amp;REC<br>
	Spirometry Device		&amp;DEV<br>
<b>EMG [Neurology]</b> <br>
(for full list, review E31.16 draft specifications,<br>
available as listed on footnote 12, Section 2.4)  <br>
<b>EEG [Neurology]</b> 		95816<br>
(for full list, review E31.16 draft<br>
specifications, available as listed<br>
on footnote 12, Section 2.4)  <br>
<b>OBGYN Ultrasound (OBGYN)</b><br>
 <u>Root Code:</u><br>
	Echography, pregnant uterus,<br>
	  B-scan and/or real time with<br>
	  image documentation; complete		76805<br>
 <u>Extensions</u>/:<br>
	Fetal Biparietal diameter (cm) 	.1<br>
	Fetal Head circumference (cm)  	.2<br>
	Fetal Abdominal circumference (cm)	.3<br>
	Fetal Femur length (cm)  	.4<br>
	Longitudinal Ovary Axis Right (cm)	.5<br>
	Longitudinal Ovary Axis Left (cm) 	.6<br>
	Transverse Ovary Axis Right  (cm) 	.7<br>
	Transverse Ovary Axis Left(cm) 	.8<br>
	A - P Ovary Axis Right  (cm)	.9<br>
	A - P Ovary Axis Left(cm)	.10<br>
	Longitudinal Uterus Axis (cm)  	.11<br>
	Transverse Uterus Axis(cm)  	.12<br>
	A - P  Uterus Axis(cm)	.13<br>
	Gestational age-size (weeks)	.14<br>
	Gestational age-menstrual period (months)	.15<br>
	Ob-Gyn US Impression		&amp;IMP<br>
	Ob-Gyn US Recommendation		&amp;REC<br>
	Ob-Gyn US Device		&amp;DEV<br>
<b>CXR </b>	 <br>
 <u>Root Code: </u><br>
	Radiologic examination, chest<br>
	 single view, frontal		71020<br>
 <u>Extensions:</u><br>
	Cardiac width	.1<br>
	Cardiac/thoracic ratio	.2<br>
	Largest mass size (rough diameter) (cm) 	.3<br>
	Largest mass size height (cm)	.4<br>
	# masses	.5<br>
	CXR Impression		&amp;IMP<br>
	CXR Recommendation		&amp;REC<br>
	CXR Device		&amp;DEV<br>
	<br>
<b>Endoscopy </b><br>
<b> </b><u>Root Code</u><br>
	Esophageal endoscopy		43200<br>
	UGI endoscopy		43234<br>
	ERCP		43260<br>
	Small bowel endoscopy		44360<br>
	Sigmoidoscopy fixed		45300<br>
	Sigmoidoscopy flexible		45330<br>
	Colonoscopy		45358<br>
 <u>Extensions</u><br>
	Polyp size (mm)	.1<br>
	Polyp number (#)	.2<br>
	Maximum polyp size (mm)	.3<br>
	Max depth instrument reached (cm)	.4<br>
	Ulcer(s) (#)	.5<br>
	Maximum ulcer size (cm)		.6<br>
	Duration of procedure (min)	.7<br>
	Endoscopy impression		&amp;IMP<br>
	Endoscopy device		&amp;DEV<br>
	Endoscopy recommendation	&amp;REC<br>
<b>Cardiac Catheterization Measure</b><br>
Cardiac Cath Measurements<br>
 <u>Root Code:</u>		1030<br>
 <u>Extension:</u>	<br>
	Central Venous Pressure [mm(hg)]	.1<br>
	Wedge Pressure [mm(hg)]	.2<br>
	Cardiac Index (l/min/mm2)	.3<br>
	Cardiac Output (l/min)	.4<br>
	Left Ventricular Ejection Fraction (%)	.5<br>
	LAM	.6<br>
	CCW	.7<br>
	Pulmonary Artery Systolic Pressure [mm(hg)]	.8<br>
	Pulmonary Artery Diastolic Pressure [mm(hg)]	.9<br>
	Intracoronary Pressure [mm(hg)]	.10<br>
	Aortic Root Diastolic Pressure [mm(hg)] 	.11<br>
	Aortic Root Mean [mm(hg)]	.12<br>
	LV Systolic  [mm(hg)]	.13<br>
	LV Diastolic [mm(hg)]	.14<br>
	LV Mean [mm(hg)]	.15<br>
	RA Mean [mm(hg)]	.16<br>
	RV Systolic [mm(hg)]	.17<br>
	RV Diastolic [mm(hg)]	.18<br>
	RV Mean [mm(hg)]	.19<br>
	Cardiac Catheterization Impression		&amp;IMP<br>
<b>Angiogram Coronary Artery Lesions</b><br>
	Answer given as percent obstruction<br>
 <u>Root Code:</u>	1101<br>
 <u>Extension:</u><br>
	RCA Proximal Obstruction (%)	.2<br>
	RCA Med Obstruction (%)	.3<br>
	RCA Distal Obstruction (%)	.4<br>
	RFDA Obstruction (%)	.5<br>
	RPLS Obstruction (%)	.6<br>
	1st RPL Obstruction (%)	.7<br>
	2nd RPL Obstruction (%)	.8<br>
	3rd RPL Obstruction (%)	.9<br>
	Acute Marginal Obstruction (%)	.10<br>
	RV BRANF Obstruction (%)	.11<br>
	Left Anterior Descend Obstruction (%)	1102.2<br>
	LCD Proximal Obstruction (%)	.3<br>
	LCD Med Obstruction (%)	.4<br>
	LCD Distal Obstruction (%)	.5<br>
	1st DIG Obstruction (%)	.6<br>
	2nd DIG Obstruction (%)	.7<br>
	1st Septal Obstruction (%)	.8<br>
	Prox CX Obstruction (%)	.9<br>
	Distal CX Obstruction (%)	.10<br>
	Interradiate Obstruction (%)	.11<br>
	1st cm Obstruction (%)	.12<br>
	2nd cm Obstruction (%)	.13<br>
	LAV Obstruction (%)	.14<br>
	1st LPL Obstruction (%)	.15<br>
	2nd LPL Obstruction (%)	.16<br>
	3rd LPL Obstruction (%)	.17<br>
	LPDA Obstruction (%)	.18<br>
<b>Electrocardiographic Measures</b><br>
	Note: all measures will not apply to all instruments<br>
 <u>Root Code</u><br>
	Holter (use for all durations)		93266<br>
	Rhythm Strip		93040<br>
	EKG 12-Lead		93000<br>
	Signal Averaged/High Resolution ECG	 5000<br>
 <u>Extension</u><br>
	Ventricular rate EKG/min 	.2<br>
	Atrial rate EKG/min 	.3<br>
	P interval  (ms)	.25<br>
	P-R interval  (ms) 	.4<br>
	QRS - interval  (ms)	.5<br>
	QT  - interval  (ms)	.6<br>
	Q wave width  (ms) 	.7<br>
	Q wave depth  (mv)	.8<br>
	# PVCs  (min)  	.9<br>
	# PACs  (min)  	.10<br>
	ST-elevation  (mv) 	.11<br>
	P-wave axis (deg) 	.12<br>
	QRS-axis (deg)	.13<br>
	T-wave axis (deg)	.14<br>
	EKG axis (deg)	.26<br>
	EKG.Rhythm	.15<br>
	<u>Answers</u>	<br>
	Atrial fibrillation<br>
	Atrial Flutter<br>
	Atrial premature contractions (/min)<br>
	Atrial tachycardia<br>
	Artificial Pacemaker<br>
	Bigeminy<br>
	Junctional complex<br>
	Junctional tachycardia<br>
	Normal<br>
	Paired VPC<br>
	Sinus arrhythmia<br>
	Sinus bradycardia<br>
	Sinus tachycardia<br>
	Trigeminy<br>
	Ventricular Premature contractions (/min)<br>
	Ventricular Tachycardia<br>
	Pacemaker Model<u>  </u>	.16<br>
	Pacemaker type	.28<br>
	Pacemaker	.29<br>
	EKG Conduction	.17<br>
	ST-T waves	.27<br>
	<u>Answers</u><br>
	Normal<br>
	1st deg block<br>
	AV Wenckebach<br>
	AV Mobitz II<br>
	AV dissociation<br>
	Right bundle branch block<br>
	Left bundle branch block<br>
	Incomplete RBBB<br>
	Incomplete LBBB<br>
	Bilateral BBB	<br>
	Accelerated Conduction<br>
	Delta Wave<br>
	Cardiac Pacemaker.EKG	.18<br>
	<u>Answers</u><br>
	Sinus<br>
	Atrial<br>
	Ventricular<br>
	HV Bundle<br>
	Morphology Atrial.EKG	.19<br>
	<u>Answers</u><br>
	Normal<br>
	Right Atrial Hypertrophy RAH<br>
	Left Atrial Hypertrophy LAH<br>
	Morphology Ventricle.EKG	.20<br>
	<u>Answers</u><br>
	Normal<br>
	Right Ventricular Hypertrophy RVH<br>
	Left Ventricular Hypertrophy LVH<br>
	Myocardial.Infarct.EKG(Age)	.21<br>
	<u>Answers</u><br>
	Acute<br>
	Old<br>
	Age indeterminate<br>
	Myocardial.Infarct.EKG(Location)	.22<br>
	<u>Answers</u><br>
	Septal MI(V1-3)<br>
	Lateral MI(I,L,V5-6)<br>
		Interior MI(II,3,F)<br>
	High Lateral MI(I,L)<br>
		Anterior MI(V3-4)<br>
	Extensive Anterior MI(I,L,V1-0)<br>
	Anterior Septal MI(V1-4)<br>
	Anterior Lateral MI(V3-6)<br>
	<br>
	EKG miscellaneous	.30<br>
	EKG lead placement	.31<br>
  	<br>
	Other Morphology.EKG	.23<br>
	<u>Answers</u><br>
	  	high peaked T wave<br>
	  	large U wave<br>
	Monitor duration (min)	.24<br>
 	Holter/Ambulatory Extensions<br>
	Holter recording duration(HH:MM)	.32<br>
	Holter number of heart beats recorded	.33<br>
	Holter mean heart rate (BPM)	.34<br>
	Holter Maximum heart rate (BPM)	.35<br>
	Holter Minimum heart rate (BPM)	.36<br>
	Holter Maximum heart rate time stamp	.37<br>
	Holter Minimum heart rate time stamp 	.38<br>
	Holter Maximum VT rate (BPM)	.39<br>
	Holter SVT rate (BPM)	    	.40<br>
	S-T depression (mm)	.41<br>
	Number of ventricular ectopics	.42<br>
	Number of VT runs	.43<br>
	Longest VT run (number of beats)	.44<br>
	Number of supraventricular ectopics)	.45<br>
	Number of SVT runs	.46<br>
	Longest SVT run (number of beats)	.47<br>
	Number of pauses	.48<br>
	Final impressions (uncoded text)	.49<br>
 Signal Averaged/High Resolution ECG<br>
	Signal number of beats averaged	.50<br>
	Signal number of beats detected	.51<br>
	Signal QRS duration, unfiltered (ms)	.52<br>
	Signal QRS duration, filtered (ms)	.53<br>
	Signal RMS voltage in terminal 40 ms	.54<br>
	Signal HFLA (High Frequency <br>
	 Low Amplitude)	.55<br>
	  Duration (ms)	.56<br>
Note: the filter setting may be used as a Sub ID<br>
for identification.  At the present time, the<br>
following filters are most  commonly used - 25hz,<br>
40hz to 250hz, 60hz to 250hz, and 80hz to 250hz.<br>
These filter settings refer to the filtered values in<br>
the signal averaged ECG.<br>
	EKG Impression		&amp;IMP<br>
	EKG Device		&amp;DEV<br>
<b>Physiologic Observations</b> (No specific CPT-4 codes.<br>
Have used ASTM 4-digit codes to identify)<br>
 Miscellaneous<br>
 <u>Root Code:</u><br>
 Miscellaneous clinical findings:		1000<br>
 <u>Extensions:</u><br>
	Stool output (ml/60min)	.13<br>
	Pupil size R (mm)	.14<br>
	Pupil size L (mm)	.15<br>
	Glasgow Score	.16<br>
	Apache score	.17<br>
	CVP pressure [mm(hg)]	.18<br>
	Cardiac output (l/min)	.19<br>
	#Bowel movements/8hrs	.20<br>
	Calorie count/shift (kcal)	.21<br>
	Apgar score 1 min	.22<br>
	Apgar score 5 min	.23<br>
 <b>Medical History</b><br>
 <u>Root Code:</u>	2000<br>
 <u>Extensions:</u><br>
	Chief complaint	.40<br>
	Source of history	.01<br>
	Present illness	.02<br>
	Family Hx	.03<br>
	Social Hx	.04<br>
	Functional status Hx	.05<br>
	Travel Hx	.06<br>
	Occupational Hx	.07<br>
	Childhood Disease Hx	.08<br>
	Surgical Procedures Hx	.09<br>
	Allergy Hx	.10<br>
	Medication Hx	.11<br>
	Review of Systems (header):	.12<br>
	Smoking Hx total (pack/yr)	.30<br>
	Smoking Hx current (pack/day)	.31<br>
	Dermatologic Hx	.13<br>
	Head Hx	.14<br>
	Eyes (vision) Hx	.15<br>
	Ears (hearing) Hx	.16<br>
	Nose (smell) Hx	.17<br>
	Mouth/throat/teeth Hx	.18<br>
	Respiratory Hx	.19<br>
	Neurologic Hx	.20<br>
	Musculoskeletal Hx	.21<br>
	Cardiovascular Hx	.22<br>
	Urinary Hx	.23<br>
	Sexual/reproductive Hx	.24<br>
	Date last menstrual period (OBM)	.32<br>
	Menstrual status	.33<br>
	<u>Answers</u><br>
	Amenorrheic<br>
	Premenarche<br>
	Follicular phase<br>
	Periovulatory<br>
	Luteal phase<br>
	Amenorrheic<br>
	Menstruating<br>
	Pregnant<br>
	Postmenopausal<br>
	Birth control method	.34<br>
	<u>Answers</u><br>
	Not needed<br>
	Not used<br>
	Birth control pills<br>
	Condom<br>
	Cervical cap<br>
	Spermicide<br>
	Tubal Ligation<br>
	IUD<br>
	Rhythm<br>
	Diaphragm<br>
	Vasectomy<br>
	Depo-provera hormone<br>
	<br>
	Endocrine Hx	.35<br>
	Hematologic Hx	.36<br>
	Psychiatric Hx	.37<br>
	Industrial exposure Hx	.38<br>
<b>Physical Exam</b><br>
 <u>Root Code:</u>		3000<br>
 <u>Extensions:</u><br>
	General status Px	.01<br>
	Vital signs Px	.02<br>
	Skin Px	.03<br>
	Head Px	.04<br>
	Eyes Px	.05<br>
	Ears Px	.06<br>
	Nose Px	.07<br>
	Mouth/throat/teeth Px	.08<br>
	Thorax/lungs Px	.09<br>
	Breasts Px	.10<br>
	Heart Px	.11<br>
	Abdomen Px	.12<br>
	Back Px	.13<br>
	Pelvic exam (female) Px	.14<br>
	Genitourinary exam (male) Px	.15<br>
	Rectal Px	.16<br>
	Limbs/extremities Px	.17<br>
	Vessels Px	.18<br>
	Neurologic Px (may be used instead of<br>
	  the following more discrete categories)	.19<br>
	Mental status Px	.20<br>
	Deep tendon reflex Px	.21<br>
	Sensation Px	.22<br>
	Balance, coordination Px	.23<br>
	Strength Px	.24<br>
<b>Hospital Discharge</b> <br>
 <u>Root Codes:</u>		4000<br>
 <u>Extension:</u><br>
	Patient Name	.1<br>
	Admission Discharge	.2<br>
	Discharge Date	.3<br>
	Admission DX	.4<br>
	Discharge DX	.5<br>
	History	.6<br>
	Findings	.7<br>
	Procedures	.8<br>
	Hospital Course	.9<br>
	Consultations	.10<br>
	Discharge Disposition	.11<br>
	Discharge Meds	.12<br>
	Discharge Instructions	.13<br>
	Staff	.14<br>
	Dictated by	.15<br>
<b>Surgical Report</b> 	<br>
<u>Root Code:</u>		5000<br>
<u>Extension:</u><br>
	Patient	.1<br>
	Date	.2<br>
	Preoperative DX	    	.3<br>
	Postoperative DX	    	.4<br>
	Staff Surgeon	    	.5<br>
	Resident Surgeon	    	.6<br>
	Operation	    	.7<br>
	Anesthesia	    	.8<br>
	Indications	    	.9<br>
	Findings	    	.10<br>
	Description of Oper	    	.11<br>
	Specimens	    	.12<br>
	Fluids	    	.13<br>
	Estimated Blood Loss	.14<br>
	Complications	    	.15<br>
	Dictated by	    	.16<br>
<b>Body Temperature</b> (TEMP)<br>
NOTE:  The default and preferred units are given in parentheses.  The result
segment has space for a specified unit.  When  the measurement units differ
from the default they must be stored in the units field of the result segment.
E.g., if the  temperature was transmitted as F&#176; instead of Celsius, the
units should be transmitted using standard ANSI unit abbreviations (see section
10.7.1).<br>
<u>Root Code</u>	1000<br>
 <u>Extension:</u><br>
	Temp Method	.1<br>
	<u>Answer</u><br>
	Glass thermometer<br>
	Digital probe<br>
	Color strip<br>
	Infrared sensor<br>
	Temp.Oral (cel)	.2<br>
	Temp.Rectal (cel)	.3<br>
	Temp.Axillary (cel)	.4<br>
	Temp.Other (cel)	.5<br>
	Temp Body Source Other	.6<br>
	<u>Answers</u><br>
	Oral	Urinary Bladder<br>
	Auxiliary	Central Line<br>
	Rectal	Trachea<br>
	Forehead	Urinary Catheter<br>
	Temp Device	.&amp;DEV <br>
<b>Blood Pressure</b> (BP)	<br>
	<u>Measure</u>	<br>
<u>Code</u><br>
	Blood Pressure 	  	 = BP<br>
	Systolic Blood Pressure    = SYS BP<br>
	Diastolic Blood Pressure   = DIAS BP<br>
	Mean Blood Pressure= MED BP<br>
 <u>Root Code:</u>  	1002<br>
 <u>Extension:</u><br>
	BP Method	.1<br>
 	  <u>Answers</u><br>
	  Manual by Palpation<br>
	  Manual by Cuff &amp; Stethoscope <br>
	  Automatic Oscillatory<br>
	  Automatic Auscultation<br>
	  Automatic Arterial Lines<br>
	<u>Measures</u> (The default --standard-- unit of measure is mmHg)<br>
	BP.SYS [mm(hg)]	.2<br>
	BP.DIAS [mm(hg)]	.3<br>
	BP.MEAN [mm(hg)]	.4<br>
	BP Measure SITE (may apply to cuff<br>
     or arterial line)	.6<br>
	   <u>Answers</u><br>
	   Right Arm		Left Arm	<br>
	   Right Forearm	Left Forearm<br>
	   Right Thigh		Left Thigh<br>
	   Right Brachial	Left Brachial	<br>
	   Right Radial		Left Radial	<br>
	   Right Ulnar		Left Ulnar	<br>
	   Right Femoral	Left Femoral	<br>
	   Right Popliteal	Left Popliteal	<br>
	   Right Post Fibular	Left PostFibular	<br>
	   Right Dorsal Pedal	Left Dorsal Pedal	<br>
	   Right Carotid	Left Carotid<br>
	   Umbilical	<br>
	BP CUFF POSITIONS (applies only to<br>
    cuff-based methods)	.7<br>
	   <u>Answers</u><br>
	   Right Arm  		Left Arm<br>
	   Right Forearm	Left Forearm<br>
	   Right Thigh		Left Thigh <br>
	   Right Calf		Left Calf<br>
<b>Heart Rate (HR = Pulse)</b>	<br>
	Pulse can be ascertained by many methods - from EKG tracings, blood pressure
tracings, palpation auscultation<br>
 <u>Root Code:</u>		1006<br>
 <u>Extension:</u><br>
	HR Method	.1<br>
	<u>Answers</u><br>
	Palpation	<br>
	Stethoscope	<br>
	Automatic BP Oscillatory	<br>
	Automatic BP Auscultation	<br>
	Arterial Line	<br>
	EKG monitor<br>
	Impedance <br>
	HR (/min)	.2<br>
	HR SITE	.3<br>
	<u>Answers</u><br>
	Right Arm  	Left Arm<br>
	Right Forearm	Left Forearm<br>
	Right Thigh		Left Thigh<br>
	Right Brachial		Left Brachial<br>
	Right Radial		Left Radial<br>
	Right Ulnar		Left Ulnar<br>
	Right Femoral		Left Femoral<br>
	Right Popliteal	Left Popliteal<br>
	Right Post Fibular	Left Post Fibular<br>
	Right Dorsal Pedal	Left Dorsal Pedal<br>
	Umbilical<br>
	PULSE.STRENGTH (1-4)	.4<br>
	PULSE QUALITY	.5<br>
	PULSE RHYTHM	.6<br>
	  <u>Answers</u><br>
	  Regular	<br>
	  Irregular<br>
	  Premature Beats<br>
	PREMATURE BEATS (/min)	.7<br>
<b>Respiratory Rate (RR)</b><br>
	 <u>Root Code</u>:	1007<br>
	 <u>Extension:</u><br>
	RR Method	.1<br>
	<u>Answers</u><br>
	visual <br>
	ventilator<br>
	stethoscope<br>
	chest stretch sense<br>
	pressure sense<br>
	RR (/min)	.2<br>
	RR.QUAL	.4<br>
	 <u>Answers</u><br>
	 Stridor	Wheezing<br>
	 Labored	Cyclical<br>
<b>General Patient State</b>  (may apply to any of the above)	<br>
	 <u>Root Code:</u>	1008<br>
	 <u>Extension:</u><br>
	General Measure <br>
	  (Body Position)	.2<br>
	<u>Answers</u><br>
	Standing	Lying<br>
	Sitting<br>
 	Measure Exercise	.3<br>
	<u>Answers</u>	<br>
	Rest		Maximum Exercise<br>
	Post Exercise<br>
	<br>
	Time Post Exercise (min)	.4<br>
	Maximum Exercise (EKG/min)	.5<br>
<b>Body Weight</b><br>
 <u>Root Code:</u>	1010<br>
 <u>Extension:</u><br>
	Body Weight (kg)	.1<br>
	Type of Scale	.2<br>
 	<u>Answer</u><br>
	Standing Scale            Bed Scale<br>
<b>Height</b><br>
 <u>Root Code:</u><br>
 <u>Extension:</u><br>
	Height (cm)	.3<br>
<b>Intake and Output</b>	<br>
<b> Urine Output</b><br>
 <u>Root Code</u>:		1013<br>
 <u>Extension:</u><br>
	Urine.Output.Method	.1<br>
	Measure as quantity urine output<br>
	  <u>Answers</u><br>
	  Manual<br>
	  Automatic<br>
	  Urine.Output.Spot (ml)	.2<br>
	  Urine.Output.Shift.Total (ml)	.3<br>
	  Urine.Output.24H Total (ml)	.4<br>
	  Urine.Output Device	&amp;DEV<br>
	  Urine.Output.Color	.6<br>
	<u>Answers</u><br>
	Bloody	Yellow<br>
	Brown	Clear<br>
<b> NG Output</b><br>
 <u>Root Code:</u>		1014<br>
 <u>Extension:</u><br>
	Ng Output Method	.1<br>
	Ng Output.Spot (ml)	.2<br>
	Ng Output.Shift Total (ml)	.3<br>
	Ng Output.24H Total (ml)	.4<br>
	Ng Output.Device 		&amp;DEV<br>
	Ng Output.Qual 	.6<br>
	<u>Answers</u><br>
	Bloody			Green<br>
	Coffeegrounds	Food<br>
	Yellow			Pill particles<br>
<b> Chest Tube Output</b><br>
 <u>Root Code:</u>		1015<br>
 <u>Extension:</u><br>
	Chest Tube Output Methods	.1<br>
	Chest Tube Output Spot (ml)	.2<br>
	Chest Tube Output.Shift total (ml)	.3<br>
	Chest Tube Output 24H total (ml)	.4<br>
	Chest Tube Output Device	&amp;DEV<br>
	Chest Tube Output.Qual 	.6<br>
<b> Stool Output</b><br>
 <u>Root Code</u>:		1016<br>
 <u>Extension:</u><br>
	Stool Output Method	.1<br>
	Stool Output Spot (ml)	.2<br>
	Stool Output.Shift Total (ml)	.3<br>
	Stool Output.24H Total (ml)	.4<br>
	Stool Output Device (ml)	&amp;DEV<br>
	Stool Output.Qual (ml) 	.6<br>
	<u>Answers</u><br>
	Watery	Bloody<br>
	Loose		Blood-streaked<br>
	Soft<br>
<b> Surgical Drain Output </b><br>
 <u>Root Code:</u>	1017<br>
 <u>Extension:</u><br>
	Surgical Drain Output Method	.1<br>
	Surgical Drain Output Spot (ml)	.2<br>
	Surgical Drain Output.Shift Total (ml)	.3<br>
	Surgical Drain Output.24H Total (ml)	.4<br>
	Surgical Drain Output Where (ml)	.5<br>
	Surgical Drain Output.Qual (ml) 	.6<br>
<b> IV Intake </b><br>
 <u>Root Code:</u>	1020<br>
 <u>Extension:</u><br>
	IV Intake Volume (ml)	.1<br>
	IV Intake Type	.2<br>
	IV Intake Na (mmol)	.3<br>
	IV Intake Cal (kcal)	.4<br>
	IV Intake K+ (mmol)	.5<br>
	IV Intake Where	.6<br>
	IV Intake Device		&amp;DEV<br>
<b> PO Intake</b><br>
 <u>Root Code:</u>		1030<br>
 <u>Extension:</u><br>
	PO Intake Spot Volume (ml)	.1<br>
	PO Intake Type	.2<br>
	PO Intake Shift Total (ml)	.3<br>
	PO Intake 24H Total (ml)	.4<br>
<b> GT Intake (gastric tube)</b><br>
 <u>Root Code</u>:	1031<br>
 <u>Extension:</u><br>
	GT Intake Spot Volume (ml)	.1<br>
	GT Intake Type	.2<br>
	GT Intake Shift Total (ml)	.3<br>
	GT Intake 24H Total (ml)	.4<br>
 <b>NG Tube Intake</b><br>
 <u>Root Code:</u>		1032<br>
 <u>Extension:</u>	<br>
	NG Tube Intake Spot Volume (ml)		.1<br>
	NG Tube Intake Type	.2<br>
	Ng Tube Intake Shift Total (ml)	.3<br>
	Ng Tube Intake 24H Total (ml)	.4<br>
 <b>Peritoneal Intake</b><br>
 <u>Root Code:</u>	1033<br>
 <u>Extension:</u><br>
	Peritoneal Intake	.1<br>
	Peritoneal Shift Total (ml)	.2<br>
	Peritoneal 24H Total (ml)	.3<br>
<b>Drug related clinical variables (excluding antibiotic sensitivities)</b><br>
Root codes (examples are WHO drug record numbers and salt extensions). The Who
codes provide unique identifiers for each single component drug at the generic
drug-salt level and every combination drug -- a total of over 6,500 chemical
substances and 8,700 multiple ingredient drugs.<br>
Chloroquine phosphate		000010 02<br>
Chloroquine sulfate		000010 03<br>
Chloroquine diorotate		000010 05<br>
Chloroquine hydrochloride		000010 06<br>
Atromid-S		000013 01<br>
Amantadine hydrochloride		000559 02<br>
Amantadine sulfate		000559 01<br>
To construct a code for identifying the variable type for drug X, append the
string that identifies the drug variable type to the WHO record number code for
drug X. Measurements labeled QN are measures of amount. Measurements labeled QL
are qualitative, given as CE codes, indicating presence or absence. <br>
<b>Codes related to drug measurement:</b><br>
Drug X peak serum level QN	.1<br>
Drug X trough serum level QN	.2<br>
Drug X time post dose level drawn 	.3<br>
Drug X dose given (see below)	<br>
Drug X random serum level QN	.4<br>
Drug X random serum level QL	.5<br>
Drug X urine level spot QN	.6<br>
Drug X urine level spot QL	.7<br>
Drug X urine level 24 hr QN	.8<br>
Drug X saliva measure QL	.9<br>
Drug X saliva measure QN	.10<br>
Drug X hair measure QL	.11<br>
Drug X hair measure QN	.12<br>
Drug X RBC measure QN	.13<br>
Drug X frequency of dosing (ST) e.g., BID, TID<br>
<b>Codes related to dosing and prescription:</b><br>
Drug X dose amount given	.21<br>
 (the date-time of dose would be recorded in<br>
 OBX-15 and units in OBX-6 used to report the<br>
 dose given before a peak or a trough) <br>
Drug X dose route given	.22<br>
 (CE data type use, HL7 route codes)<br>
Drug X who prescribed  (CE)<br>
Drug X dose prescribe a point in time	.22<br>
 E.g., if dose was 5 mg three times per day (TID)<br>
 value would be "5", and units "mg"<br>
Drug dose prescribed average per day  (NM) 	.23<br>
 E.g., if dose was 5 mg TID the value would<br>
 be 15 and units mg.  If dose was 5 mg<br>
 alternating with 10 mg on alternate days,<br>
 the value would be 7.5 and units would be mg<br>
Drug dose percent compliance patient <br>
estimate  (NM)	.24<br>
 This is recorded as patients estimate of<br>
 percent of doses taken.  Could be more than<br>
 100%. E.g., if he/she missed half of the <br>
 afternoon dose of twice a day insulin and<br>
 none of the morning doses the percent compliance<br>
 would be 75%)<br>
Drug dose percent compliance dispensing <br>
estimate  (NM)	.26<br>
 This is compliance estimated by pharmacy<br>
 dispensing. (Could be more than 100%)<br>
Drug dose percent compliance automatic count	.27<br>
 This records the actual drug doses removed<br>
 from an automatic pill dispenser compared to <br>
 the number that was supposed to be take over<br>
 a unit time. <br>
Number of doses per day.	.28<br>
 Recorded as the number of doses taken per day.<br>
 For if prescribed three times a day its value<br>
 would be 3. If four times a day or every 6 hours,<br>
 it would be 4. If every other day it would be .5<br>
Drug dose frequency instructions (TX)  	.29<br>
Drug prescribing instructions full (TX) 	.30<br>
The full instructions as written by the physician<br>
Cumulative dose (total dose of drug <br>
 given relative to a time)	.31<br>
Date time of cumulative dose started	.32<br>
<b>Health Outcome Variables (from Health Outcomes Institute)</b><br>
The following lists a large number of health outcomes variables and their
codes.  (The code system designation is HI) available from the Health Outcomes
Institute (17). The Health Outcomes Institute is collecting outcomes variables
such as those defined in the RAND 36 questions health status questionnaire, and
the InterStudy TyPE specifications. These are being used by a consortium of 36
large group practices. The full questionnaires are available from the Health
Outcomes Institute (2001 Killebrew Dr, Suite 122, Bloomington, MN 55425).  <br>
We list the variables here to give concrete examples of outcome variables that
are being used in real outcomes data bases, and to provide yet another
illustration of how OBX segments can communicate data related to different
master code files.<br>
The codes listed are the complete codes for Health Outcomes Institute, not
extensions intended for constructing codes.<br>
<b>GENERAL HEALTH STATUS</b><br>
 In general, would you say your health is:	1.1<br>
Change in Health in General Over One Year<br>
   Change in health over last year	2.1<br>
Physical Function<br>
   Vigorous activities limited by health	 3.1<br>
   Moderate activities now limited by health	3.2<br>
   Lifting or carrying groceries limited by health	3.3<br>
   Climbing several flights of stairs limited by health	3.4<br>
   Climbing one flight of stairs limited by health	3.5<br>
   Bending, kneeling or stooping limited by health	3.6<br>
   Walking more than a mile is limited by health	3.7<br>
   Walking several blocks is limited by health	3.8<br>
   Walking one block is limited by health	3.9<br>
   Bathing or dressing self is limited by health	3.10<br>
Role Physical Items<br>
   Limit amount of time spent on work	 4.1<br>
   Accomplish less than you would like	4.2<br>
   Limited in kind of work performed	4.3<br>
   Difficulty performing work	4.4<br>
Role Mental Items<br>
   Cut down amount of time spent on work or other <br>
     activities - past 4 we	5.1<br>
   Accomplish less than you would like over the last <br>
     4 weeks 	5.2<br>
   Didn't do work or other activities as carefully as<br>
     usual over the past	5.3<br>
Social Function Items I<br>
   Extent physical/emotional problems interfered with<br>
     social activities	 6.1<br>
Pain Items I<br>
   Pain experienced over last four weeks	 7.1<br>
Pain Items II<br>
   Extent pain interferes with normal work, last four weeks	 8.1<br>
General Health Perceptions<br>
   I seem to get sick a little easier than other people	  11.1<br>
   I am as healthy as anybody I know	11.2<br>
   I expect my health to get worse	11.3<br>
   My health is excellent	11.4<br>
Present Height and Weight (Feet, Inches, Pounds)<br>
   Patient height	110.1<br>
Three Item Depression Screener<br>
   Two weeks or more of past year was depressed	121.1<br>
   Two years in life feeling depressed or sad most days	121.2<br>
   Felt depressed or sad much of the time in past year	121.3<br>
Energy, Fatigue, Emotional Status (InterStudy)<br>
   Did you feel full of pep?	122.1<br>
   Have you been a nervous person?	122.2<br>
   Have you felt so down nothing could cheer you?	122.3<br>
   Have you felt calm and peaceful?	122.4<br>
   Did you have a lot of energy?	122.5<br>
   Have you felt downhearted and blue?	122.6<br>
   Did you feel worn out?	122.7<br>
   Have you been a happy person?	122.8<br>
   Did you feel tired?	122.9<br>
   Health limits social activity	122.10<br>
Initial Diagnosis Related to Hip Replacement<br>
Progression of Disease - Clinical &amp; Radiological<br>
   Clinical progression of disease	132.1<br>
   Radiologic progression of disease	132.2<br>
Failure of Previous Operations Other Than THR<br>
   Failure of previous operations other than THR	133.1<br>
Complications of Total Hip Replacement<br>
   THR complications	134.1<br>
   THR complication type	134.2<br>
Previous Hip Surgeries<br>
   Previous hip surgeries	135.1<br>
   Procedures of previous hip surgeries	135.2<br>
Lab Tests Done During Clinic Visit<br>
   Were the tests performed this visit outside of<br>
     specified ranges	137.2<br>
Leg Lengths<br>
   hip leg length	140.1<br>
   hip study - leg length measurement method	140.2<br>
Trendelenburg Lurch/Sign<br>
   trendelenburg lurch	141.1<br>
   hips trendelenburg sign left	141.2<br>
   hips trendelenburg sign right	141.3<br>
Asthma Awakens at Night<br>
   awakens at night	146.1<br>
Type of Hip Replacement and Acute Complications<br>
   acute hip complications	206.1<br>
   type of complication	206.2<br>
   type of hip replacement	206.3<br>
Post-Joint Replacement Radiographic Evaluation<br>
   post op radiographic evaluation	207.1<br>
Form Administration Information<br>
   hip administration, who completed form	208.1<br>
Operative Hip<br>
   Operative hip	224.1<br>
Racial Background<br>
   Respondents racial background	364.1<br>
   Patient of Hispanic/Spanish ancestry	364.2<br>
Income and Number of Dependents<br>
   Family's total income	366.1<br>
   How many people are dependent on family income	366.2<br>
Have You Been Told by your Dr.<br>
 You Have Asthma?<br>
   Have you ever been told by a doctor that you asthma?	368.1<br>
About How Old Were You When Your<br>
 Asthma Began?<br>
   About how old were you when your asthma began?	369.1<br>
Have You Ever Been Hospitalized for Asthma?<br>
   Have you ever been hospitalized for asthma?	370.1<br>
   Most recent asthma hospitalization	370.2<br>
   Asthma hospitalizations last 6 months	370.3<br>
When Was the Last Severe Flare-Up <br>
 of Your Asthma?<br>
   Last severe flare-up of asthma	371.1<br>
   Number of severe flare-ups last 6 months	371.2<br>
   Severe asthma treatment site	371.3<br>
Enough Infor. by Your Doctor About Asthma?<br>
   Enough infor. by your Dr. about asthma?	374.1<br>
Have You Received Written Direction <br>
 About Your Med<br>
   How you received written directions about<br>
     your Medicine.	375.1<br>
How Often Have Asthma Attacks Awakened<br>
 You?<br>
   How often have asthma attacks awakened<br>
     you from sleep?	376.1<br>
How Often Do You Have Symptoms of Asthma?<br>
   How often have you had symptoms of asthma <br>
     when you awaken to start	377.1<br>
Has Your Asthma Impaired Your <br>
  Performance at Work?<br>
   Has your asthma impaired you performance<br>
     at work, school, or in other	378.1<br>
Based On Your Asthma Have You Had Problems<br>
 at Work?<br>
   Cut down on work or other activities	379.1<br>
   Accomplished less than would have liked	379.2<br>
   Limited in kind of activities	379.3<br>
   Difficulty performing activities	379.4<br>
Does Your Asthma Cause You To Feel <br>
 Anxious, Etc.<br>
   Anxiousness, depression, irritability<br>
     due to asthma	380.1<br>
Your Asthma Interfered With Your Normal<br>
 Activities<br>
   Your asthma interfered with your normal social<br>
     activities with family	381.1<br>
Have You Missed From Work Because of Asthma?<br>
   Have you missed from work, school, or your<br>
     usual activities because o	382.1<br>
Is Your Activity Limited by Other Condition?<br>
   Is your physical activity limited by any condition<br>
     other than asthma?	383.1<br>
During the Past 4 Weeks Having Feelings <br>
 of Anxious<br>
   Cut down on time spent on work or other activities	384.1<br>
   Accomplished less than would have liked	384.2<br>
   Didn't do work or activities as carefully as possible	384.3<br>
What Medication Do you Take to Control<br>
 Your Asthma<br>
   Taken Prednisone, Medrol, or another steroid<br>
     pill/cortisone in last 6	385.1<br>
   Taken Prednisone, Medrol, or other<br>
     steroid/cortisone for short period	385.2<br>
   Number of treatments last 6 months	385.3<br>
   How regularly is medications used to <br>
     control asthma	385.4<br>
   Number of times needed to suddenly increase<br>
     dosage to control asthma	385.5<br>
   Steroid/cortisone injection last 6 months	385.6<br>
Hip - Post Discharge Antithrombotic Methods<br>
   Coumadin - Post discharge	386.1<br>
   Heparin - Post discharge	386.2<br>
   Other Drug - Post discharge	386.3<br>
   Other mechanical - Post discharge	386.4<br>
   None - Post discharge	386.5<br>
Do You Take Any Other Pills or Liquids For<br>
 Asthma?<br>
   Other pills or liquids taken for asthma	394.1<br>
Choose the Following Pills or Liquids You Take<br>
   Slo-phyllin, Theo-24, Quibron, Slo-bid,<br>
     Theodur, Uniphyl, or other 	395.1<br>
   Brethine, Bricanyl, Proventil, Ventolin, <br>
     Alupent, Metaprel, Terbutali	395.2<br>
   Other medications taken regularly	395.3<br>
Do You Use Inhalers For Asthma?<br>
   Use of any inhalers	396.1<br>
 <br>
   Use of Alupent, Proventil, Ventolin, Tornalate,<br>
     Brethair, Maxair, Bro	396.2<br>
   Use of Primatine, Bronkaid	396.3<br>
   Use of Atrovent	396.4<br>
   Use of Intal, Cromolyn	396.5<br>
   Use of Azmacort, Vanceril, Beclovent, Aerobid, <br>
     or other inhaled stero	396.6<br>
   Use of other inhalers	396.7<br>
   Use of Extender or spacer	396.8<br>
   Use of nebulizer with air compressor	396.9<br>
   Use of Alupent, Proventil, Ventolin, Brethine, <br>
     Bronkosol in nebulizer	396.10<br>
   Use of Atropine, Robinal in nebulizer	396.11<br>
   Use of Intal, Cromolyn in nebulizer	396.12<br>
   Use of other medications in nebulizer	396.13<br>
How Often Forget Med<br>
   How often patient forgets to take medications	400.1<br>
Complications From Medication<br>
   Difficulty sleeping	401.1<br>
   Shakiness	401.2<br>
   Heart palpitations	401.3<br>
   Headaches	401.4<br>
   Nervousness, moodiness, irritability	401.5<br>
   Hoarseness	401.6<br>
   Thrush or yeast infections	401.7<br>
Problems Due to Expense of Medication<br>
   Problems due to expense of asthma medications	402.1<br>
Do You Take Your Med for Asthma<br>
   Medications not taken due to cost	403.1<br>
Do You Have a Pet?<br>
   Pets in home?	404.1<br>
Do You Have a Peak Flow Meter?<br>
   Do you have a peak flow meter?	405.1<br>
   When is peak flow meter used	405.2<br>
   Is the peak flow meter helpful?	405.3<br>
   Adjust medications or call physician based<br>
     on peak flow readings	  405.4<br>
   Do you know your personal best/normal pfm reading	  405.5<br>
Do You Smoke?<br>
   Do you smoke?	406.1<br>
Are You Exposed to Significant Tobacco?<br>
   Exposed to significant tobacco smoke?	407.1<br>
What Trigger Your Acute Asthma Attacks?<br>
   Pets in home	408.1<br>
   Cats, dogs, or other animals	408.2<br>
   Household dust	408.3<br>
   Pollens or certain seasons during the year	408.4<br>
   Aspirin	408.5<br>
   Foods	408.6<br>
   Exercise	408.7<br>
   Smoke, cold air, or other irritants	408.8<br>
Exposure in Current Work Place Affects Your Asthma<br>
   Do you think exposure to something in your current work<br>
     place affects	410.1<br>
Exposure to Something at Home Effect Your Asthma?<br>
   Do you think exposure to something in your home<br>
     effects your asthma?	411.1<br>
Over the Past Year Has Your Asthma Gotten Better?<br>
   Improvement in asthma over past year	412.1<br>
Does Asthma Affect the Quality of Your Life?<br>
   How much asthma effects quality of life	413.1<br>
How Often Do You Have the Following Symptoms?<br>
   Cough	414.1<br>
   Sputum	414.2<br>
   Chest tightness	414.3<br>
   Wheezing or whistling sound in chest	414.4<br>
   Shortness of breadth	414.5<br>
   Heartburn	414.6<br>
Have You Ever Had Allergic, etc...<br>
   Allergic rhinitis, hay fever, or nasal allergy	415.1<br>
   Hives	415.2<br>
   Eczema	415.3<br>
   Family members with asthma, hay fever, or eczema	415.4<br>
   Recurrent sinusitis	415.5<br>
   Nasal polyps	415.6<br>
   Worsening of asthma before periods or during<br>
    pregnancy	415.7<br>
What Is Your Quality of Care For <br>
 Asthma Treatment?<br>
   Quality of care received for asthma last 3 months	416.1<br>
Have You Had an Evaluation?<br>
   Evaluation done by:	417.1<br>
Who Filled Out This Form?<br>
   Who filled out this form?	418.1<br>
First You Have Seen This Patient For Asthma?<br>
   First time seen this patient for asthma	419.1<br>
Convincing Clinical History?<br>
   Convincing clinical history of hyperactive<br>
    airways disease	420.1<br>
Improvement of FEV1<br>
   Improvement of FEV1 &gt; 15% with treatment	421.1<br>
Response to Methacholine Challenge Test?<br>
   Response to methacholine challenge test	422.1<br>
Fixed Obstructive Airway Disease<br>
   Patient with fixed obstructive airway disease	423.1<br>
Indicating Patient's Asthma<br>
   Asthma severity	424.1<br>
   Level of control of asthma	424.2<br>
   Patient compliance with medication treatment	424.3<br>
   Patient compliance of suggested environmental changes	424.4<br>
   Patient understanding of asthma and treatment	424.5<br>
Patient Has Used Systemic Steroid<br>
   Use of systemic steroid medications	429.1<br>
Patient Hospitalized<br>
   Hospitalizations in past 6 months for asthma	430.1<br>
Emergency Room Treatment for Asthma<br>
   Emergency room treatment for asthma last 6 months	431.1<br>
Patient Asthma Medication History<br>
   Inhaled beta agonist	432.1<br>
   Oral beta agonist	432.2<br>
   Inhaled corticosteroid	432.3<br>
   Oral corticosteroid	432.4<br>
   Oral methylxanthine	432.5<br>
   Inhaled anticholinergic	432.6<br>
   Inhaled cromolyn	432.7<br>
   Nebulized beta anonist and anticholinergic	432.8<br>
Patient Been Receiving Desensitization<br>
   Patient receiving desensitization treatments?	433.1<br>
Patient Currently Manifest Complications Known<br>
   Steroids	434.1<br>
   Beta agonists	434.2<br>
   Theophylline	434.3<br>
   Beta blockers	434.4<br>
What is Your Primary Specialty?<br>
   Physician's primary specialty	435.1<br>
Certified or Board Eligible in This Specialty?<br>
   Physician's board certification in this specialty	436.1<br>
Info From Physician<br>
   Info from physician	437.1<br>
Satisfaction Again<br>
   A second set of questions	438.1<br>
Relevance of Questions to Patient<br>
   How relevant were questions to patient?	443.1<br>
   Patient was able to answer questions accurately.	443.2<br>
Time To Fill Out Questionnaire<br>
   Time to complete questionnaire	444.1<br>
Patient Perception of Length of Forms<br>
   Patient perception of form length	445.1<br>
Patient Response to Forms<br>
   Patients response to forms	446.1<br>
Current Health Conditions<br>
   Congestive Heart Failure	447.1<br>
   Chronic lung disease	447.2<br>
   Blindness or trouble seeing	447.3<br>
   Deafness or trouble hearing	447.4<br>
   Sugar diabetes	447.5<br>
   Asthma	447.6<br>
   Ulcer or gastrointestinal bleeding	447.7<br>
   Arthritis or rheumatism	447.8<br>
   Sciatica or chronic back problem	447.9<br>
History of Conditions<br>
   Hypertension	448.1<br>
   Angina	448.2<br>
   Heart attack or myocardial infarction	448.3<br>
   Stroke	448.4<br>
   Kidney disease	448.5<br>
   Cancer (excluding skin cancer)	448.6<br>
People Living in Household<br>
   Number of adults living in household	449.1<br>
   Number of children living in household	449.2<br>
Household Income<br>
   Household Income	450.1<br>
Frequency of Hip Pain Limiting Activities<br>
   How often does hip pain limit your activities?	452.1<br>
   Frequency right hip limits activity	  452.2<br>
How Often Do You Have Stiffness?<br>
   Frequency stiffness, weakness limits activity - Left Hip	453.1<br>
   Frequency stiffness, weakness in right hip limits activity	453.2<br>
Does Your Hip Limit Your Ability?<br>
   Degree left hip limits physical ability	454.1<br>
   Right hip limit recreational activities	454.2<br>
Frequency of Hip Pain Limiting Sexual Activity<br>
   Left hip limits or interferes with sexual activity	  455.1<br>
   Degree Right hip limits sexual activity	455.2<br>
Does Your Hip Limit Your Ability to Work?<br>
   Left hip limits ability to work	  459.1<br>
   Degree Right hip limits ability to work	459.2<br>
How Much Pain Do You Have in Your Hip?<br>
   Perceived pain in Left hip	460.1<br>
   Perceived pain in right hip	460.2<br>
When Does Your Hip Pain Bother You?<br>
   Conditions causing pain in left hip	461.1<br>
   Conditions causing pain in right hip	461.2<br>
Past Four Weeks How Often Has Your <br>
  Hip Interfered<br>
   Past four weeks, how often has your hip<br>
     interfered with social intera	462.1<br>
   Extent right hip interfered with social <br>
     interaction over last 4 weeks	462.2<br>
Hip Interfered With Your Sleep?<br>
   Frequency left hip interfered with your <br>
     sleep, last 4 weeks	463.1<br>
   Extent to which RH interfered with sleep over <br>
     last four weeks	463.2<br>
Do You Have Difficulty Putting On Your Shoes?<br>
   Difficulty putting on your shoes and socks	464.1<br>
   Level of difficulty to put on shoes and socks	464.2<br>
Describes How You Go Up Stairs?<br>
   Stairclimbing method	465.1<br>
Best Describes How Your Go Down Stairs?<br>
   Best describes how you go down stairs?	466.1<br>
Do You Have Difficulty Moving From a Sitting <br>
 To A Standing?<br>
   Ability to rise from sitting position	467.1<br>
Ambulation - Type of Support Required<br>
   Support used when walking	468.1<br>
Ambulation - Minutes Walked - Without Support<br>
   Duration able to walk without support	469.1<br>
Ambulation - Minutes Walked - With Support<br>
   Walk with support	470.1<br>
Ambulation - Degree of Limp - Without Support<br>
   Limp without support	471.1<br>
Ambulation - Degree of Limp - With Support<br>
   Degree of limp with support	472.1<br>
How Would You Describe Your Cigarette<br>
 Smoking?<br>
   Cigarette smoking habits	473.1<br>
Satisfaction With Results of Hip Replacement<br>
   Level of satisfaction with the results of<br>
     hip replacement	474.1<br>
Vision - Self Rating - Both Eyes<br>
   How would you rate your vision	476.1<br>
Vision - Affect of Bright Light<br>
   How does bright light affect your vision	477.1<br>
Vision - Self Rating, Right Eye<br>
   How would you rate the vision in your right eye	478.1<br>
Vision Hinders Activity <br>
   Extent vision hinders from participating in <br>
     daily activities	479.1<br>
   Ability to recognize people and things across<br>
     the street	479.2<br>
   Extent ability to drive in daytime is hindered	479.3<br>
   Extent ability to drive at night is hindered	479.4<br>
   Extent ability to read street signs is hindered	479.5<br>
   Extent ability to see traffic lights is hindered	479.6<br>
   Extent ability to watch tv is hindered	479.7<br>
Vision - Self Rating, Left Eye<br>
   How would you rate the vision in your left eye	480.1<br>
Vision - Close-up Activities<br>
   Extent vision hinders from performing close-up<br>
     activities (reading)	481.1<br>
   Extent vision hinders from crafts &amp; hobbies	481.2<br>
   Extent vision hinders reading labels in stores	481.3<br>
   Extent depth perception is limited	481.4<br>
Sex<br>
   Sex	  483.1<br>
Occupation<br>
   Occupation:	  484.1<br>
Vision - Hindered by Glare<br>
   Extent glare limits participation in daily activities	493.1<br>
   Extent limited fr reading shiny paper	493.2<br>
   Extent hindered by sun, headlight glare when driving	493.3<br>
   Extent limited fr walking outside on a sunny day	493.4<br>
   Extent limited fr reading glare-y signs in supermarket	493.5<br>
Expectation of Vision After Surgery<br>
   After surgery I expect my vision to be:	494.1<br>
Expected Post-Operative Performance of <br>
 Usual Activ<br>
   Expected improvement in performance of usual daily <br>
     activities	495.1<br>
Past Medical History of Patient<br>
   No known medical conditions	496.1<br>
   Cardiac disease	496.2<br>
   Diabetes requiring medical treatment	496.3<br>
   Hypertension	496.4<br>
   Past stroke	496.5<br>
   Autoimmune/rheumatoid disease	496.6<br>
   COPD	496.7<br>
   Mental illness	496.8<br>
   Cancer, excluding skin	496.9<br>
   Other conditions	496.10<br>
No Eye Disease besides Cataract<br>
   No known eye disease besides cataract	  497.1<br>
   No known OS disease besides cataract	497.2<br>
Systemic Medications Taken by Patient<br>
   Patient currently not regularly medication	498.1<br>
   Patient taking aspirin	498.2<br>
   Patient taking insulin	498.3<br>
   Patient taking Coumadin	498.4<br>
   Patient taking steroids	498.5<br>
   NSAID	498.6<br>
   Other	498.7<br>
Stage of Glaucoma Treatment<br>
   Procedures to treat OD glaucoma	499.1<br>
   Procedures to treat OS glaucoma	499.2<br>
   Laser trabeouloplasty treatment - glaucoma	499.3<br>
   OD past filtering surgery - glaucoma	499.4<br>
   OS no current treatment	499.5<br>
   OS topical therapy	499.6<br>
   OS laser trabeouloplasty	499.7<br>
   OS past filtering surgery	499.8<br>
Other Eye Disease<br>
   Amblyopia	500.1<br>
   Other OD nerve disease	500.2<br>
   Previous cataract extraction and implant	500.3<br>
   History of cataract extraction and implant	500.4<br>
   OD significant eye trauma	500.5<br>
   OD chronic uveltis	500.6<br>
   OD diabetic retinopathy	500.7<br>
   OD macular degeneration	500.8<br>
   OD other significant problems	500.9<br>
   OS amblyopia	500.10<br>
   OS other optic nerve disease	500.11<br>
   OS previous cataract extract/implant	500.12<br>
   OS history of cataract extraction &amp; implant	500.13<br>
   Significant OS trauma	500.14<br>
   OS chronic uveltis	500.15<br>
   OS diabetic retinopathy	500.16<br>
   OS macular degeneration	500.17<br>
   Other significant OS problems	500.18<br>
Pupils<br>
   OD pupil	501.1<br>
   OS pupils	501.2<br>
Amsler Grid<br>
   OD Amsler Grid	  502.1<br>
   OS Amsler Grid	502.2<br>
Corneal Examination<br>
   OD normal cornea	503.1<br>
   Guttata w/o edema	503.2<br>
   OD confluent guttata w/o edema	503.3<br>
   OD corneal edema	503.4<br>
   OD central corneal opacity	503.5<br>
   OD corneal dystrophy or degeneration	503.6<br>
   OD corneal interstitial keratitis	503.7<br>
   OD herpetic disease	503.8<br>
   OD other corneal pathology	503.9<br>
   OD previous corneal transplant	503.10<br>
   OD cornea cannot be assessed	503.11<br>
   OS normal cornea	503.12<br>
   OS corneal guttata w/o edema	503.13<br>
   OS corneal confluent guttata w/o edema	503.14<br>
   OS edema	503.15<br>
   OS central corneal opacity	503.16<br>
   OS corneal dystrophy	503.17<br>
   OS interstitial keratitis	503.18<br>
   OS herpetic disease	503.19<br>
   OS other corneal pathology	503.20<br>
   OS previous corneal transplant	503.21<br>
   OS cornea cannot be assessed	503.22<br>
   OS shallow cornea	503.23<br>
   OS cornea cannot be assessed	503.24<br>
Anterior Chamber Findings<br>
   OD AC normal	504.1<br>
   OD AC flare only	504.2<br>
   OD AC cells only	504.3<br>
   OD AC keratic precipitates	504.4<br>
   OD AC posterior synechiae	504.5<br>
   OD pupil mydriatis	504.6<br>
   OD pupil irregular	504.7<br>
   OD shallow AC	504.8<br>
   OD transillumination defects	504.9<br>
   OD cannot assess	504.10<br>
   OS AC normal	504.11<br>
   OS AC flare only	504.12<br>
   OS AC cells only	504.13<br>
   OS keratic precipitates	504.14<br>
   OS posterior synechiae	504.15<br>
   OS pupil mydriasis	504.16<br>
   OS pupil irregular	504.17<br>
   OS shallow AC	504.18<br>
   OS transillumination defects	504.19<br>
   OS cannot assess anterior chamber	504.20<br>
Predominant Lens Findings<br>
   Normal OD lens	505.1<br>
   Normal OS lens	  505.2<br>
Type of Cataract<br>
   Type of Cataract (nuclear, cortical, PSC, hypermature)	506.1<br>
   OS cataract type	506.2<br>
   OD cataract etiology	506.3<br>
   OS cataract etiology	506.4<br>
Pseudophakia<br>
   OD P/C IOL	507.1<br>
   OS P/C IOL	507.2<br>
   OD A/C IOL	507.3<br>
   OS A/C IOL	507.4<br>
   OD posterior capsule opacification	507.5<br>
   OS posterior capsule opacification	507.6<br>
   OD posterior capsulotomy	507.7<br>
   OS posterior capsulotomy	507.8<br>
Other Lens Findings<br>
   OD surgical aphakia	508.1<br>
   OS surgical aphakia	508.2<br>
   OD dislocated/subluxed crystalline lens	508.3<br>
   OS dislocated/subluxed crystalline lens	508.4<br>
   OD exfoliation syndrome	508.5<br>
   OS exfoliation syndrome	508.6<br>
   OD other lens findings	508.7<br>
   OS other lens findings	508.8<br>
   OD cannot assess lens	508.9<br>
   OS cannot assess	508.10<br>
Optic Nerve (Note All Abnormalities)<br>
   Optic Nerve findings - OD	509.1<br>
   OS Nerve findings	509.2<br>
   OD C/D ratio - horizontal	509.3<br>
   OS C/D ratio - horizontal	509.4<br>
   OD C/D ratio - vertical	509.5<br>
   OS C/D ratio - vertical	509.6<br>
Retina<br>
   OD normal retina	510.1<br>
   OS normal retina	510.2<br>
   OD macular edema	510.3<br>
   OS macular edema	510.4<br>
   Od macular hole	510.5<br>
   OS macular hole	510.6<br>
   OD epimacular membrane	510.7<br>
   OS epimacular membrane	510.8<br>
Diabetic Retinopathy<br>
   OD diabetic retinopathy	511.1<br>
   OS Diabetic Retinopathy	511.2<br>
   OD proliferative diabetic retinopathy	511.3<br>
   OS proliferative diabetic retinopathy	511.4<br>
   OD vitreous hemorrhage	511.5<br>
   OS vitreous hemorrhage	511.6<br>
   OD prior laser therapy	511.7<br>
   OS prior laser therapy	511.8<br>
   OD prior vitrectomy	511.9<br>
   OS prior vitrectomy	511.10<br>
Macular Degeneration<br>
   OD rare drusen	512.1<br>
   OS rare drusen	512.2<br>
   OD scattered drusen	512.3<br>
   OS scattered drusen	512.4<br>
   OD confluent drusen	512.5<br>
   OS confluent drusen	512.6<br>
   OD geographic atrophy	512.7<br>
   OS geographic atrophy	512.8<br>
   OD active subretinal NVM	512.9<br>
   OS active subretinal NVM	512.10<br>
   OD prior laser therapy	512.11<br>
   OS prior laser therapy	512.12<br>
   OD disciform scar	512.13<br>
   OS disciform scar	512.14<br>
Retinal Detachment<br>
   OD current retinal detachment	513.1<br>
   OS current retinal detachment	513.2<br>
   OD prior retinal detachment surgical therapy	513.3<br>
   OS prior retinal detachment surgical therapy	513.4<br>
   OD current retinal break	513.5<br>
   OS current retinal break	513.6<br>
   OD prior surgical therapy	513.7<br>
   OS prior surgical therapy	513.8<br>
Retinal Vascular Occlusion<br>
   OD BRVO	514.1<br>
   OS BRVO	514.2<br>
   OD CRVO	514.3<br>
   OD BRVO	514.4<br>
   OD BRAO	514.5<br>
   OS BRAO	514.6<br>
   OD CRAO	514.7<br>
   OS CRAO	514.8<br>
Other Retinal Findings<br>
   OD other retinal findings	515.1<br>
   OS other retinal findings	515.2<br>
   Cannot assess OD retina	515.3<br>
   Cannot assess OS retina	515.4<br>
Ocular Exam: Recent Visual Acuity<br>
   SC	516.1<br>
   CC	516.2<br>
   PH	516.3<br>
   MR w/in 3 months	516.4<br>
   Glare	516.5<br>
   PAM	516.6<br>
Recent Visual Acuity - OS<br>
   SC	517.1<br>
   CC	517.2<br>
   PH	517.3<br>
   MR w/in 3 months	517.4<br>
   Glare	517.5<br>
   PAM	517.6<br>
OD Recent Refraction<br>
   OD recent refraction, sign value, spherical	518.1<br>
   OD recent refraction, spherical (hundredths)	518.2<br>
   OD recent refraction, sign for cylindrical value	518.3<br>
   OD recent refraction, cylindrical (hundredths)	518.4<br>
   OD recent refraction, axis	518.5<br>
Operated Eye<br>
   Operated eye	519.1<br>
Operation Type<br>
   Cataract operation type	520.1<br>
   Total time, (tenths of minutes)	520.2<br>
   Power (tenths)	520.3<br>
Acetabular Graft Data<br>
   Acetabular graft type	521.1<br>
   Acetabular Graft source - Femoral head	521.2<br>
   Acetabular Graft source - Femur	521.3<br>
   Acetabular Graft source - Freeze dried	521.4<br>
   Acetabular Graft source - Local	521.5<br>
   Acetabular Graft source - Iliac Crest	521.6<br>
   Acetabular Graft source - Structural	521.7<br>
   Acetabular Graft source - Other	521.9<br>
   Acetabular Graft source - Morselized	521.10<br>
   Acetabular Graft location - Superior	521.11<br>
   Acetabular Graft location - Medial	521.12<br>
   Acetabular Graft location - Posterior	521.13<br>
   Acetabular Graft location - Anterior	521.14<br>
Acetabular Bone Defects Found Intra-Operatively<br>
   Acetabular Bone defects - Contained Anterior	522.1<br>
   Acetabular Bone defects - Contained Superior	522.2<br>
   Acetabular Bone defects - Contained Posterior	522.3<br>
   Acetabular Bone defects - Contained Medial	522.4<br>
   Acetabular Bone defects - Segmental Anterior	522.5<br>
   Acetabular Bone defects - Segmental Superior	522.6<br>
   Acetabular Bone defects - Segmental Posterior	522.7<br>
   Acetabular Bone defects - Segmental Medial	522.8<br>
   Acetabular Bone defects - Central	522.9<br>
   Acetabular Bone defects - Pelvic Discontinuity	522.10<br>
Intraop Blood Transfusions<br>
   Intraoperative Blood transfusions - Autologous Blood	523.1<br>
   Intraoperative Blood transfusions - Bank Blood	523.2<br>
Surgical Time<br>
   Elapsed time of surgery	524.1<br>
Anesthesia<br>
   Cataract surgery anesthesia	525.1<br>
Duration of Procedure<br>
   Total duration of cataract procedure	526.1<br>
Intraocular Lens Type<br>
   Intraocular lens type	527.1<br>
   IOL irrigation	527.2<br>
   Visco-elastic IOL	527.3<br>
Antibiotic Coverage<br>
   Erythromycin	528.1<br>
   Velosef usage	528.2<br>
   Other antibiotics usage	528.3<br>
   Subconjunctival Gentamycin	528.4<br>
Steroid Treatment<br>
   Use of Kenalog	529.1<br>
   Use of Hexadrol	529.2<br>
   Weeks of topical steroid use	529.3<br>
   Weeks of topical steroid use	529.4<br>
Location of Incision<br>
   Millimeters from limbus	530.1<br>
   Quadrant of incision	530.2<br>
   Type of incision	530.3<br>
Desired Spherical Equivalent Refraction<br>
   Desired spherical refraction (hundredths)	531.1<br>
   Desired spherical refraction to the hundredths	531.2<br>
Intraoperative events<br>
   Intraoperative events	532.1<br>
   Retrobulbar hemorrhage	532.2<br>
   Vitreous loss	532.3<br>
   Choroid hemorrhage	532.4<br>
   Loss of nuclear fragment	532.5<br>
   Significant residual cortical material	532.6<br>
   Residual posterior capsule opacity	532.7<br>
   Broken capsule	532.8<br>
   Zonule dehiscence	532.9<br>
   Retinal break	532.10<br>
   Retinal detachment	532.11<br>
   IOL malposition	532.12<br>
   Other interoperative events	532.13<br>
   Other interoperative events	532.14<br>
Dilated Pupil Size (mm) at Commencement <br>
 of Surgery<br>
   Dilated pupil size at commencement of surgery in mm	533.1<br>
Cord Incision Length<br>
   Cord incision length in mm	534.1<br>
Size of Capsulectomy<br>
   Size of capsulectomy in mm	535.1<br>
   Continuous tear capsulorrhexis	535.2<br>
   Can-opener capsulorrhexis	535.3<br>
   Other capsulorrhexis	535.4<br>
   Meri?? extension of capsul??	535.5<br>
OS Recent Refraction<br>
   OS recent refraction, sign value	536.1<br>
   OS recent refraction, spherical (hundredths)	536.2<br>
   OS recent refraction, sign of cylindrical value	536.3<br>
   OS recent refraction, cylindrical (hundredths)	536.4<br>
   OS recent refraction, axis	536.5<br>
Intraocular Pressure<br>
   OD intraocular pressure	537.1<br>
   OS intraocular pressure	537.2<br>
OD K Readings<br>
   OD K1 readings, spherical (hundredths)	538.1<br>
   OD K2 readings, cylindrical, (hundredths)	538.2<br>
   OD K readings, axis	538.3<br>
K Readings  -  OS<br>
   OS K1 readings, spherical, (hundredths)	539.1<br>
   OS K2 readings, cylindrical, (hundredths)	539.2<br>
   OS K readings, axis	539.3<br>
Axial Length<br>
   OD axial length, (hundredths)	540.1<br>
   OS axial length (hundredths)	540.2<br>
Corneal Edema<br>
   Corneal epithelial edema	542.1<br>
   Stromal K edema	542.2<br>
   Folds decemet	542.3<br>
Wound Status<br>
   Normal	543.1<br>
   Broken suture	543.2<br>
   Leak present	543.3<br>
   Filtering blebs	543.4<br>
   Choroidal hemorrhage	543.5<br>
Anterior Chamber<br>
   Cell, anterior chamber	544.1<br>
   Flare, anterior chamber	544.2<br>
   Vitreous present in AC	544.3<br>
   Hyphema	544.4<br>
   Endophthalmitis	544.5<br>
Pupil Exam Items<br>
   Normal pupil characteristics	545.1<br>
   Mydriatic pupil &gt; 4mm	545.2<br>
   Irregular pupil	545.3<br>
   Pupillary block	545.4<br>
   Other pupil characteristics	545.5<br>
Intraocular Lens Dislocation<br>
   IOL dislocation	546.1<br>
   IOL dislocation length	546.2<br>
   Optically significant	546.3<br>
   Optically significant	546.4<br>
Posterior Capsule<br>
   Clear posterior capsule	547.1<br>
   Visually significant opacity	547.2<br>
   Retained cortex	547.3<br>
   S/P yag or surgical capsulotomy	547.4<br>
   Pitting of lens	547.5<br>
Optic Nerve<br>
   Status of optic nerve	548.1<br>
   OD horizontal cup to disk ratio to the hundredths	548.2<br>
   OS horizontal C/D ratio, to the hundredths	548.3<br>
   OD vertical CD ratio (hundredths)	548.4<br>
   OS vertical C/D ratio	548.5<br>
Post-op Fundus Findings<br>
   Same as pre-op	549.1<br>
   Uncovered pre-op disease	549.2<br>
   New post-op disease	549.3<br>
   CME	549.4<br>
   Filtering blebs	549.5<br>
   Choroidal detachment	549.6<br>
   Epimacular membranes	549.7<br>
   Retinal break since surgery	549.8<br>
   Retinal detachment since surgery	549.9<br>
Suture Lysis Performed, Date<br>
   Suture lysis performed	550.1<br>
   Month of suture lysis	550.2<br>
   Day of suture lysis	550.3<br>
   Year of suture lysis	550.4<br>
   Day of suture lysis	550.5<br>
   Year of yag capsulotomy	550.6<br>
   Month of yag capsulotomy	550.7<br>
   Day of yag capsulotomy	550.8<br>
   Year of yag capsulotomy	550.9<br>
   Month of eyeglass Rx	550.10<br>
   Day of eyeglass Rx	550.11<br>
   Year of eyeglass Rx	550.12<br>
   Year of eyeglass Rx	550.13<br>
Intraocular Pressure<br>
   Intraocular pressure	551.1<br>
   Status of glaucoma	551.2<br>
   IOP	551.3<br>
Visual Acuity<br>
   SC	552.1<br>
   CC	552.2<br>
   PH	552.3<br>
   MR	552.4<br>
   PAM	552.5<br>
   Near vision with correction	552.6<br>
Refraction<br>
   Sign for spherical value	553.1<br>
   Spherical value (hundredths)	553.2<br>
   Sign of cylindrical value	553.3<br>
   Cylindrical  (hundredths)	553.4<br>
   Axis	553.5<br>
Change in Vision<br>
   Significant change in vision	554.1<br>
   Macular degeneration	554.2<br>
   Glaucoma	554.3<br>
   Optic nerve disease	554.4<br>
   Diabetic retinopathy	554.5<br>
   Other	554.6<br>
Perioperative IOP<br>
   Perioperative IOP - day 1	  555.1<br>
   Final day, perioperative IOP	555.2<br>
   Perioperative IOP - day n	555.3<br>
Patient Satisfaction With Results of Surgery<br>
   Patient satisfaction with results of surgery	556.1<br>
Patient's Willingness to Repeat<br>
   Patient willing to undergo same procedure	557.1<br>
Iris Color<br>
   OD iris color	558.1<br>
   OS iris color	558.2<br>
Visual Field Loss<br>
   OD mild visual field loss	559.1<br>
   OD mod visual field loss	559.2<br>
   OD severe visual field loss	559.3<br>
   OS mild visual field loss	559.4<br>
   OS moderate visual field loss	559.5<br>
   OS severe visual field loss	559.6<br>
Pupils - Additional<br>
   OD mydriatis &gt; 4mm	560.1<br>
   OD irregular pupils	560.2<br>
   OS mydriatis &gt; 4mm	560.3<br>
   OS irregular pupil	560.4<br>
Intraocular Lens Decentralization<br>
   Intraocular lens decentralization - OD	561.1<br>
   Intraocular lens decentralization - OS	561.2<br>
Alternative Version - Visual Field Loss<br>
   OD visual field loss	562.1<br>
   OS visual field loss	562.2<br>
Etiology of Cataract<br>
   Etiology of Cataract <br>
    (nuclear, cortical, PSC, hypermature)	601.1<br>
   OS cataract etiology	601.2<br>
Cup to Disc Ratio<br>
   OD C/D ratio - horizontal (hundredths)	602.1<br>
   OS C/D ratio (hundredths)	602.2<br>
   OD C/D ratio - vertical (hundredths)	602.3<br>
   OS C/D ratio - vertical (hundredths)	602.4<br>
Retinal Break<br>
   OD current retinal break	603.1<br>
   OS current retinal break	603.2<br>
   OD retinal break prior surgical therapy	603.3<br>
   OD retinal break prior surgical therapy	603.4<br>
Intraocular Irrigation<br>
   IOL irrigation	604.1<br>
Visco-elastic<br>
   Visco-elastic	605.1<br>
Yag Capsulotomy Performed<br>
   Yag capsulotomy	606.1<br>
   Month of yag capsulotomy	606.2<br>
   Day of yag capsulotomy	606.3<br>
   Year of yag capsulotomy	606.4<br>
Eyeglass RX<br>
   Eyeglass Rx written	607.1<br>
   Month of eyeglass Rx	607.2<br>
   Day of eyeglass Rx	607.3<br>
   Year of eyeglass Rx	607.4<br>
Type of Suture<br>
   Type of suture	633.1<br>
Employment Status - Attributed to Vision<br>
   Current employment status of patient	634.1<br>
Time it Took to Reach Current Vision Status<br>
   Patient - Time it took to reach current vision status	635.1<br>
Energy, Fatigue, Emotional Status Items<br>
   Did you feel full of pep?	694.1<br>
   Have you been a nervous person?	694.2<br>
   Have you felt so down nothing could cheer you?	694.3<br>
   Have you felt calm and peaceful?	694.4<br>
   Did you have a lot of energy?	694.5<br>
   Have you felt downhearted and blue?	694.6<br>
   Did you feel worn out?	 694.7<br>
   Have you been a happy person?	  694.8<br>
   Did you feel tired?	  694.9<br>
Social Function During Past Four Weeks<br>
   Physical health/emotional problems interfered with social	695.1<br>
APPENDIX 7.B (Normative) TEST/OBSERVATION MASTER SEGMENTs (OMx)</p>
<h3>
</h3>

<h3>
<A NAME="Heading69">7.6.2  General Approach </A></h3>

<p><br>
	These segments define the format for the general information about the
observations that a clinical or diagnostic service produces and sends to its
"clients."  This format can be used to send the producer's entire
test/observation definition or a few of the producer's observations, such as
those with procedure, technique, or interpretation changes.<br>
	In anticipation of an object-oriented organization of segments in future
releases of this standard, the attributes of observations/batteries have been
grouped into six different segments: <br>
		OM1 	contains attributes that apply to all observations<br>
		OM2 	applies to numerically-valued observations<br>
		OM3 	applies to text or code-valued observations<br>
		OM4 	applies to observations or batteries that require specimens<br>
		OM5 	contains attributes of batteries, or sets of observations or other
batteries<br>
		OM6 	contains quantities (observations in a most general sense) that are
calculated from one or more other observations<br>
	Thus, the full definition of a numerically-valued laboratory observation would
require the transmission of OM1, OM2, and OM4.<br>
	In the following discussion, we use OMx to refer to any of the six
observation-defining segments.  Each instance of an OMx segment contains
information about one observation or observation battery.  These OMx segments
are designed to be "inclusive" and accommodate the attributes of many kinds of
observations.  Thus, the fact that a field is listed in a particular segment
should not be construed as meaning that a producer must include information
about that item in its definition transmission.  Many fields will apply to some
terms; others will not.  One observation producer may choose to populate one
set of fields; another may choose to populate a different set of fields,
according to the requirements of that producer's "client."<br>
	Most of the fields of data type TX in those segments are intended to include
information typically contained in a diagnostic service's user manual.  Such
fields should describe how the data is to be interpreted or used, and are not
intended for computer interpretation.<br>
	One or more observation definition segments (OMx) may be included in any
message, but they should immediately follow the MSH segment and precede any
other kinds of segments except the error (E) segment in the message.<br>
	Remember that the magnitude of a treatment can also be regarded as an
observation and, as such, can be represented as an observation within these
segments.  Many examples exist.  When a blood gas is transmitted, the
requesting service usually transmits the amount of inspired O2 (a treatment) on
requisition.  (In an electronic transmission, the service would send this as an
OBX segment, along with the electronic order for the test.)  When blood levels
are drawn, the amount and time of the last dose are routinely included as
observations on the request for service.  A pharmacy system could routinely
send to a medical record system the average daily dose of each outpatient
medication it dispenses.  In such cases, the treatment amounts would be
observations to the receiving system and would be transmitted as OBX segments.
When received, they would be treated like any other observation.  A medical
record system could then create, for example, a flowchart of lab results, or
lab results mixed with relevant treatments.</p>
<h3>
</h3>

<h3>
<A NAME="Heading70">7.6.3  Message Structure </A></h3>

<p><br>
	The message structure is as follows:<br>
<tt>	MSH</tt><br>
<tt>	{ OM1</tt><br>
<tt>		[ other segments(s) ]</tt><br>
<tt>	}</tt><br>
where <i>other segments</i> can be any of the following combinations:<br>
<tt>		[</tt><br>
<tt>		    [ OM2 ]</tt><br>
<tt>		    [ OM3 ]</tt><br>
<tt>		    [ OM4 ]</tt><br>
<tt>		]</tt><br>
	or<br>
<tt>		[ OM3</tt><br>
<tt>		  [ { OM4 } ]</tt><br>
<tt>		]</tt><br>
	or<br>
<tt>		[ OM5</tt><br>
<tt>		  [ { OM4 } ]</tt><br>
	or<br>
<tt>		[ OM6</tt><br>
<tt>		  OM2 ]</tt><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b>Note:</b>
A result may have both an OM2 (numeric) and OM3 (categorical) segment included
in case the value may be either numeric and/or categorical.
</p>
<BR></TD></TR></TABLE><p></p>
<h3>
</h3>

<h3>
<A NAME="Heading71">7.6.4  OM1 - General Segment (Fields That Apply to Most Observations) </A></h3>

<p><br>
	The OM1 segment contains attributes that apply to the definition of most
observations.  This segment also contains the field attributes that specify
what additional segments might also be defined for this observation.<br>
<center>Figure 7B-1  OM1 attributes</center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8<br>
9<br>
10<br>
11<br>
12<br>
13<br>
14<br>
15<br>
16<br>
17<br>
18<br>
19<br>
20<br>
21<br>
22<br>
23<br>
24<br>
25<br>
26<br>
27<br>
28<br>
29<br>
30<br>
31<br>
32<br>
33<br>
34<br>
35<br>
36<br>
37<br>
38<br>
39<br>
40<br>
41<br>
42
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
200<br>
12<br>
1<br>
200<br>
200<br>
200<br>
200<br>
30<br>
8<br>
200<br>
1<br>
60<br>
200<br>
1<br>
1<br>
40<br>
1<br>
200<br>
20<br>
26<br>
26<br>
20<br>
20<br>
40<br>
5<br>
200<br>
1000<br>
400<br>
1<br>
200<br>
64K<br>
64K<br>
200<br>
80<br>
64K<br>
200<br>
200<br>
200<br>
60<br>
64K
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
CE<br>
ID<br>
ID<br>
CE<br>
CE<br>
CE<br>
ST<br>
ST<br>
ST<br>
ST<br>
ID<br>
CE<br>
CE<br>
ID<br>
ID<br>
TN<br>
ID<br>
CE<br>
ST<br>
TS<br>
TS<br>
NM<br>
NM<br>
ID<br>
ID<br>
CE<br>
AD<br>
TN<br>
ID<br>
CE<br>
TX<br>
CE<br>
CE<br>
ST<br>
CE<br>
TX<br>
CE<br>
TX<br>
ST<br>
TX
</p>
<BR></TD>
<TD colspan=1 align="center"><p>R<br>
R<br>
R<br>
R<br>
R<br>
R<br>
R<br>
R
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
Y<br>
Y<br>
Y<br>
Y<br>
Y<br>
Y<br>
Y<br>
Y<br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
0125<br>
0174<br>
0168<br>
0176<br>
0177
</p>
<BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00587<br>
00588<br>
00589<br>
00590<br>
00591<br>
00592<br>
00593<br>
00594<br>
00595<br>
00596<br>
00597<br>
00598<br>
00599<br>
00600<br>
00601<br>
00602<br>
00603<br>
00604<br>
00605<br>
00606<br>
00607<br>
00608<br>
00609<br>
00610<br>
00611<br>
00612<br>
00613<br>
00614<br>
00615<br>
00616<br>
00617<br>
00618<br>
00619<br>
00620<br>
00621<br>
00622<br>
00623<br>
00624<br>
00625<br>
00626
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequence Number<br>
Producer's Test/Observation ID<br>
Permitted Data Types<br>
Specimen Required<br>
Producer ID<br>
Observation Description<br>
Other Test/Observation IDs for the Observation<br>
Other Names<br>
Preferred Report Name for the Observation<br>
Preferred Short Name or Mnemonic for Observation<br>
Preferred Long Name for the Observation<br>
Orderability<br>
Identity of Instrument Used to Perfrom this Study<br>
Coded Representation of Method<br>
Portable<br>
Observation Producing Department/Section <br>
Telephone Number of Section<br>
Nature of Test/Observation<br>
Report Subheader<br>
Report Display Order<br>
Date/Time Stamp for any change in Def Attri for Obs<br>
Effective Date/Time of Change<br>
Typical Turn-around Time<br>
Processing Time<br>
Processing Priority<br>
Reporting Priority<br>
Outside Site(s) Where Observation may be Performed<br>
Address of Outside Site(s)<br>
Phone Number of Outside Site<br>
Confidentiality Code<br>
Observations Required to Interpret the Obs<br>
Interpretation of Observations<br>
Contraindications to Observations<br>
Reflex Tests/Observations<br>
Rules that Trigger Reflex Testing<br>
Fixed Canned Message<br>
Patient Preparation<br>
Procedure Medication<br>
Factors that may Effect the Observation<br>
Test/Observation Performance Schedule<br>
Description of Test Methods
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.3.1.0	OM1 field definitions</b></p>

<h4>
<A NAME="Heading72">7.6.4.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
	Definition:  the string OM1 - identifies a record as a general observation
definition segment.</p>

<h4>
<A NAME="Heading73">7.6.4.2 Sequence Number (NM) 00586</A></h4>

<p><br>
	Definition:  the first OM1 segment in a message is described as 1, the second
as 2, and so on.</p>

<h4>
<A NAME="Heading74">7.6.4.3 Producer's Test/Observation ID (CE) 00587</A></h4>

<p><br>
<tt>	Components:  &lt;identifier&gt; ^ &lt;text&gt; ^ &lt;name of coding
system&gt;^ &lt;alternate identifier&gt; ^ &lt;alternate text&gt; ^ &lt;name of
alternate coding system&gt;</tt><br>
	Definition:  the producer's usual or preferred identification of the test or
observation.   Only three components should be included: &lt;ID
code&gt;^&lt;service text name/description&gt;^&lt;source list of code&gt;.
All components should be non-null.  The source list may be any of those
included in ASTM Tables 3 and 5, or a local code.</p>

<h4>
<A NAME="Heading75">7.6.4.4 Permitted Data Types (ID) 00588</A></h4>

<p><br>
	Definition:  the allowed data type(s) for this observation. The codes are the
same as those listed OBX (a given observation may, under different
circumstances, take on different data types). Indeed, under limited
circumstances, an observation can consist of one or more fragments of different
data types. When an observation may have more than one data type, e.g., coded
(CE) and numeric (NM) the allowable data types should be separated by repeat
delimiters.  Refer to <i>table 0125 - value type</i> for valid values.</p>

<h4>
<A NAME="Heading76">7.6.4.5 Specimen Required (ID) 00589</A></h4>

<p><br>
	Definition:  a flag indicating whether or not at least one specimen is
required for the test/observation.  Refer to <i>table 0136 - Y/N indicator</i>
as defined in Chapter 2.<br>
		Y 	one or more specimens are required to obtain this observation<br>
		N 	a specimen is not required<br>
	When a specimen is required, segment OM4 will usually be included (one per
specimen is required).</p>

<h4>
<A NAME="Heading77">7.6.4.6 Producer ID (CE) 00590</A></h4>

<p><br>
	Definition:  uniquely identifies the service producing the observation
described in this segment.  Three components should be included:  an
identifying code, the name of the producer, and the identity of the coding
system (e.g., 323-5678^Acme Special Lab^MC).  The identity of the coding system
will usually be MC (Medicare provider number or HIBCC site codes) in the United
States.  Each country may want to specify its preferred coding system and
define a coding system ID to identify it.<br>
	Remember that the magnitude of a treatment or the setting on a machine, such
as a ventilator, can be regarded as an observation.  Thus, pharmacy,
respiratory care, and nursing may be producers of such observations.</p>

<h4>
<A NAME="Heading78">7.6.4.7 Observation Description (TX) 00591</A></h4>

<p><br>
	Definition:  a text description of this observation.</p>

<h4>
<A NAME="Heading79">7.6.4.8 Other Test/Observation IDs for the Observation (CE) 00592</A></h4>

<p><br>
	Definition:  lists all alias codes/identifiers for this observation.  If more
than one alias code needs to be specified, multiple three-component, CE-format
entries (&lt;code 1&gt;^&lt;name 1&gt;^&lt;code system 1&gt;) may be given,
separated by repeat delimiters.  An observation may have as many names/codes as
are applicable (e.g., ICD9, ACR-NEMA, SNOMED, and READ).  We encourage the
inclusion of as many different codes as may apply to assist cross-system
mapping of terminology.  All components of each triplet should be non-null
(that is, names and coding system IDs within the CE data type are required in
addition to codes).  The source list may be any of those included in ASTM
Tables 3 and 5.<br>
	Because the size (dose) of a treatment can also be an observation, codes that
identify treatments (e.g., NDC, ICCS) may also be included in this field.<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b>Note:</b>
	In this field, the names within the CE data type are required.
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading80">7.6.4.9 Other Names (Recognized by the Producer for the Observation) (ST) 00593</A></h4>

<p><br>
	Definition:  include any text aliases, or synonyms for the name in the context
of the ordering service.  These are alternative names, not associated with a
particular coding system, by which the battery, test, or observation (e.g.,
measurement, test, diagnostic study, treatment) is known to users of the
system.  Multiple names in this list are separated by repeat delimiters.</p>

<h4>
<A NAME="Heading81">7.6.4.10 Preferred Report Name for the Observation (ST) 00594</A></h4>

<p><br>
	Definition:  the preferred name for reporting the observation or battery.  The
name can contain up to 30 characters (including blanks).  It is the preferred
name for columnar reports that require a maximum name size.</p>

<h4>
<A NAME="Heading82">7.6.4.11 Preferred Short Name or Mnemonic for the Observation (ST) 00595</A></h4>

<p><br>
	Definition:  a name that can be used in space-limited reports (e.g., specimen
labels) to identify the observation for the convenience of human readers.  The
name can contain up to eight characters.</p>

<h4>
<A NAME="Heading83">7.6.4.12 Preferred Long Name for the Observation (ST) 00596</A></h4>

<p><br>
	Definition:  the fully specified name for the observation or battery.  It may
include the full (unabbreviated) multiple-word names and contain up to 200
characters. It should be as scientifically precise as possible.</p>

<h4>
<A NAME="Heading84">7.6.4.13 Orderability (ID) 00597</A></h4>

<p><br>
	Definition:  whether or not a test/observation is an orderable code.   Refer
to <i>table 0136 - Y/N indicator</i> as defined in Chapter 2.<br>
		Y 	the test/observation is an orderable code<br>
		N 	the test/observation is not orderable<br>
	For example, blood differential count is usually an orderable "test."  MCV,
contained within the differential count, is usually not independently orderable.</p>

<h4>
<A NAME="Heading85">7.6.4.14 Identity of Instrument Used to Perform This Study (CE) 00598</A></h4>

<p><br>
	Definition:  when applicable, specifies the instrument or device that is used
to generate this observation or battery.  Examples are the automated instrument
in the laboratory, the imaging device and model number in radiology, and the
automatic blood pressure machine on the ward.  The instrument is specified as a
coded entry in anticipation that these identifiers could be specified as codes.
Initially, we expect that most of the information about devices will be
transmitted as text in the second component of the CE identifier.  If more than
one kind of instrument is used, all of them can be listed, separated by repeat
delimiters.</p>

<h4>
<A NAME="Heading86">7.6.4.15 Coded Representation of Method (CE) 00599</A></h4>

<p><br>
	Definition:  method(s) used to produce the observation should be recorded in a
computer-understandable (coded) form here.  This field should report the same
method(s) reported in narrative in the following field.  More than one method
may be listed, but only if they produce results that are clinically
indistinguishable.  Multiple methods must be separated by repeat delimiters.</p>

<h4>
<A NAME="Heading87">7.6.4.16 Portable (ID) 00600</A></h4>

<p><br>
	Definition:  whether or not a portable device may be used for the
test/observation.  Refer to <i>table 0136 - Y/N indicator</i> as defined in
Chapter 2.<br>
		Y 	the observation can be obtained with a portable device brought to the
patient<br>
		N 	the patient or specimen must be transported to the device.<br>
 </p>

<h4>
<A NAME="Heading88">7.6.4.17 Observation Producing Department/Section (ID) 00601</A></h4>

<p><br>
	Definition:  permits the sorting of observation orders and values by the
providing service's department/section.  It provides "source oriented"
reporting when required.  The codes for this field should be taken from ASTM
Table 15 (Diagnostic Service Codes).  Free text may be used instead of these
codes, but in that case, they should be recorded as the second "component" of
the field to distinguish them from the standard codes.  Multiple codes in this
field are separated by repeat delimiters.</p>

<h4>
<A NAME="Heading89">7.6.4.18 Telephone Number of Section (TN) 00602</A></h4>

<p><br>
	Definition:  the telphone number for calling responsible parties in this
section to ask results or advice about the use of this test.</p>

<h4>
<A NAME="Heading90">7.6.4.19 Nature of Test/Observation (ID) 00603</A></h4>

<p><br>
	Definition:  whether the definition entry identifies a test battery, an entire
functional procedure or study, a single test value (observation), multiple test
batteries or functional procedures as an orderable unit (profile), or a single
test value (observation) calculated from other independent observations.  The
possible options are the following:<br>
<center>User-defined Table 0174 - Nature of test/observation</center><br>
</p>
<TABLE><TR align="left">
<TD colspan=1 align="left"><p><b><u></u></b><u>Value</u></p>
<BR></TD>
<TD colspan=1 align="left"><p><u>Description</u></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>P</p>
<BR></TD>
<TD colspan=1 align="left"><p>Profile
or battery consisting of many independent atomic observations (e.g., SMA12,
electrolytes), usually done at one instrument on one specimen
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>F</p>
<BR></TD>
<TD colspan=1 align="left"><p>Functional
procedure that may consist of one or more interrelated measures (e.g., glucose
tolerance test, creatine clearance), usually done at different times and/or on
different specimens
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>A</p>
<BR></TD>
<TD colspan=1 align="left"><p>Atomic
test/observation (test code or treatment code)
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>S</p>
<BR></TD>
<TD colspan=1 align="left"><p>Superset--a
set of batteries or procedures ordered under a single code unit but processed
as separate batteries (e.g., routines = CBC, UA, electrolytes)<br>
This set indicates that the code being described is used to order multiple
test/observation batteries.  For example, a client who routinely orders a CBC,
a differential, and a thyroxine as an outpatient profile might use a single,
special code to order all three test batteries, instead of having to submit
three separate order codes.
</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>C</p>
<BR></TD>
<TD colspan=1 align="left"><p>Single
observation calculated via a rule or formula from other independent
observations (e.g., Alveolar--arterial ratio, cardiac output)
</p>
<BR></TD></TR></TABLE><p><br>
	Codes P, F, and S identify sets (batteries) and should be associated with an
OM5 segment that defines the list of elements.  The definitions for the
contained elements would have to be sent in other independent OMx segments, one
for each contained element.  In the ASTM context, most text reports--such as
discharge summaries, admission H&amp;Ps, and chest x-ray reports--are
considered as sets, in which each section of the report (e.g., description,
impression, and recommendation of an x-ray report) is considered a separate
observation.<br>
	Code A identifies a single direct observation and would usually be associated
with an OM2 and/or OM3 segments.<br>
	Code C identifies a derived quantity and would usually be associated with an
OM6 segment.<br>
	All of these codes can be associated with one or more OM4 (specimen) segments.</p>

<h4>
<A NAME="Heading91">7.6.4.20 Report Subheader (CE) 00604</A></h4>

<p><br>
	Definition:  an optional string that defines the preferred header under which
this observation should be listed on a standard display.  For example, if the
test is hemoglobin, this string might be "Complete blood count."  It is
represented as a coded data type so that a battery can be a header.  Only the
description part of the string may be included in case the subheader does not
have an associated code.  When a series of observations is displayed according
to the sort order given below, the subheader that groups those observations is
presented whenever the subheader changes.</p>

<h4>
<A NAME="Heading92">7.6.4.21 Report Display Order (ST) 00605</A></h4>

<p><br>
	Definition:  an optional string that defines the sort order in which this
observation is presented in a standard report or display that contains many
observations.</p>

<h4>
<A NAME="Heading93">7.6.4.22 Date/Time Stamp for Any Change in Definition for the Observation (TS) 00606</A></h4>

<p><br>
	Definition:  the date and time that the last of any field change was made and
in the host's record corresponding to the OM1 segment.</p>

<h4>
<A NAME="Heading94">7.6.4.23 Effective Date/Time of Change in Test Procedure That Make Results Non-Comparable (TS) 00607</A></h4>

<p><br>
	Definition:  the date and time of the last change in the test procedure that
would make previous results incompatible with new results, e.g., the last time
that normal reference range or units changed for a numeric test/observation.<br>
	We strongly suggest that observation producers never use the same observation
ID when the measurement procedures changes in such a way that results produced
under the new procedure are clinically different from those produced with the
old procedure. Rather the producer should try to adjust the new procedure so
that its values are clinically indistinguishable from the old. Failing that,
one should create a new observation ID for the observation produced under the
new procedure.<br>
	In the rare circumstances when a procedure change occurs and neither of the
above two options are viable, this field shall be used to transmit the
effective date-time of the new procedure. The receiving system shall assume
that any values that come across under this observation ID are under the new
procedure after this date and take appropriate steps to distinguish the old
from the new observations.<br>
	This number is included to provide a means of communicating with the
observation producing service when they have questions about particular
observations or results.</p>

<h4>
<A NAME="Heading95">7.6.4.24 Typical Turn-around Time from Receipt of Specimen/Subject to Result Produced (NM)  00608</A></h4>

<p><br>
	Definition:  typical processing time for single test/observation.  This field
indicates the time from the delivery of a specimen or transport of a patient to
a diagnostic service and the completion of the study.  It includes the usual
waiting time.  The units are measured in minutes. </p>

<h4>
<A NAME="Heading96">7.6.4.25 Processing Time (NM) 00609</A></h4>

<p><br>
	Definition:  usual length of time (in minutes) between the start of a test
process and its completion.</p>

<h4>
<A NAME="Heading97">7.6.4.26 Processing Priority (ID) 00610</A></h4>

<p><br>
	Definition:  specifies one or more available priorities for performing the
observation or test.  This is the priority that can be placed in
<i>OBR-28-quantity/timing</i>.  For tests that require a specimen, this field
may contain two components in the format &lt;specimen
priority&gt;^&lt;processing priority&gt;.  The first component in this case
indicates the priority with which the specimen will be collected and is the
priority that is specified in an OBR segment when ordering the observation.
The second component indicates the corresponding priority with which the
producer service will process the specimen, produce the observation, and return
results, when this differs from collection priority.  Permitted priority values
are the following:<br>
<center>	Table 0168 - Processing Priority</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>S<br>
A<br>
R<br>
P<br>
T<br>
C<br>
B
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Stat
(do immediately)<br>
As soon as possible (a priority lower than stat)<br>
Routine<br>
Preoperative (to be done prior to surgery)<br>
Timing critical (do as near as possible to requested time)<br>
Measure continuously (e.g., arterial line blood pressure)<br>
Do at bedside or portable (may be used with other codes)
</p>
<BR></TD></TR></TABLE><p><br>
	The priority for obtaining the specimen is included in OM4.  Multiple
priorities may be given, separated by repeat delimiters.  For example,
S~A~R~P~T indicates that the test may be ordered using codes S, A, R, P, or T.</p>

<h4>
<A NAME="Heading98">7.6.4.27 Reporting Priority (ID) 00611</A></h4>

<p><br>
	Definition:  the available priorities reporting the test results when the user
is asked to specify the reporting priority independent of the processing
priority.  The available codes are:<br>
<center>Table 0169 - Reporting Priority</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u></u></b><u>Value</u></p>
<BR></TD>
<TD colspan=1 align="left"><p><u>Description</u></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>C<br>
R
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Call
back results<br>
Rush reporting
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading99">7.6.4.28 Outside Site(s) Where Observation May Be Performed (CE) 00612</A></h4>

<p><br>
	Definition:  if an outside service or services produce the observation, this
field contains the identification(s) of the outside service(s).  The format of
this CE field uses the producer ID (as defined in <i>OM1-6-producer ID</i>) and
the name of the service separated by component delimiters.  An example is
39221^ACME lab^MC.  If multiple services are used, they should be separated by
repeat delimiter(s).</p>

<h4>
<A NAME="Heading100">7.6.4.29 Address of Outside Site(s) (AD) 00613</A></h4>

<p><br>
	Definition:  record in this field the address of the outside services listed
in <i>OM1-28-outside site(s) where observation may be performed</i>.  If
multiple services are recorded in that field, their addresses should be
separated by repeat delimiters, and the addresses should appear in the same
order in which the services appear in the preceding field.</p>

<h4>
<A NAME="Heading101">7.6.4.30 Phone number of outside site (TN) 00614 </A></h4>

<p><br>
	Definition:  the telephone number of the outside site.</p>

<h4>
<A NAME="Heading102">7.6.4.31 Confidentiality Code (ID) 00615</A></h4>

<p><br>
	Definition:  the degree to which special confidentiality protection should be
applied to the observation.  For example, a tighter control may be applied to
an HIV titer than to a CBC.  Refer to user-defined <i>table 0177 -
confidentiality code</i> for suggested values.<br>
<center>User-defined Table 0177	Confidentiality Code</center><br>
</p>
<TABLE><TR align="left">
<TD colspan=1 align="left"><p><b><u></u></b><u>Value</u></p>
<BR></TD>
<TD colspan=1 align="left"><p><u>Description</u></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>V<br>
R<br>
U<br>
EMP<br>
UWM<br>
VIP<br>
PSY<br>
AID<br>
HIV<br>
ETH
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Very
restricted<br>
Restricted<br>
Usual control<br>
Employee<br>
Unwed mother<br>
Very important person or celebrity<br>
Psychiatric patient<br>
AIDS patient<br>
HIV(+) patient<br>
Alcohol/drug treatment patient
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading103">7.6.4.32 Observations Required to Interpret This Observation (CE) 00616</A></h4>

<p><br>
	Definition:  list of variables that the diagnostic service needs to interpret
the results of an ordered study.  The observations specified here should be
sent to the diagnostic service as OBX segments along with the order (OBR)
segment.<br>
<i>	Example for cervical pap smear:</i><br>
		2000.32^date last menstrual period^AS4~2000.33^menstrual state^AS4<br>
<i>	Example for arterial blood gas:</i><br>
		94700^inspired 02^AS4<br>
	These examples use AS4 codes in code/text format to identify the variables.
Separate multiple items by repeat delimiters.</p>

<h4>
<A NAME="Heading104">7.6.4.33 Interpretation of Observations (TX) 00617</A></h4>

<p><br>
	Definition:  clinical information about interpreting test results.  Examples
are the conditions (drugs) that may cause false abnormals, and the information
about the sensitivity and specificity of the test for diagnoses.</p>

<h4>
<A NAME="Heading105">7.6.4.34 Contraindications to Observations (CE) 00618</A></h4>

<p><br>
	Definition:  list diagnosis or problem for which the test is a
contraindication or of possible danger (e.g., pacemaker, pregnancy, diabetes).
For example, if the test identified in OM1 was an intravenous pyelogram, this
field would include warnings about the use of contrast media in diabetes. The
contraindication diagnoses should be separated by repeat delimiters.<br>
	Most contraindication rules will be transmitted as free text.  In such cases,
the contents serves only as information for human reading.  However, an
alternative for machine readable contraindication rules also exists. The rule
may be defined formally in the Arden syntax (ASTM 1460-1992) which has syntax
for defining algebraic and transcendental equations, as well as temporal and
logical selection criteria based on patient information stored in the computer
record. Reflex rules that are written in Arden Syntax should begin and end with
a double semi-colon (;;), the Arden slot delimiter.</p>

<h4>
<A NAME="Heading106">7.6.4.35 Reflex Tests/Observations (CE) 00619</A></h4>

<p><br>
	Definition:  includes the test names as type CE (i.e., &lt;code&gt;^&lt;text
name&gt;^&lt;coding system&gt;) that may be ordered automatically by the
diagnostic service, depending on the results obtained from the ordered battery.
A screening CBC might trigger a reticulocyte count if the Hgb is less than 12.
Multiple reflex tests are separated by repeat delimiters.</p>

<h4>
<A NAME="Heading107">7.6.4.36 Rules That Trigger Reflex Testing (TX) 00620</A></h4>

<p><br>
	Definition:  the rules that trigger the reflex tests listed above.  If
multiple reflex tests are listed in <i>OM1-35-reflex tests/observations</i>
separated by repeat delimiters, a set of corresponding rules will be included
in this section.  The first rule will apply to the first test, the second to
the second test, and so on. <br>
	Most reflex rules will usually be transmitted as free text.  In such cases,
the contents serves only as information for human reading.  However, an
alternative for machine readable rules also exists. The rule may be defined
formally in the Arden syntax (ASTM 1460-1992) which has syntax for defining
algebraic and transcendental equations, as well as temporal and logical
selection criteria based on patient information stored in the computer record.
Reflex rules that are written in Arden Syntax should begin and end with a
double semi-colon (;;), the Arden slot delimiter.</p>

<h4>
<A NAME="Heading108">7.6.4.37 Fixed Canned Message (CE) 00621</A></h4>

<p><br>
	Definition:  codes and a fixed text message that is always associated with an
abbreviation.  The field may include multiple messages separated by repeat
delimiters.<br>
	Most rules about patient testing will be transmitted as free text.  In such
cases, the contents serves only as information for human reading.  However, an
alternative for machine readable rules also exists. The rule may be defined
formally in the Arden syntax (ASTM 1460-1992) which has syntax for defining
algebraic and transcendental equations, as well as temporal and logical
selection criteria based on patient information stored in the computer record.
Rules about patient preparation are written in Arden Syntax should begin and
end with a double semi-colon (;;), the Arden slot delimiter.</p>

<h4>
<A NAME="Heading109">7.6.4.38 Patient Preparation (TX) 00622</A></h4>

<p><br>
	Definition:  for tests or observations that require special patient
preparation, diet, or medications, record them here.  For GI contrast studies,
this field would contain the pretest diet, e.g., low residue for two days, NPO
before study, and the preferred purgatives.  Each separate med, diet, or
preparation should be delimited by a repeat delimiter.  Separate each
requirement by a repeat delimiter.  Example for a sigmoidectomy: clear liquid
diet full day before procedure~take 8 oz mag citrate 6pm day before
procedure~take 2 ducat tabs (5m) at 4pm day before procedure~NPO past midnight.</p>

<h4>
<A NAME="Heading110">7.6.4.39 Procedure Medication (CE) 00623</A></h4>

<p><br>
	Definition:  treatments that may be needed as part of the procedure.  Examples
are radioactive iodine for a thyroid screen, and methacholine for a
methacholine spirometry challenge.  This field should be identified as a CE
data type.</p>

<h4>
<A NAME="Heading111">7.6.4.40 Factors That May Effect the Observation (TX) 00624</A></h4>

<p><br>
	Definition:  text description of the foods, diagnoses, drugs, or other
conditions that may influence the interpretation of the observation.
Information about the direction of the effect, and any recommendation about
altering the diet, conditions, or drug before initiating the test
observation.<br>
	Most rules about factors that effect the test interpretation will be
transmitted as free text.  In such cases, the contents serves only as
information for human reading.  However, an alternative for machine readable
rules also exists. The rule may be defined formally in the Arden syntax (ASTM
1460-1992) which has syntax for defining algebraic and transcendental
equations, as well as temporal and logical selection criteria based on patient
information stored in the computer record. Rules about patient preparation are
written in Arden Syntax should begin and end with a double semi-colon (;;), the
Arden slot delimiter.</p>

<h4>
<A NAME="Heading112">7.6.4.41 Test/Observation Performance Schedule (ST) 00625</A></h4>

<p><br>
	Definition:  for diagnostic studies/tests that are performed only at certain
times during the course of a work day or work week, this field indicates the
maximum interval between successive test performances (the test may actually be
performed more frequently).  The format given in ASTM Table 17, Codes for
Service Intervals, should be used.  If necessary, multiple codes may be given,
separated by repeat delimiters.  The use of multiple codes indicates that the
test is performed at multiple concurrent intervals.  For example, Q6H indicates
that the test is performed at least once every 6 hours around the clock.  Q1J
indicates that the test is performed at least every week on Mondays.  QAM~QPM
indicates that the test is performed at least once every morning and every
evening.  Q1J~Q3J~Q5J indicates that the test is performed at least every week
on Mondays, Wednesdays, and Fridays.  C indicates that the test is performed
continuously, 7 days per week.</p>

<h4>
<A NAME="Heading113">7.6.4.42 Description of Test Methods (May Include Bibliographic Citations) (TX) 00626</A></h4>

<p><br>
	Definition:  text description of the methods used to perform the text and
generate the observations.  Bibliographic citations may be included.</p>
<h3>
</h3>

<h3>
<A NAME="Heading114">7.6.5  OM2 - Numeric Observation Segment </A></h3>

<p><br>
	This segment contains attributes of observations with continuous values
(including those with data types of numeric, date, or time stamp).  It can be
applied to observation batteries of type A and C (see <i>OM1-19-nature of
test/observation</i>).<br>
<center>Figure 7B-2  OM2 attributes</center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8<br>
9<br>
10<br>
11
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
60<br>
10<br>
20<br>
60<br>
200<br>
200<br>
200<br>
200<br>
20
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
CE<br>
NM<br>
CE<br>
TX<br>
CM<br>
CM<br>
CM<br>
CM<br>
NM
</p>
<BR></TD>
<TD colspan=1 align="center"><p>R</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
Y<br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00627<br>
00628<br>
00629<br>
00630<br>
00631<br>
00632<br>
00633<br>
00634<br>
00635
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequence Number<br>
Units of Measure<br>
Range of Decimal Precision<br>
Corresponding SI Units of Measure<br>
SI Conversion Factor<br>
Reference (Normal) Range - Ordinal &amp; Continuous Obs<br>
Critical Range for Ordinal &amp; Continuous Obs<br>
Absolute Range for Ordinal &amp; Continuous Obs<br>
Delta Check Criteria<br>
Minimum Meaningful Increments
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.4.1.0	OM2 field definitions</b></p>

<h4>
<A NAME="Heading115">7.6.5.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
<b>	Definition:  the string OM2 - identifies a record as a numeric observation
segment.</b></p>

<h4>
<A NAME="Heading116">7.6.5.2 Sequence Number (NM) 00586</A></h4>

<p><br>
<b>	Definition:  the same value as the sequence number of the associated OM1
segment.</b></p>

<h4>
<A NAME="Heading117">7.6.5.3 Units of Measure (CE) 00627</A></h4>

<p><br>
<b>	Definition:  for single tests/observations (those with a nature code of A
or C, as described in <i>OM1-19-nature of test/observation</i>) that have
numeric values, this field contains their customary units of measure.</b></p>

<h4>
<A NAME="Heading118">7.6.5.4 Range and Decimal Precision (NM) 00628</A></h4>

<p><br>
<b>	Definition:  used for numerically valued single observations (code A or C
as described in OM1;15), specifies the total length in characters of the field
needed to display the observation, and the number of digits displayed to the
right of the decimal point.  This is coded as a single number in the format
&lt;length&gt;.&lt;decimal-digits&gt;.  For example, a value of 6.2 implies 6
characters total (including the sign and decimal point) with 2 digits after the
decimal point.  For integer values, the period and &lt;decimal-digits&gt;
portion may be omitted (that is, 5.0 and 5 are equivalent).  More than one such
mask may be transmitted (separated by repeat delimiters) when it is necessary
to define multiple display formats that are possible.</b></p>

<h4>
<A NAME="Heading119">7.6.5.5 Corresponding SI Units of Measure (CE) 00629</A></h4>

<p><br>
<b>	Definition:  for single tests/observations - the corresponding SI units of
measure in the format, when these differ from the customary units of measure
given in the previous field.</b></p>

<h4>
<A NAME="Heading120">7.6.5.6 SI Conversion Factor (TX) 00630</A></h4>

<p><br>
<b>	Definition:  for continuous, numerically valued tests/observations, with a
nature code of A or C (see <i>OM1-19-nature of test/observation</i>).  This is
a factor for converting the customary units to SI units.</b><br>
<b>	In the case that the observation units are not SI units, this fields
provide the formula needed to convert from the reported units to SI units, this
shall include the equation needed to convert from the reporting to the SI
units. </b><br>
<b>	In the case that the relation is simply multiplicative, this field shall
include only the conversion factor.  E.g., if (results SI units) = c * (results
reporting units). Then only c would be stored in this field.  In the case of
any other functional relationship, the entire equation would be stored as a test.</b></p>

<h4>
<A NAME="Heading121">7.6.5.7 Reference (Normal) Range for Ordinal and Continuous Observations (CM) 00631</A></h4>

<p><br>
<b>	Definition:  provides reference (normal) ranges for "numeric"
observations/tests with a nature code of A or C (see <i>OM1-19-nature of
test/observation</i>). It can identify different reference (normal) ranges for
different categories of patients according to age, sex, race, and other
conditions.</b><br>
<b>	The general format is</b><br>
&lt;ref. (normal) range<sub>1</sub>&gt;^&lt;sex<sub>1</sub>&gt;^&lt;age
range<sub>1</sub>&gt;^&lt;age
gestation<sub>1</sub>&gt;^&lt;species<sub>1</sub>&gt;^&lt;race/subspecies<sub>1</sub>&gt;^&lt;text
condition<sub>1</sub>&gt;~<br>
&lt;ref. (normal) range<sub>2</sub>&gt;^&lt;sex<sub>2</sub>&gt;^&lt;age
range<sub>2</sub>&gt;^&lt;age
gestation<sub>2</sub>&gt;^&lt;species<sub>2</sub>&gt;^&lt;race/subspecies<sub>2</sub>&gt;^&lt;text
condition<sub>2</sub>&gt;~<br>
				&#183;<br>
				&#183;<br>
				&#183;<br>
&lt;ref. (normal) range<sub>n</sub>&gt;^&lt;sex<sub>n</sub>&gt;^&lt;age
range<sub>n</sub>&gt;^&lt;age
gestation<sub>n</sub>&gt;^&lt;species<sub>n</sub>&gt;^&lt;race/subspecies<sub>n</sub>&gt;^&lt;text
condition<sub>n</sub>&gt;<br>
<b>	The components are defined in the following sections.</b></p>

<h5>
<A NAME="Heading122">7.6.5.7.1  The Reference (Normal) Range</A></h5>

<p><br>
<b>	The format of this component is &lt;low value &amp; high value&gt;, where
the range is taken to be inclusive (i.e., the range includes the end points).
In this specification, the units are assumed to be identical to the reporting
units given in <i>OM2-3-units of measure</i>).</b></p>

<h5>
<A NAME="Heading123">7.6.5.7.2 Sex</A></h5>

<p><br>
<b>	The sex of the patient.</b></p>

<h5>
<A NAME="Heading124">7.6.5.7.3 Age Range</A></h5>

<p><br>
<b>	The age range (in years or fractions thereof) is specified as two values
separated by a subcomponent delimiter (i.e., &lt;low value &amp; high
value&gt;) in order to allow a simple and consistent machine interpretation of
this component.  Ages of less than one year should be specified as a fraction
(e.g., 1 month = 0.0830, 1 week = 0.01920, 1 day = 0.0027300).  However, for
most purposes involving infants, the gestational age (measured in weeks) is
preferred.  The lower end of the range is not indicated; the upper end is,
assuring that series of ranges do not overlap.</b></p>

<h5>
<A NAME="Heading125">7.6.5.7.4 Gestational Age Range</A></h5>

<p><br>
<b>	The gestational age is relevant only when the reference range is influenced
by the stage of pregnancy.  A range of values separated by a component
delimiter is required, i.e., &lt;low value &amp; high value&gt;.  The
gestational age is measured in weeks from conception.  For example,
&lt;1&amp;10&gt; implies that the normals apply to gestational ages from 1 week
to 4 weeks inclusive (1&amp;4).  The lower end of the range is not included;
the upper end is, assuring  that series of age ranges do not overlap.</b></p>

<h5>
<A NAME="Heading126">7.6.5.7.5 Species</A></h5>

<p><br>
<b>	This field is assumed to be human unless otherwise stated.  The species
should be represented as text (e.g., rabbit, mouse, rat).</b></p>

<h5>
<A NAME="Heading127">7.6.5.7.6 Race/Subspecies</A></h5>

<p><br>
<b>	In the case of humans (the default), the race is specified when race
influences the reference range.  When normal ranges for animals are being
described, this component can be used to describe subspecies or special breeds
of animals.</b></p>

<h5>
<A NAME="Heading128">7.6.5.7.7 Conditions</A></h5>

<p><br>
<b>	The condition is simply free text.  This component allows for definition of
normal ranges based on any arbitrary condition, e.g., phase of menstrual cycle
or dose of a particular drug.  It is provided as a way to communicate the
normal ranges for special conditions.  It does not allow automatic checking of
these text conditions.</b></p>

<h5>
<A NAME="Heading129">7.6.5.7.8 Examples</A></h5>

<p><br>
<b><i>	A range that applies unconditionally, such as albumin, is transmitted
as:</i></b><br>
		3.0 &amp; 5.5<br>
<b><i>	A normal range that depends on sex, such as Hgb, is transmitted
as:</i></b><br>
		13.5 &amp; 18^M~<br>
		12.0 &amp; 16^F<br>
<b><i>	A normal range that depends on age, sex, and race (a concocted example)
is:</i></b><br>
		10 &amp; 13   ^M^0  &amp;  2 ^^^B<br>
		11 &amp; 13.5 ^M^2  &amp; 20 ^^^B~<br>
		12 &amp; 14.5 ^M^20 &amp; 70 ^^^B~<br>
		13 &amp; 16.0 ^M^70 &amp;    ^^^B<br>
<b>	When no value is specified for a particular component, the range given
applies to all categories of that component.  For example, when nothing is
specified for race/species, the range should be taken as the human range
without regard to race.  If no age range is specified, the normal range given
is assumed to apply to all ages.  If the upper or lower end of a range is left
out, it is assumed to be +infinity or -infinity, respectively.</b><br>
<b>	When two different methods result in two different reference ranges, two
different observations and corresponding OMx segments should be defined.</b></p>

<h4>
<A NAME="Heading130">7.6.5.8 Critical Range for Ordinal and Continuous Observations (CM) 00632</A></h4>

<p><br>
<b>	Definition:  applies only to single tests/observations (i.e., a nature code
of A or C, as described in <i>OM1-19-nature of test/observations</i>) with
numeric results.  When a critical range is defined for such observations, it
should be recorded here in the same format as the normal range (see
<i>OM2-7-reference (normal) range-ordinal and continuous obs</i>).</b></p>

<h4>
<A NAME="Heading131">7.6.5.9 Absolute Range for Ordinal and Continuous Observations (CM) 00633</A></h4>

<p><br>
<tt>	Components:  &lt;range&gt; ^ &lt;numeric change&gt; ^ &lt;%/a change&gt; ^
&lt;days&gt;</tt><br>
<b>	Definition:  applies only to single tests/observations with a nature code
of A or C (see <i>OM1-19-nature of test/observation</i>).  It defines the range
of possible results.  Results outside this range are not possible.  The field
should be recorded in the same format as the normal and critical ranges.</b></p>

<h4>
<A NAME="Heading132">7.6.5.10 Delta Check Criteria (CM) 00634</A></h4>

<p><br>
<b>	Definition:  applies to numeric tests/observations with a nature code of A
or C (see <i>OM1-19-nature of test/observation</i>).  The field describes the
information that controls delta check warnings and includes four
components.</b><br>
<b>	1)  	The range to which the following applies: &lt;low &amp;
high&gt;</b><br>
<b>		All the ranges are defined in terms of the customary reporting units given
in <i>OM2-3-units of measure</i>.  If no value range is given, the check
applies to all values.</b><br>
<b>	2)  	The numeric threshold of the change that is detected, e.g., 10</b><br>
<b>	3)  	Whether the change is computed as a percent change or an absolute
change.  This component can have two possible values:</b><br>
<b>		    %	Indicates a percent change</b><br>
<b>		    a	Absolute change</b><br>
<b>	4)  	The length of time that the service retains a value for computing
delta checks.  This is recorded in number of days.</b><br>
<b>	More than one delta check rule can apply.
13&amp;16^10^%^100~16.1&amp;20^2^a^100 implies that the delta check will
trigger on a 10% change when the value of the observation is between 13 and 16.
The check will trigger on an absolute change of 2 when the value is between
16.1 and 20.  In both cases, the system will keep the last result for 100 days.
In this example, beyond 100 days, the computer will not compute a delta check
because it will not have a comparison value.</b></p>

<h4>
<A NAME="Heading133">7.6.5.11 Minimum Meaningful Increments (NM) 00635</A></h4>

<p><br>
<b>	Definition:  used for numerically valued single observations (a nature code
of A or C, as described in <i>OM1-19-nature of test/observation</i>) and
specifies the smallest meaningful difference between reported values (the
effective resolution of the measuring instrument or technique for continuous
data, or the smallest discrete interval that can occur for discrete
data).</b></p>
<h3>
</h3>

<h3>
<A NAME="Heading134">7.6.6  OM3 - Categorical Test/Observation Segment </A></h3>

<p><br>
<b>	This segment applies to free text and other non-numeric data types.</b><br>
<center><b>Figure 7B-3  OM3 attributes</b></center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b></b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
5<br>
60<br>
200<br>
200<br>
200<br>
2
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
ID<br>
CE<br>
CE<br>
CE<br>
CE<br>
ID
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p><br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00636<br>
00637<br>
00638<br>
00639<br>
00640<br>
00641
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequnce Number<br>
Preferred Coding System<br>
Valid Coded "Answers"<br>
Normal Text/Codes for Categorical Observations<br>
Abnormal Text/Codes for Categorical Observations<br>
Critical Text Codes for Categorical Observations<br>
Data Type
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.5.1.0	OM3 field definitions</b></p>

<h4>
<A NAME="Heading135">7.6.6.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
<b>	Definition:  the string OM3 - identifies a record as a categorical
test/observation segment.</b></p>

<h4>
<A NAME="Heading136">7.6.6.2 Sequence Number (NM) 00586</A></h4>

<p><br>
<b>	Definition:  the same value as the sequence number of the associated OM1
segment.</b></p>

<h4>
<A NAME="Heading137">7.6.6.3 Preferred Coding System (ID) 00636</A></h4>

<p><br>
<b>	Definition:  for observations whose categorical responses are taken from a
specified table of codes (e.g., CE data types), record the preferred coding
system for this observation (e.g., ICD9, SNOMED III).  Take the codes from ASTM
Table 3 or 5, or specify a local code.</b></p>

<h4>
<A NAME="Heading138">7.6.6.4 Valid Coded "Answers" (CE) 00637</A></h4>

<p><br>
<b>	Definition:  in the case that the list of coded answers is easily
enumerated, list the valid coded answers for this observation here using the
preferred coding system given in <i>OM3-3-preferred coding system</i>.  If for
example, the given observation was VDRL, the valid answers might be
non-reactive, 86^ intermediate, and 87^ reactive.</b></p>

<h4>
<A NAME="Heading139">7.6.6.5 Normal Text/Codes for Categorical Observations (CE) 00638</A></h4>

<p><br>
<b>	Definition:  certain observations/tests with a nature code of A or C (see
<i>OM1-19-nature of test/observation</i>) have text (alpha) results (e.g.,
reactive, nonreactive).  Alpha normals for those tests should be entered in
this field (e.g., "nonreactive").</b><br>
<b>	The format of this field is: </b><br>
<b>	The first component is a code taken from a standard code source list.  The
second component is the text associated with the code.  The third component is
the identification of the code table source.  When only a text description of a
possible answer is available, it is recorded as ^&lt;text&gt;.</b><br>
<b>	Care should be taken to transmit only those results that are considered
normal for that test.  A drug screen may have possible results of "negative"
and "positive."  However, only a result of "negative" is considered to be
normal.  When an observation has more than one "normal" result, multiple values
in this field should be separated with a repeat delimiter.</b></p>

<h4>
<A NAME="Heading140">7.6.6.6 Abnormal Text/Codes for Categorical Observations (CE) 00639</A></h4>

<p><br>
<b>	Definition:  a list of the text answers that are abnormal for the test.  </b></p>

<h4>
<A NAME="Heading141">7.6.6.7 Critical Abnormal Text/Codes for Categorical Observations (CE) 00640</A></h4>

<p><br>
<b>	Definition:  a list of coded results that are critically abnormal for this
observation.</b></p>

<h4>
<A NAME="Heading142">7.6.6.8 Data Type (ID) 00641</A></h4>

<p><br>
<b>	Definition:  the allowed data type for a single categorical observation
(code A or C in <i>OM1-19-nature of observation</i>).</b></p>
<h3>
</h3>

<h3>
<A NAME="Heading143">7.6.7  OM4 - Observations That Require Specimens </A></h3>

<p><br>
<center><b>Figure 7B-4  OM4 attributes</b></center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4<br>
5<br>
6<br>
7<br>
8<br>
9<br>
10<br>
11<br>
12<br>
13<br>
14<br>
15
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
60<br>
60<br>
20<br>
60<br>
60<br>
60<br>
10K<br>
10K<br>
20<br>
20<br>
10K<br>
60<br>
20
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
ID<br>
TX<br>
NM<br>
CE<br>
CE<br>
CE<br>
TX<br>
TX<br>
CQ<br>
CQ<br>
TX<br>
ID<br>
CQ
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p><br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><p><br>
0170<br>
0027
</p>
<BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00642<br>
00643<br>
00644<br>
00645<br>
00646<br>
00647<br>
00648<br>
00649<br>
00650<br>
00651<br>
00652<br>
00653<br>
00654
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequence Number<br>
Derived Specimen<br>
Container Description<br>
Container Volume<br>
Container Units<br>
Specimen<br>
Additive<br>
Preparation<br>
Special Handling Requirements<br>
Normal Collection Volume<br>
Minimum Collection Volume<br>
Specimen Requirements<br>
Specimen Priorities<br>
Specimen Retention Time
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.6.1.0	OM4 field definitions</b></p>

<h4>
<A NAME="Heading144">7.6.7.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
<b>	Definition:  this segment applies to observations/batteries that require a
specimen for their performance.  When an observation or battery requires
multiple specimens for their performance (e.g., creatinine clearance requires a
24-hour urine specimen and a serum specimen), multiple segments may be
included, one for each specimen type.</b></p>

<h4>
<A NAME="Heading145">7.6.7.2 Sequence Number (NM) 00586</A></h4>

<p><br>
<b>	Definition:  the same value as the sequence number of the associated OM1
segment.</b></p>

<h4>
<A NAME="Heading146">7.6.7.3 Derived Specimen (ID) 00642</A></h4>

<p><br>
<b>	Definition:  for some diagnostic studies -- especially in microbiology --
the initial specimen (e.g., blood) is processed to produce results (e.g., the
identity of the bacteria grown out of the culture).  The process also produces
new "specimens" (e.g., pure culture of staphylococcus, and E. Coli), and these
are studied by a second order process (bacterial sensitivities).  This field
contains codes that identify the parents (e.g., blood culture) and children
(e.g., penicillin MIC) in such cases. The codes are the following:</b><br>
<center>Table 0170 - Derived Specimen</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>P<br>
C<br>
N
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Parent
Observation<br>
Child Observation<br>
Not Applicable
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading147">7.6.7.4 Container Description (TX) 00643</A></h4>

<p><br>
	Definition:  the physical appearance, including color of tube tops, shape, and
material composition (e.g., red-top glass tube).  Note that the color is not
necessarily a unique identifier of the additive and/or use of the tube.  This
is especially true for black and some blue tube tops, as can be seen above.
Color is included here for user convenience.  </p>

<h4>
<A NAME="Heading148">7.6.7.5 Container Volume (NM) 00644</A></h4>

<p><br>
	Definition:  the capacity of the container.</p>

<h4>
<A NAME="Heading149">7.6.7.6 Container Units (CE) 00645</A></h4>

<p><br>
	Definition:  reports the units of measure of the container volume.  If the
units are ISO+ units, they should be recorded as single case abbreviations.  If
the units are ANS+ or L (local), the units and the source code table must be
recorded, except that in this case, component delimiters should be replaced by
subcomponent delimiters.  For example, 1 indicates liters, whereas
pt&amp;&amp;ANS+ indicates pints (ANSI units).  The default unit is milliliters
(ml), which should be assumed if no units are reported.</p>

<h4>
<A NAME="Heading150">7.6.7.7 Specimen (CE) 00646</A></h4>

<p><br>
	Definition:  the specimen should be reported as one of the specimen codes
described in ASTM Table 14 of 1238-91.  If multiple kinds of specimen are
associated with this observation (as in the case for a creatinine clearance),
separate them with repeat delimiters.</p>

<h4>
<A NAME="Heading151">7.6.7.8 Additive (CE) 00647</A></h4>

<p><br>
	Definition:  codes should be those provided by NCCLS<a name="fnB5"
href="#fn5">[6]</a>.  The following list is not exhaustive; it includes only
examples.<br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p>NAME</p>
<BR></TD>
<TD colspan=1 align="left"><p>
 NCCLS<br>
  Code	Color
</p>
<BR></TD>
<TD colspan=1 align="left"><p>DESCRIPTION</p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>(1)
Lithium Heparin -- anticoagulant<br>
(2)	Sodium Heparin -- anticoagulant<br>
(3)	Ethylenediaminetetraacetic acid;    dipotassium salt [EDTA(K<sub>2</sub>)]
<br>
(4)	Ethylenediaminetetraacetic acid; tripotassium salt [EDTA (K<sub>3</sub>)]
<br>
(5)	Ethylenediaminetetraacetic acid; disodium salt [EDTA (Na<sub>2</sub>)]
</p>
<BR></TD>
<TD colspan=1 align="left"><p>LIH
  	Green<br>
NAH    	Green<br>
K2E		Lavender<br>
K3E		Lavender<br>
N2E		Lavender
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Dry
powder.  10 to 30 USP units per mL of blood<br>
Dried solution.  10 to 30 U.S.P. units per mL of blood<br>
Dry powder. 1.5 to 2.2 mg per mL of blood<br>
Clear solution. 1.5 to 2.2 mg per mL of blood
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading152">7.6.7.9 Preparation (TX) 00648</A></h4>

<p><br>
	Definition:  the special processing that should be applied to the container,
e.g., add acidifying tablets before sending.</p>

<h4>
<A NAME="Heading153">7.6.7.10 Special Handling Requirements (TX) 00649</A></h4>

<p><br>
	Definition:  record special handling requirements here (e.g., ice specimen,
deliver within 2 hours of obtaining).</p>

<h4>
<A NAME="Heading154">7.6.7.11 Normal Collection Volume (CQ) 00650</A></h4>

<p><br>
	Definition:  record the normal specimen volume required by the lab.  This is
the amount used by the normal methods and provides enough specimens to repeat
the procedure at least once if needed.  The default unit is milliliters (ml).</p>

<h4>
<A NAME="Heading155">7.6.7.12 Minimum Collection Volume (CQ) 00651</A></h4>

<p><br>
	Definition:  the amount of specimen needed by the most specimen sparing method
(e.g., using micro techniques).  The minimum amount allows for only one
determination.  The default unit is milliliters (ml).</p>

<h4>
<A NAME="Heading156">7.6.7.13 Specimen Requirements (TX) 00652</A></h4>

<p><br>
	Definition:  other requirements for specimen delivery and special handling
(e.g., delivery within one hour, iced).</p>

<h4>
<A NAME="Heading157">7.6.7.14 Specimen Priorities (ID) 00653</A></h4>

<p><br>
	Definition:  the allowed priorities for obtaining the specimen.  Note that
they may be different from the processing priorities given in
<i>OM1-26-processing priority</i>.  When a test is requested, the specimen
priority given in <i>OBR-27-quantity/timing</i> should be one of the priorities
listed here.  Multiple priorities are separated by repeat delimiters.
Permitted specimen values are the following:<br>
<center>Table 00027 - Priority</center><br>
</p>
<TABLE BORDER><TR align="left">
<TD colspan=1 align="left"><p><b><u>Value</u></b></p>
<BR></TD>
<TD colspan=1 align="left"><p><b><u>Description</u></b></p>
<BR></TD></TR><TR align="left">
<TD colspan=1 align="left"><p>S<br>
A<br>
R<br>
P<br>
T
</p>
<BR></TD>
<TD colspan=1 align="left"><p>Stat
(do immediately)<br>
As soon as possible (a priority lower than stat)<br>
Routine<br>
Preoperative (to be done prior to surgery)<br>
Timing critical (do as near as possible to requested time)
</p>
<BR></TD></TR></TABLE><p></p>

<h4>
<A NAME="Heading158">7.6.7.15 Specimen Retention Time (CQ) 00654</A></h4>

<p><br>
	Definition:  record the usual time that a specimen for this observation is
retained after the observation is completed, for the purpose of additional
testing.  The first component is the duration, and the second component is an
ISO time unit.</p>
<h3>
</h3>

<h3>
<A NAME="Heading159">7.6.8  OM5 - Observation Batteries (Sets) </A></h3>

<p><br>
	This segment contains information about batteries and supersets (a nature code
of F, P or S, as described in <i>OM1-19-nature of test/observation</i>).<br>
<center>Figure 7B-5 - OM5 attributes</center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b></b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>1<br>
2<br>
3<br>
4
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
200<br>
200
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
CE<br>
ST
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p><br>
Y
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00655<br>
00656
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequence Number<br>
Test/Observations Included w/an Ordered Test Battery<br>
Observation ID Suffixes
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.7.1.0	OM5 field definitions</b></p>

<h4>
<A NAME="Heading160">7.6.8.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
	Definition:  the string OM5 - identifies a record as an observation battery
(set).</p>

<h4>
<A NAME="Heading161">7.6.8.2 Sequence Number (NM) 00586</A></h4>

<p><br>
	Definition:  the same value as the sequence number of the associated OM1
segment.</p>

<h4>
<A NAME="Heading162">7.6.8.3 Tests/Observations Included Within an Ordered Test Battery (CE) 00655</A></h4>

<p><br>
	Definition:  lists the codes and names of all tests/observations included
within a single battery (nature code P, as described in <i>OM1-19-nature of
test/observation</i>), a single functional procedure (nature code F), or a
given superset (nature code S).  When a segment includes a list of component
elements, the sending  system should be sure that the segments defining all of
the components are sent before the segment that reference them.  An entry in
this list can itself be a battery.<br>
	The individual test/observation IDs should be recorded as type CE, i.e., in
the standard format for coded observation identifiers.  Multiple observations
should be separated by repeat delimiters.<br>
	If the definition segment defined serum electrolytes, this field might look
like the following:<br>
		84132^potassium^AS4~<br>
		84295^sodium^AS4~<br>
		82435^chloride^AS4~<br>
		82374^HCO3^^AS4~<br>
	For S (superset) parameters, this field contains the batteries that are
included within the "super" battery.  For example, ROUTINES might be defined
as:<br>
		402^Electrolytes~352^Urinalysis~432^CBC~520^SMA12</p>

<h4>
<A NAME="Heading163">7.6.8.4 Observation ID Suffixes (ST) 00656</A></h4>

<p><br>
	Definition:  for tests or procedures that produce a type which uses
observation ID suffixes following the test/observation ID code, this field
lists the possible options.  The applicable three-character mnemonics given in
ASTM Table 20 (or others appropriate to the application) are listed, separated
by repeat delimiters.  For example, a chest x-ray may use the suffixes IMP,
REC, DEV, or others.  Each of the expected suffixes should be listed here.</p>
<h3>
</h3>

<h3>
<A NAME="Heading164">7.6.9  OM6 - Observations That Are Calculated from Other Observations </A></h3>

<p><br>
	This segment contains information about quantities that are derived from one
or more other quantities or direct observations by mathematical or logical
means.<br>
<center>Figure 7B-6  OM6 attributes</center><br>
</p>
<TABLE BORDER><TR align="center">
<TD colspan=1 align="center"><p><b></b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>SEQ</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>LEN</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>DT</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>R/O</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>RP/#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>TBL#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ITEM#</b></p>
<BR></TD>
<TD colspan=1 align="center"><p><b>ELEMENT
NAME
</b></p>
<BR></TD></TR><TR align="center">
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>1<br>
2<br>
3
</p>
<BR></TD>
<TD colspan=1 align="center"><p>3<br>
4<br>
10K
</p>
<BR></TD>
<TD colspan=1 align="center"><p>ST<br>
NM<br>
TX
</p>
<BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><BR></TD>
<TD colspan=1 align="center"><p>00585<br>
00586<br>
00657
</p>
<BR></TD>
<TD colspan=1 align="center"><p>Segment
Type ID<br>
Sequence Number<br>
Derivation Rule
</p>
<BR></TD></TR></TABLE><p><br>
<b>7.B.8.1.0	OM6 field definitions</b></p>

<h4>
<A NAME="Heading165">7.6.9.1 Segment Type ID (ST) 00585</A></h4>

<p><br>
	Definition:  the string OM6 - identifies a record as an observation that is
derived or calculated from one or more other observations.</p>

<h4>
<A NAME="Heading166">7.6.9.2 Sequence Number (NM) 00586</A></h4>

<p><br>
	Definition:  the same value as the sequence number of the associated OM1
segment.</p>

<h4>
<A NAME="Heading167">7.6.9.3 Derivation Rule (TX) 00657</A></h4>

<p><br>
	Definition:  in the case of patient variables that are derived from one or
more other patient variables (e.g., creatinine clearance, ideal weight, maximum
daily temperature, average glucose, framingham risk), this field contains the
rules for deriving the value of this variable (i.e., nature code C, as given in
<i>OM1-19-nature of test/observation</i>).  These can be described in terms of
humanly understandable formulas or descriptions.<br>
	When possible, however, they should be defined in terms of the Arden syntax
for specifying selection and transcendative functions and algebraic operations,
ASTM E1460-92.  Derivation rules that are represented in Arden syntax should
begin and end with an Arden slot delimiter (;;).  Within this syntax, variables
should be identified by <i>OM1-3-producer's test/observation ID</i>.  We
recommend the use of the Arden syntax because it permits the unambiguous
specification of most such derived values and is a published standard for
medical logic modules.<br>
 <br>
Message<br>
	ORU  7-14<br>
Narrative Reports  7-4<br>
OBR  7-16<br>
Observation Reporting  7-1<br>
OBX  7-17<br>
OM1  7-58<br>
OM2  7-68<br>
OM3  7-73<br>
OM4  7-74<br>
OM5  7-77<br>
OM6  7-78<br>
ORU  7-14<br>
Query<br>
	results observation  7-15<br>
Reporting Units  7-9<br>
Segments<br>
	OBR  7-16<br>
	OBX  7-17<br>
	OM1  7-58<br>
	OM2  7-68<br>
	OM3  7-73<br>
	OM4  7-74<br>
	OM5  7-77<br>
	OM6  7-78<br>
Test/Observation Master Segments  7-57<br>
Universal (AS4) Identifiers  7-35
</p>
<HR><a name="fn0" href="#fnB0">[&#160;]</a><p>&#160;&#160;&#160;<sup>1</sup>These
AS4 codes are taken directly from ASTM 1238-91, and are printed/adopted with
their permission.<a name="fn1"
href="#fnB1">[&#160;&#160;&#160;&#160;]</a><sup>2</sup>	The length of the
observation value field is variable, depending upon value type.  See
<i>OBX-2-value type</i>.<br>
<a name="fn2" href="#fnB2">[&#160;&#160;&#160;&#160;]</a><sup>3</sup>	The
content Appendix 7.A is taken directly from ASTM 1238 and is printed/adapted
with their permission.<br>
<a name="fn3" href="#fnB3">[&#160;&#160;&#160;&#160;]</a><sup>4</sup>	Contact:
Michael Huber, Health Outcomes Institute, 2001 Killebrew Dr., Suite 122,
Bloomington, MN 55425; <br>
	(612) 858 9188.<br>
<a name="fn4" href="#fnB4">[&#160;&#160;&#160;&#160;]</a><sup>5</sup> 	Contact
Georges DeMoor, M.D., State University Hospital Gent, De Pintelaan 185-5K3,
9000 Gent, Belgium. <br>
<a name="fn5" href="#fnB5">[&#160;&#160;&#160;&#160;]</a><sup>6</sup>	NCCLS
Document H1-A3: Evacuated tubes for blood specimen collection -- Third Edition,
Volume 11, Number 9,	Approved standard. July 1991.
</p>

</body></html>
